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The cerebral cortex is a highly complex, layered, grey matter structure which plays 
major roles in processes such as consciousness, memory, and perception. In 
humans, it is the cortex which bestows us with cognitive abilities unique to our 
species, in part due to the massive expansion of cortical progenitors during embryonic 
development. The mature cortex of mammals is composed of a highly heterogenous 
population of cells, however only the glutamatergic projection neurons are generated 
within the embryonic neocortex itself. These cells are formed from apical and basal 
cortical progenitors in the developing dorsal telencephalon, and in the mouse cortical 
neurogenesis begins at approximately embryonic day 10.5 (E10.5).  
Regulation of the differentiation of progenitors into neurons is a tightly regulated 
process, under the control of a strict interplay between signalling molecules and 
transcription factors. The zinc-finger transcription factor Gli3 plays established roles 
in regulating the development of the dorsal telencephalon. Through the evaluation of 
a number of mutants, Gli3 has been shown to function in patterning, the production 
and fate of cortical neurons, lamination, and axon tract formation, amongst other 
things. It is shown here that Gli3 is highly expressed in Pax6+ apical progenitors in the 
dorsal telencephalon, the largest population of progenitors between E11.5 and E12.5. 
The aim of this thesis was to evaluate how Gli3 regulates the proliferation and 
differentiation of cortical progenitors into neurons during these time points in the 
mouse. 
Embryos of the Gli3Xt/Pdn mutant, which exhibit a reduction in Gli3, were used. At 
E11.5, the proportions of apical, basal, and early-born cortical neurons were altered 
in the dorsal telencephalon of the mutant. Microarray analysis revealed an up-
regulation of Cdk6 in Gli3Xt/Pdn embryos compared to control. Cdk6 is required for the 
transition from G1-phase into S-phase during the cell cycle, and shortening of G1-
phase has been shown to correlate with progenitors self-renewing instead of 
differentiating. In agreement with the function of Cdk6, G1-phase and the length of 
the total cell cycle were shortened in the E11.5 Gli3Xt/Pdn mutant. At E12.5, the length 
of G1-phase and total cell cycle length were also shortened, and the proportion of 
apical and basal progenitors and early-born neurons were altered. It appears as 
though there is a delay in apical progenitor differentiation into basal progenitors and 
17 
 
neurons in the Gli3Xt/Pdn embryo, which correlates with the shortening of G1-phase 
observed. Interestingly, the length of S-phase was also decreased in the mutant at 
both E11.5 and E12.5, despite no obvious candidates indicative of S-phase regulation 
being identified in the microarray screen. Taken together, the evidence demonstrates 
that Gli3 plays a key role in regulating the differentiation of cortical progenitors at the 
correct time, likely in part due to regulation of the cell cycle, in order to regulate growth 
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Chapter 1: Introduction    
  
1.1 Early embryogenesis   
  
The mature mammalian nervous system can be subdivided into two main 
components: the central nervous system (CNS), comprising the brain and spinal cord, 
and the peripheral nervous system (PNS), comprising all nervous tissue outside of 
the CNS. The PNS receives information from within and without the body and 
transmits it to the CNS, which collates and processes that information. The CNS then 
determines an appropriate response, which it transmits back to the PNS to produce 
that response (Purves et al., 2008). Development of both the CNS and PNS occurs 
in the womb, and failure in this process can have major implications postnatally 
resulting in intellectual and physical disabilities. Therefore, study of embryonic 
nervous system development is vital.   
The focus of this thesis is development of the cerebral cortex, the most anterior part 
of the brain. The mature cerebral cortex is a six-layered structure comprised of 
glutamatergic projection neurons, GABAergic interneurons and glia (Molyneaux et al., 
2007) , and plays major roles in consciousness, memory, attention, language, and 
thought. Whilst the focus here will be development of the cortex in utero, it is important 
to remember that postnatal modifications including the production of new neurons and 
neuronal cell death will occur throughout an organism’s lifetime (Lindsey et al., 2018). 
Development of the cortex was studied using the mouse as a model.   
Following fertilisation of an egg by a sperm cell, a zygote is formed which will go on 
to form the embryo. The fertilised cell will divide within the zona pellucida, a 
membrane which surrounds the egg until implantation. The fertilised egg will undergo 
multiple rounds of division within the confines of the zona pellucida, during a process 
called cleavage, to form a morula (Maître, 2017). Following cleavage, the cells begin 
to cluster in the middle of the zona pellucida and the cells on the outside differentiate. 
The outer layer is comprised of cells known as trophoblasts, whilst the cells in the 
middle are known as embryoblasts. Between embryonic days 3.0-4.0 (E3.0-4.0) in 
the mouse the embryoblasts begin to cluster at one end of the morula, forming the 
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inner cell mass. This leaves a cavity at the other end called the blastocoel, creating a 
structure called the blastocyst. During this process, the zona pellucida degenerates, 
leaving the trophoblasts as the outer layer of cells and allowing implantation into the 
uterine wall to occur (Price et al., 2011; Yamanaka et al., 2006).   
At E5.0 in the mouse, the inner cell mass restructures to form the amniotic cavity in 
the middle, and the layer of embryoblasts bisecting the middle of the trophoblast outer 
layer differentiate to form hypoblasts and epiblasts. Collectively, the two layers of 
epiblasts and hypoblasts form the bilaminar disc (Morris et al., 2010). Following this, 
the process of gastrulation occurs at around E6.0. Cells along the centre of the 
epiblast layer begin to migrate forming a line known as the primitive streak, which is 
first recognisable at E6.5, through which they pass to form a layer of cells between 
the hypoblasts and epiblasts (Tam et al., 1993). A trilaminar disc has now formed 
composed of the three germ layers. The layer formed from epiblasts is now known as 
the ectoderm, the newly formed middle layer is the mesoderm and the layer formed 
from hypoblasts is the endoderm. The ectoderm will give rise to the surface ectoderm, 
which will develop into for example skin and hair, the neural crest, which will give rise 
to the PNS, and the neural tube, which will form the CNS (Favarolo & López, 2018).    
After gastrulation, neurulation begins at approximately E7.0. Underneath where the 
primitive streak was located, cells in the mesoderm begin to differentiate and form a 
chord-like structure known as the notochord, which expresses Sonic Hedgehog (Shh). 
Bone morphogenetic proteins (BMP) and Wingless-Type MMTV Integration Site 
Family Members (Wnt) inhibitors expressed in the node of the primitive streak prevent 
the ectoderm from taking on a surface ectoderm fate, instead inducing a 
neuroectodermal fate. The neuroectoderm thickens and flattens, forming the neural 
plate. The mediolateral, dorsoventral, and rostrocaudal/anteroposterior axes of the 
embryo are formed, with the notochord running down the midline at the ventral surface 
of the forming neural tube, and the notochord running along the anteroposterior axis. 
The midline of the neural plate anchors to the notochord whilst the lateral edges of 
the plate begin to fold dorsally. In the mouse, the lateral edges of the neural plate first 
fuse together at the hindbrain/cervical boundary. This fusion then runs both anteriorly 
and posteriorly, resulting in the neural tube. The anterior most end of the neural tube 
closes around E8.0-E8.5, where the forebrain and eventual cerebral cortex will form 
(Vermeren & Keynes, 2010, Colas & Schoenwolf, 2001) (figure 1.1).   
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The anterior end of the neural tube begins to bulge and can be subdivided into three 
primary brain vesicles anteroposteriorly; the prosencephalon (forebrain), 
mesencephalon (midbrain), and rhombencephalon (hindbrain). The posterior end of 
the neural tube will form the spinal cord. The primary brain vesicles will develop further 
into the secondary brain vesicles. The prosencephalon will subdivide to form the 
telencephalon, giving rise to the cerebrum, and the diencephalon, giving rise to the 
hypothalamus, thalamus, and optic vesicles. The mesencephalon will give rise to the 
midbrain. Finally, the rhombencephalon will subdivide into the metencephalon, giving 
rise to the cerebellum and pons, and the myelencephalon, giving rise to the medulla 
oblongata (Ishikawa et al., 2012; Kiecker & Lumsden, 2005) (figure 1.2). The focus of 






















Figure 1.1: Primary neurulation. A schematic showing the process of neural tube 
formation in a transverse section through the anteroposterior axis. Neural crest cells 
are shown in green, neuroectoderm and surface ectoderm are shown in blue, and the 
















Figure 1.2: Brain vesicles. A. Schematic showing the primary brain vesicles, 
prosencephalon in blue, mesencephalon in green, and rhombencephalon in red, with 
the spinal cord shown in yellow. B. Schematic showing the secondary brain vesicles, 
telencephalon and diencephalon in blue and light blue, mesencephalon in green, 
metencephalon and myelencephalon in red and pink, with the spinal cord in yellow. 








1.2 Telencephalic patterning   
  
The mechanisms by which the neural tube becomes regionalised into the brain 
vesicles, which then further differentiate into different brain regions, are complex. The 
homogenous population of neuroectodermal cells of the neural tube must somehow 
form the wide variety of cells which make up the mature brain. This is regulated by 
the interplay of both cell intrinsic and extrinsic factors, which are in part determined 
by the location of a cell and so which signalling molecules it is being exposed to, the 
duration that that cell is exposed to the signals it is receiving, and the competency of 
that cell to respond to those signals.   
The telencephalon can be divided into two parts, the dorsal telencephalon or pallium, 
which gives rise to the cerebral cortex, and the ventral telencephalon or subpallium, 
which gives rise to the basal ganglia. Throughout the dorsal and ventral 
telencephalon, there are a number of major signalling centres which secrete 
morphogens to assist in patterning the forebrain. Beginning in the ventral 
telencephalon, whilst the notochord does not extend so far rostrally into the 
telencephalon, a homologous tissue known as the prechordal plate exits in the ventral 
telencephalon which expresses Shh and noggin, a BMP inhibitor. The prechordal 
plate induces Shh expression in the ventral telencephalon, creating a high-ventral to 
low-dorsal Shh gradient. Conversely, the roof plate is formed where the two lateral 
edges of the neural plate fused, along the dorsal midline (Chizhikov & Millen, 2004). 
The non-neural/epidermal ectoderm which flanks the roof plate is a source of BMPs, 
which in turn induce expression of BMP4 in the roof plate, creating a high-dorsal to 
low-ventral expression pattern, complimentary to that of Shh. The roof plate is also a 
source of Wnts (Chizhikov & Millen, 2004). As forebrain development progresses, the 
cells of the roof plate begin to invaginate as the two cerebral hemispheres form. The 
roof plate specifies a new signalling centre in the midline of the cortical hemispheres 
ventral to the hippocampus primordium and dorsal to the choroid plexus (Grove et al., 
1998), the cortical hem (Gupta & Sen, 2016). The cortical hem is identifiable from 
E9.5 in the mouse and is defined by the expression of Wnt3a, Wnt5a, and Wnt2b 
(Grove et al., 1998) and a number of BMPs (Furuta et al., 1997). It is required for 
mediolateral dorsal telencephalon patterning. Rostrally, the anterior neural ridge 
(ANR) is a major source of Fibroblast Growth Factors (Fgfs), which regulate the 
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anteroposterior patterning of the dorsal telencephalon (Shimamura & Rubenstein, 
1997). Finally, located in the lateral telencephalon at the boundary between the dorsal 
and ventral telencephalons, also known as the pallial/subpallial boundary, is the 
antihem. This forms later, at approximately E12.5-E13.5 and expresses Fgf7, Fgf15, 
Sfrp2 (a secreted Wnt antagonist), and three members of the Epidermal Growth 
Family (EGF) Tgf, Neuregulin 1 and Neuregulin 3 (Borello et al., 2008; 
Assimacopoulos et al., 2003). At the moment, the function of the antihem in patterning 
remains unclear. (Figure 1.3).  
The secreted molecules produced by these signalling molecules each create a high-
to-low gradient of expression as distance from their source is increased, creating 
highly regulated spatial patterning across the developing telencephalon. Cells in 
discrete locations will be exposed to differing concentrations of morphogens, thereby 
allowing them to express specific transcription factors. These transcription factors are 
then able to regulate the progression of neuronal development, allowing the 
differentiation of progenitors to form the heterogeneous populations of cells which 















Figure 1.3: Signalling centres of the developing telencephalon. A schematic 
showing an E12.5 mouse telencephalon with the signalling centres depicted with the 
morphogens they secrete and the anteroposterior (A-P), dorsoventral (D-V) and 
mediolateral (M-L) axes. The cortical hem is shown in blue in the midline of the dorsal 
telencephalon where the neural tube invaginates to create the two cerebral 
hemispheres, from which BMPs and Wnts are secreted. The antihem (yellow) is 
located along the lateral edge of the telencephalon at the pallial/subpallial boundary, 
which secretes EGFs, Fgf7, Fgf15, and Sfrp2. The anterior neural ridge is shown in 
red at the rostral end of the dorsal telencephalon, from where Fgfs are secreted. 
Finally, the floor plate is shown in the ventral telencephalon in green from which Shh 








1.2.1 Shh   
Shh is a member of the Hedgehog family of signalling proteins, alongside Desert 
Hedgehog and Indian Hedgehog, and mediates signalling from the notochord, 
prechordal plate and floor plate. Expression of Shh is first detectable in the primitive 
streak during the late stages of gastrulation in the midline of the mesoderm. From 
here the notochord forms and continues to express Shh, which then diffuses into the 
overlying ectoderm promoting ventralisation of the neural plate. A subset of cells 
within the neural plate lying directly above the notochord will differentiate into the floor 
plate and begin to express Shh in what will become the ventral midline of the CNS 
(Echelard et al., 1993). By E9.5, the medial ganglionic eminences (MGEs) highly 
express Shh in the ventral telencephalon (Shimamura et al., 1995), creating its 
characteristic high-ventral to low-dorsal expression pattern.  
After excretion from a cell, Shh diffuses away from that cell and binds to its receptor 
Patched1 (Ptch1) on a target cell. This prevents Ptch1 from inhibiting Smoothened 
(Smo), which is then able to accumulate in the primary cilium and activate signalling 
through the Gli family of transcription factors. In the absence of Shh, Ptch1 inhibits 
Smo accumulation in the primary cilium, thereby allowing Gli3, and to a lesser extent 
Gli2, transcription factors to undergo processing into transcriptional repressors 
(Goodrich et al., 1996).  
In the forebrain, Shh is most well known for its role in patterning of the ventral 
telencephalon, where high levels of Shh signalling regulate expression of the 
transcription factors Nkx2.1 and Gsx2 (Fuccillo et al., 2004; Corbin et al., 2003). 
Nkx2.1 is required for the correct specification of the MGE (Sussel et al., 1999), which 
during early neurogenesis is the primary source of cortical interneurons which will 
migrate tangentially into the cortex (Gelman & Marín, 2010; Marín & Rubenstein, 
2001). Gsx2 is however required for the correct specification of the lateral ganglionic 
eminence (LGE) (Hsieh-Li et al., 1995). In the mature brain, the MGE will have given 
rise to the globus pallidus, whilst the LGE will have given rise to the striatum. Differing 
temporal exposure to Shh and competence to respond to it allows for the MGE and 
LGE to generate an array of ventral cell types (Kohtz et al., 1998). Rash & Grove, 
(2007) reported that in the Shh null mutant mouse Shh-/-, cortical primordium 
developed in both the dorsal and ventral telencephalon, resulting in the ventral 
telencephalon differentiating into cortical layers. Again, this highlighted that Shh is 
required in the ventral differentiation programme in the ventral telencephalon. 
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However, Shh also contributes to the development of the dorsal telencephalon. In the 
developing cortex, Komada et al., (2008) detected Shh protein in apical and basal 
progenitors and neurons at E13.5 and E15.5 in the mouse. In the Shh-/- mutant Rash 
& Grove (2007) revealed that contrary to previous reports (Chiang et al., 1996) the 
dorsal telencephalon divided into two cerebral hemispheres, apart from in the rostral-
most telencephalon, and that the forebrain of these mutants was smaller than their 
wild-type littermates. When Shh signalling was knocked out specifically in the dorsal 
telencephalon through the use of Emx1Cre conditional mutants, cortical progenitor 
proliferation was reduced and the formation of the cortical layers was impaired 
(Komada et al., 2008). Furthermore, conditional deletion of Smo thereby blocking Shh 
signalling in cortical progenitors resulted in abnormally small brains with defective 
cortical layering (Wang et al., 2016).  
Conversely, ectopic activation of Shh signalling in the cortex by inactivating Ptch1 
using NestinCre led to an increase in cortical progenitor proliferation, likely through 
the Notch signalling pathway, which also led to alterations in cortical layering (Dave 
et al., 2011). In utero electroporation of a Shh expression vector into E12.5 dorsal 
telencephalon resulted in a larger and thicker cortex at E18.5 (Komada et al., 2008). 
Finally, conditional activation of Shh signalling in GFAP::Cre cortical progenitors 
through constitutive Smo expression expanded cortical progenitor populations, 
resulting in a larger cortex and leading to cortical folding (Wang et al., 2016).  
Taken together, Shh plays a role in the correct development of the dorsal 
telencephalon into the cerebral cortex. It acts to promote the proliferation of cortical 
progenitors, as evidenced by the reduction in cortex size when Shh is reduced and 
the increase in cortex size when Shh is ectopically activated.   
  
1.2.2 BMPs   
BMPs constitute a large family of growth factors belonging to the Transforming Growth 
Factor beta (TGF) superfamily (Gámez et al., 2013). Early in development, BMPs 
are expressed in the lateral edges of the neural plate which will fuse to form the neural 
tube. However, BMP inhibition is required to specify neuroectodermal tissue from 
ectodermal tissue, which is accomplished by the BMP4 antagonists noggin and 
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chordin. BMP4 expression instructs ectoderm cells to develop into non-neural 
ectoderm cells which will form the skin, but noggin and chordin expression in the node 
inhibit BMP4 and allow the overlying ectoderm to develop into neural tissue. As 
development continues, the rostral-most region of the dorsal neural tube invaginates 
to form the cerebral hemispheres, and the cortical hem becomes specified in the 
dorsomedial telencephalon, which expresses BMP2, 4, 5, 6 and 7 (Furuta et al., 
1997).  
BMPs are secreted before diffusing to target cells where they bind to cell surface BMP 
receptors (BMPRs). This binding results in the activation of the Smad family of 
proteins, which are then able to either active or repress transcription (Derynck & 
Zhang, 2003). Saxena et al. (2018) reported the presence of phosphorylated 
Smad1/5/8 in the ventricular zone (VZ) of the E11.5 cortex, where cortical progenitors 
reside, as well as in early-born neurons, indicating active BMP signalling.   
Due to the expression of BMPs in the midline of the dorsal telencephalon, they have 
been implicated in mediolateral patterning of the dorsal telencephalon. Upon 
conditional inactivation of the BMPR Bmpr1a in the telencephalon the choroid plexus, 
which produces cerebrospinal fluid to fill the ventricles, failed to form. Choroid plexus 
precursors however did not change their fate to become lateral telencephalic cells 
and instead remained proliferative, indicating a more localised role for BMP signalling 
(Hébert et al., 2002). Additionally, Bmpr1a and Bmpr1b inactivation in the forebrain 
specifically led to a loss of dorsal midline cell types leading to holoprosencephaly, a 
failure of the two cerebral hemispheres to separate (Fernandes et al., 2007).   
In explant culture, ectopic application of beads soaked in BMP4 and BMP2 to the 
lateral telencephalon induced dorsomedial cell fate. Furthermore in the dorsomedial 
telencephalon in the cortical hem, where BMPs are most highly expressed, the 
neuroectoderm experienced limited growth, alongside a reduction in cell proliferation 
and increased cell death (Furuta et al., 1997). When Bmpr1a is activated proliferation 
of dorsal progenitors is induced. Bmpr1a activation also leads to Bmpr1b expression, 
which induces progenitor mitotic arrest resulting in apoptosis. BMP activation also 
resulted in the cortical primordium being re-specified into choroid plexus (Panchision 
et al., 2001).   
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Overall, during early neurogenesis in the dorsal telencephalon BMP signalling 
promotes neuronal differentiation and inhibits progenitor proliferation.   
 
1.2.3 Wnts   
Wnts constitute a large protein ligand family which are first expressed in the primitive 
streak, yet for the correct specification of neural ectoderm rostrally the head 
mesoderm expresses Wnt antagonists (Litsiou et al., 2005). Wnt expression 
continues in the roof plate, and as development continues in the dorsal telencephalon 
Wnt2b, 3a, 5a, 7b and 8b expression is found in the cortical hem, with different Wnts 
ranging in expression from E9.5 to E13.5 (Grove et al., 1998).  
Wnts can act as morphogens through secretion by a cell followed by binding to 
Frizzled/LRP cell surface receptors on a target cell, where the signal is passed 
intracellularly to Dishevelled. Wnt signalling can then be transduced by three different 
pathways; canonical Wnt/-catenin, noncanonical planar cell polarity (PCP), and 
noncanonical Wnt/Ca2+. The canonical Wnt/-catenin pathway regulates transcription 
of Tcf/LEF target genes.  The noncanonical PCP pathway regulates the cell’s 
cytoskeleton and the noncanonical Wnt/Ca2+ pathway regulates intracellular Ca2+, 
although the noncanonical pathways can also antagonise the canonical pathway. 
Canonical Wnts include Wnt1, Wnt3a and Wnt8, whereas noncanonical Wnts include 
Wnt4, Wnt5a and Wnt11 (Kawano & Kypta, 2003; Kühl et al., 2000).   
The roles of Wnt signalling in the dorsal telencephalon are pleiotropic, although they 
are particularly important in hippocampus development. When Wnt3a was knocked 
out in mice, cortical progenitor cells appeared to be normally specified, but their 
proliferation was severely impaired, leading to almost complete loss of the 
hippocampus (Lee et al., 2000). A similar hippocampal defect was also observed 
when LEF1, a transcriptional mediator of the canonical Wnt/-catenin pathway, was 
mutated, due to defects in hippocampal field patterning and proliferation (Galceran et 
al., 2000). Furthermore, when the Wnt surface receptor LRP6 was mutated, there was 
reduced production of dentate granule neurons of the hippocampus due to a decrease 
in the number of dentate granule progenitors (Zhou et al., 2004). In the developing 
cortex, Woodhead et al. (2006) achieved loss of -catenin in a subset of cortical 
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progenitors by electroporation of a Cre recombinase expression plasmid into the 
cortex of -cateninflox/flox embryos. This resulted in cortical progenitor cell cycle exit 
and differentiation into neurons.  
On the other hand, when stabilised -catenin was expressed in neural progenitors of 
mice there was an expansion of the progenitor population due to increased progenitor 
proliferation instead of differentiation and increased cell cycle re-entry after mitosis. 
This led to enlarged brains due to an increase in the surface area of the cortex 
(Woodhead et al., 2006; Chenn & Walsh, 2002). When Wnt3a was ectopically 
expressed in the developing cortex thereby up-regulating Wnt/-catenin signalling, 
there was an expansion of cortical progenitors leading to large neuronal heterotopias 
(Munji et al., 2011).   
Collectively, Wnt signalling in the early cortex promotes the proliferation of progenitors 
at the expense of progenitor differentiation, a role opposite to that of BMPs but 
reflecting that of Shh.   
  
1.2.4 Fgfs  
The Fgf family of proteins contains 22 members in humans and mice that can be 
subdivided into seven subfamilies (Itoh & Ornitz, 2004). Fgf signalling first plays roles 
from very early on in development, regulating the differentiation of the inner cell mass 
into epiblasts and primitive endoderm (Krawchuk et al., 2013). Later in development, 
the ANR is a major source of Fgfs in the telencephalon, located at the rostromedial 
pole of the telencephalon. Fgf8, Fgf15, Fgf17 and Fgf18 are all expressed here from 
as early as E8.5 and are able to impart anteroposterior information to the developing 
cortex (Borello et al., 2008; Crossley et al., 2001; Fukuchi-Shimogori & Grove, 2001, 
2003). Fgf15 is also expressed in the antihem and shows wide expression in the 
ventral telencephalon, whilst another Fgf, Fgf2, is expressed by cortical progenitors 
themselves (Hasenpusch-Theil et al., 2017; Borello et al., 2008; Vaccarino et al., 
1999).  
There are 18 Fgfs which are secreted and able to interact with the four Fgf receptors 
(Fgfrs), whilst the remaining four members of the Fgf family are intracellular non-
signalling proteins. When a secreted Fgf binds to an Fgfr, specific cytoplasmic 
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tyrosine residues of the receptor are phosphorylated, which triggers the activation of 
cytoplasmic STAT, PI3K-AKT, RAS-MAPK and PLC signalling pathways (Ornitz & 
Itoh, 2015).  
As with many of the signalling molecules mentioned here, Fgfs play many roles in 
dorsal telencephalon development. When Fgfr3c, a receptor which sequesters Fgf 
proteins thereby by inhibiting their diffusion, was overexpressed close to the anterior 
Fgf8 source it resulted in a shifting of the anteroposterior boundary anteriorly, 
although there was no difference in hemisphere size (Fukuchi-Shimogori & Grove, 
2001). Further, in an Fgf8 hypomorphic mouse mutant the anteroposterior boundary 
also shifts anteriorly, resulting in an expansion of caudal cortical domains at the 
expense of rostral domains. This was in part due to a change in the molecular identity 
of rostral cortical progenitors (Garel et al., 2003). When the function of all Fgfrs was 
lost, cortical progenitors underwent accelerated differentiation and exit from the cell 
cycle, resulting in a depleted progenitor pool and reduction in cortical surface area as 
early as E11.5 (Rash et al., 2011). In contrast, when Fgf8 was overexpressed by in 
utero electroporation at E11.5 the anteroposterior boundary shifted posteriorly and 
the rostral cortex was expanded whilst the caudal cortex was reduced (Fukuchi-
Shimogori & Grove, 2001).   
When taken together, it would appear the primary function of Fgfs in the dorsal 
telencephalon is to promote cortical progenitor proliferation, and also to establish and 
maintain cortical anteroposterior identity. However, the role of Fgf signalling in the 
dorsal telencephalon is not so straight forward. Through the use of Fgf15-/- mutant 
mice, Borello et al. (2008) showed that Fgf15 actually suppresses proliferation and 
promotes neural differentiation, resulting in a caudoventral fate in the rostral 
telencephalon.   
  
1.2.5 Transcription factors  
Expression of the signalling molecules described above will influence progenitor cells 
in the developing dorsal telencephalon in different ways, based on the precise 
concentration and duration of morphogen exposure and the interactions of those 
morphogens. Upon binding of a morphogen to a progenitor which is competent to 
respond to it, intracellular signalling cascades are activated and influence 
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transcription factors. These transcription factors are then able to influence a 
progenitor’s activity and ultimately fate. As with signalling molecules, transcription 
factor expression is often in a gradient. Some of the transcription factors involved in 
dorsal telencephalon development and expressed in the early cortical primordium 
include Emx1, Emx2, Pax6, COUP-TF1, Foxg1 and Gli3 ( Yip et al., 2012; Sansom et 
al., 2009; Theil et al., 2002; Zhou  et al., 2001; Bishop et al., 2000; Mallamaci et al., 
2000).  
Emx2 and Pax6 display opposing gradients in the dorsal telencephalon, with Emx2 
displaying a high caudo-medial to low rostro-lateral gradient, whilst Pax6 displays a 
high rostro-lateral to low caudo-medial gradient. These transcription factors are both 
involved in cortical regionalisation but in contrasting ways. In Emx2 null mutants the 
rostral telencephalon was expanded at the expense of the caudal telencephalon, yet 
in the Pax6 null mutant the caudal telencephalon was expanded at the expense of the 
rostral telencephalon, indicating shifts in the anteroposterior and mediolateral axes 
(Bishop et al., 2000; Mallamaci et al., 2000). This highlighted that during normal 
cortical development, an antagonism between Emx2 and Pax6 is required for the 
correct regionalisation of the cortex.  
In Emx2 null mutants, Shimogori et al. (2004) reported there was an increase in Fgf8 
expression, whilst Wnt expression was reduced. As the BMP inhibitor noggin can 
induce Fgf8 expression, BMP signalling in Emx2-/- mutants was also investigated, and 
noggin expression was found to be increased and BMP activity decreased, which may 
have contributed to the Fgf8 up-regulation. Fgfs are also able to suppress Emx2 
expression (Fukuchi-Shimogori & Grove, 2003). Furthermore, Theil et al. (2002) 
identified Tcf and Smad binding sites in an Emx2 enhancer, allowing for regulation of 
Emx2 by the Wnt and BMP pathways, respectively, showing further the complexities 
of the interactions between multiple signalling molecules and just one transcription 
factor.   
In addition to its role in cortical region fate, Pax6 is able to positively regulate genes 
which influence both progenitor self-renewal and neurogenesis. These opposing 
influences on progenitors are likely mediated through its interactions with other 
transcription factors, for example Neurog2 and Hes1, and linked to the relative level 
of Pax6 and other transcription factors. A loss of Pax6 causes a decrease in cortical 
progenitor self-renewal leading to early cell cycle exit which depletes the progenitor 
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pool, alongside a loss of cortical Ngn2 and down-regulation of Tbr2 expression 
(Sansom et al., 2009; Holm et al., 2007; Quinn et al., 2007; Scardigli et al., 2003; 
Estivill-Torrus et al., 2002). The effect of Pax6 loss varies in progenitors based upon 
their wild-type expression levels, so that in regions which would normally express high 
levels of Pax6 the loss of Pax6 has a larger influence on their proliferation as opposed 
to progenitors which would normally express low Pax6 levels (Mi et al., 2013). On the 
other hand, an increase in the level of Pax6 leads to increased cortical neurogenesis 
by also increasing cell cycle exit, whilst cortical Ngn2 and Tbr2 expression are 
increased (Sansom et al., 2009; Quinn et al., 2007; Scardigli et al., 2003; Estivill-
Torrus et al., 2002). 
Another transcription factor involved in the regionalisation of the developing cortex is 
the orphan nuclear receptor COUP-TF1. It is expressed in the cortex in a high caudo-
lateral to low rostro-medial gradient, and Zhou et al. (2001) reported that in COUP-
TF1 null mice there was disruption in region specific and cortical layer specific gene 
expression.  
Foxg1 expression begins very early in the neural plate at E8.5, but by E9.5 after neural 
tube closure has occurred, it is expressed throughout most of the telencephalon 
(Kumamoto et al., 2013). Foxg1 null mutants display a loss of ventral telencephalic 
structures and also display smaller cerebral hemispheres, likely due to reduced 
progenitor proliferation and increased differentiation (Martynoga et al., 2005; Xuan et 
al., 1995). There was also a reduction in Fgf8 signalling in Foxg1 mutants, whilst 
BMP2, 4, 6, and 7 expression domains were expanded (Martynoga et al., 2005; 
Hanashima et al., 2004; Dou et al., 1999). Finally, Danesin et al. (2009) reported that 
Foxg1 can coordinate the activity of the roof and floor plate, as it is a downstream 
effector of the Shh signalling pathway which inhibits the Wnt/-catenin pathway.   
Overall, there are many transcription factors that play key roles in dorsal 
telencephalon development, and it is important not to consider these in isolation. 
Complex neural networks exist highlighting the high level of interactions between 
transcription factors and signalling molecules in defined spatial and temporal settings, 
acting together for the correct formation of the cortex.  
Gli3 is another transcription factor which is extremely important in dorsal 
telencephalon development and will be the focus of this thesis.  
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1.3 The Gli3 transcription factor   
  
Gli3 encodes a transcription factor of the Gli family, of which there are three members, 
Gli1, Gli2, and Gli3. All members of the family contain a conserved DNA binding 
domain consisting of five zinc fingers (Hui et al., 1994), which was confirmed through 
crystallographic studies (Pavletich & Pabo, 1993). The Gli proteins share a similar 
zinc-finger domain with the Drosophila segment polarity gene cubitus interruptus (ci) 
(Orenic et al., 1990), and with the sex-determining gene tra-1 of C. elegans (Zarkower 
& Hodgkin, 1992). In the dorsal telencephalon, Gli3R is able to act as a major hub 
connecting Wnt, BMP and Fgf expression (Hasenpusch-Theil et al., 2015). 
In the developing mouse spinal cord and brain, Gli3 mRNA expression can first be 
detected at around E8.5 and continues until around E16.5 in a high-dorsal to low-
ventral pattern, complimentary to that of Shh (Hui et al., 1994) (figure 1.4). In 
particular, in the developing dorsal telencephalon expression of Gli3 mRNA was noted 
in the cortex and cortical hem (Grove et al., 1998) in the VZ, where mitotically active 
cortical progenitors reside (Amaniti et al., 2013; Hui et al., 1994). Gli3 protein has also 
been described to be expressed in the VZ as well as the subventricular zone (SVZ), 
where different subtypes of cortical progenitors reside, at E16.5 (Yabut et al., 2016). 
Yabut et al. (2016) reported Gli3 expression in both the nucleus and cytoplasm.   
Gli3 can function as either a full-length transcriptional activator or a truncated N-
terminal fragment transcriptional repressor. In the dorsal telencephalon where Shh 
levels are low, the full length Gli3 activator protein can be processed into a repressor 
form. In the absence of Shh, it is thought that at the base of the primary cilium full-
length Gli3 is phosphorylated by PKA, GSK3 and CKI, allowing for ubiquitination and 
processing of the protein into the truncated repressor form, which then likely 
translocates to the nucleus (Kawano et al., 2017; Wen et al., 2010). The full length 
Gli3 protein only acts as a weak activator, and when Shh signalling is active 
undergoes rapid proteosomal degradation.  
Mice exhibiting mutations in Gli3 have played key roles in determining the functions 
of Gli3 in vivo.  The homozygous mutant Gli3XtH/XtH was first described by Johnson, 




Figure 1.4: Gli3 and Shh expression in the developing dorsal and ventral 
telencephalon. Schematics showing the complimentary expression patterns of Gli3 
and Shh at E10 (left) and E12 (right). Gli3 shows a high-dorsal to low-ventral pattern 
and Shh shows a low-dorsal to high-ventral pattern. LGE; lateral ganglionic eminence, 
MGE; medial ganglionic eminence. (Rallu et al., 2002).  
 
 
exhibits deletion of the 5’ end of Gli3. Gli3XtJ/XtJ embryos are also null mutants exhibiting 
an identical phenotype but due to a deletion of all sequences 3’ of the second zinc-
finger domain (Büscher et al., 1998; Hui & Joyner, 1993). There are severe defects in 
the dorsal telencephalon of these mutants, including a decrease in the size of the 
neocortex and loss of the hippocampus and choroid plexus due to disruption to the 
cortical hem. Cells with ventral telencephalic identity were located in the dorsal 
telencephalon, cortical layering was disrupted, and BMP, Wnt and Fgf expression 
were altered (Fotaki et al., 2006; Theil, 2005; Tole et al., 2000; Theil et al., 1999  figure 
1.5 D). Shh and Gli3 null mutants exhibit opposing effects on telencephalon 
development, yet in Shh/Gli3 double mutants the dorsalisation of the Shh mutant 
ventral telencephalon was not rescued completely whilst Gli3 patterning defects like 
loss of the hippocampus (Rallu et al., 2002) and ectopic Fgf8 and Fgf15 expression 
alongside loss of dorsal telencephalic Emx1 expression were also not rescued (Rash 
& Grove, 2007). This indicated the involvement of other factors, with Fgfs being a 
viable candidate, as in the Shh-/- mutant the expression of multiple Fgfs is reduced, 
yet when Gli3 is also reduced or abolished Fgf expression is partially restored (Rash 
& Grove, 2007).  Indeed, Kuschel et al. (2003) previously provided the first evidence 
that Fgf signalling might be a candidate by showing that Fgf8 ectopic application in 
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wild-type embryos resulted in repression of dorsal telencephalic gene expression in 
the dorsal telencephalon and induction of ventral telencephalic genes. Furthermore, 
Hasenpusch-Theil et al. (2015) reported a functional Ets binding site in an enhancer 
of Wnt8b, indicating Fgf signalling is required for Wnt8b expression in the cortical 
hem. Conversely, Fgf17 expression is repressed by Wnt/-catenin signalling in the 
dorsomedial telencephalon (Hasenpusch-Theil et al., 2017). In turn, Gli3 expression 
is regulated cooperatively by the action of Fgf and Wnt/-catenin signalling.   
The hypomorphic Polydactyly Nagoya (Gli3Pdn/Pdn) (Hayasaka et al., 1980) mouse has 
also given great insight into the endogenous functions of Gli3. The integration of a 
retrotransposon into intron 3 of Gli3, upstream of the zinc-finger domain, leads to 
alternative splicing resulting in three different transcripts being produced. The first 
transcript is formed due to an out-of-frame insertion resulting in a truncated protein 
which is regarded as non-functional due to the loss of the zinc-finger domain. The 
second transcript results from an in-frame insertion causing the addition of 
approximately 60 extra amino acids, the consequences of which remain unclear. In 
the final situation, where there is no alternative splicing, wild-type Gli3 protein is 
produced thereby leaving cells with a reduced level of functional Gli3 (Kuschel et al., 
2003; Naruse et al., 2000; Thien & Rüther, 1999). The amount of functional Gli3 
protein in Gli3Pdn/Pdn embryos is reduced by approximately three-fold at E12.5 (Magnani 
et al., 2010). These mutants also display alterations in Fgf, BMP and Wnt signalling 
(figure 1.5 B), resulting in ventralisation of the dorsal telencephalon and defects in 
midline formation though in milder form (Kuschel et al., 2003).   
Gli3Xt/Pdn embryos generated by intercrossing Gli3Xt/+ and Gli3Pdn/+ mice display Gli3 
expression levels intermittent to Gli3Xt/Xt and Gli3Pdn/Pdn embryos (Magnani et al., 2013), 
and whilst the disruption to dorsal telencephalon development is not as severe as in 
the Gli3Xt/Xt mutant, it is more severe than in the Gli3Pdn/Pdn embryo. Kuschel et al. (2003) 
described ventralisation of the dorsal telencephalon in Gli3Xt/Pdn embryos, due to 
ectopic activation of Fgf8 expression, as well as abolishment of Wnt2b, Wnt3a and 
Bmp4 expression in the cortical hem (figure 1.5 C). Emx1 expression was abolished 
by E10.5, with a reduction in Emx2, followed by a loss of the distinct high-lateral to 
low-medial Pax6 gradient by E12.5. This coincides with an up-regulation of the ventral 
telencephalon markers Dlx2 and Mash1 in a characteristic inverted “V” shape along 





Figure 1.5: Disruption to the signalling centres of the Gli3Pdn/Pdn, Gli3Xt/Pdn and 
Gli3Xt/Xt developing telencephalon. A. Schematic showing an E11.5 wild-type (Wt) 
mouse telencephalon with the signalling centres depicted with the morphogens they 
secrete. B. Schematic showing an E11.5 Gli3Pdn/Pdn telencephalon with reduced 
Wnt/BMP expression and increased Shh expression. C. Schematic showing an E11.5 
Gli3Xt/Pdn telencephalon with reduced BMP and abolished Wnt signalling, alongside an 
increased Fgf8 expression domain and increased Shh expression. D. Schematic 
showing an E11.5 Gli3Xt/Xt telencephalon with abolished Wnt/BMP expression, an 
increased Fgf8 expression domain and increased Shh expression. These schematics 
have been simplified for comparison between the changes in signalling, and do not 
show the differences in brain morphology due to the mutations. Modified schematic 
from Thomas Theil.  
 
 
differentiation programme being at least partially adopted by some dorsal progenitors 
in the rostral most telencephalon. This was shown to be independent of Shh signalling 
and instead due to ectopic Fgf activity combined with reduced BMP/Wnt signalling 
(Kuschel et al., 2003).   
Following the disruption in patterning of the dorsal telencephalon, Friedrichs et al. 
(2008) provided evidence of disruption to lamination of the Gli3Xt/Pdn dorsal 
telencephalon. The secreted protein reelin is required for lamination of the cortex 
(Goffinet, 1979), and a major source of reelin+ Cajal-Retzius (CR) cells is the cortical 
hem, which is abolished in Gli3Xt/Pdn embryos. However, other sources of CR cells are 
the Dbx1+ progenitor pools in the septum and ventral pallium (Bielle et al., 2005), and 
these pools are expanded in Gli3Xt/Pdn embryos. However, these expanded populations 
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are not sufficient to allow for lamination to proceed undisturbed. Furthermore, the 
reelin+ cells present in the Gli3Xt/Pdn dorsal telencephalon form clusters, disrupting the 
radial glia scaffold along which newly differentiated cortical neurons migrate.   
Further defects in the dorsal telencephalon of Gli3Xt/Pdn embryos were described by 
Magnani et al. (2013). Here, it was shown that Gli3Xt/Pdn embryos largely lack subplate 
neurons, an early-born neuronal population formed primarily from cortical progenitors 
(Price et al., 1997), which pioneer the projection of corticofugal axons and the corpus 
callosum (Jacobs et al., 2007; De Carlos & O’Leary, 1992; McConnell et al., 1989). In 
the rostral and intermediate cortex of Gli3Xt/Pdn embryos, cortical projection neurons do 
not express Neurofilament, a pan-axonal marker. Although these neurons are able to 
form axons, the axons are stunted and form fasciculated bundles. By transplanting 
Gli3Xt/Pdn tissue into slices of control tissue, and vice versa, Magnani et al. (2013) 
demonstrated that it is the environment through which the axons grow that result in 
defects in axon outgrowth and pathfinding, as axon outgrowth was possible when 
mutant tissue was transplanted into control, yet axons of control tissue were unable 
to grow in the mutant environment.  
Defects in cortical neurogenesis have been identified in the Gli3Xt/Xt and Gli3Xt/Pdn 
embryos. In Gli3Xt/Xt embryos, there was a delay in neurogenesis at E11.5 as identified 
by a reduction in Tbr1 expression, yet it appeared to be unaffected at E12.5 (Theil, 
2005). In Gli3Xt/Pdn embryos, there was a near complete loss of subplate neurons 
(Magnani et al., 2013). However, in Gli3Pdn/Pdn embryos neurogenesis was unaffected 
(Magnani et al., 2010). Altogether, it would appear early neurogenesis is affected 
dependent upon the level of Gli3 expression in the cortex.  
Taken together, it is clear that Gli3 is required in cortical progenitors for the correct 
development of the dorsal telencephalon. Figure 1.5 summarises how the cortical 
hem, anterior neural ridge and floor plate are altered in the Gli3Pdn/Pdn, Gli3Xt/Pdn and 






1.4 Cortical neurogenesis   
  
The complex interplay between signalling molecules and transcription factors allow 
for the development of the cortex by cortical progenitors, via the process of cortical 
neurogenesis.  The mature mammalian cortex is comprised of a heterogenous 
populations of cells, including neurons and glia. The neuronal population can be 
broadly split into two subtypes of cells; glutamatergic projection neurons and 
GABAergic inhibitory neurons. Whilst GABAergic neurons are generated in the ventral 
telencephalon and migrate into the dorsal telencephalon through tangential migration 
(Sultan & Shi, 2018), the glutamatergic projection neurons are generated in the dorsal 
telencephalon from cortical progenitors (Paridaen & Huttner, 2014). In order for the 
mature cortex to form the appropriate number of neurons and hence the correct size, 
these progenitors must divide at the correct time in the correct way.   
In the mouse, cortical neurogenesis begins after neural tube closure at approximately 
E10. Until then, neuroepithelial stem cells (NeSCs), which line the edge of the 
ventricle, undergo symmetric, self-renewing division to form two NeSCs. When 
neurogenesis begins, they begin to transform into radial glia cells (RGCs) which will 
undergo asymmetric division to produce one RGC and one neuron (Haubensak et al., 
2004; Noctor et al., 2004). RGCs extend a process radially to span the ventricular to 
pial surface, which will aid in the migration of neurons to their final position 
(Haubensak et al., 2004). RGCs are the predominant cortical progenitor subtype early 
in neurogenesis but will go on to produce a number of other cortical progenitors, which 
can largely be subdivided into two major categories; apical progenitors and basal 
progenitors. Apical progenitors, which includes RGCs, reside in the VZ closest to the 
ventricular surface. These progenitors express the transcription factor Pax6 and are 
able to undergo three modes of division: symmetrical division forming two apical 
progenitors, symmetrical division forming two basal progenitors, or asymmetrical 
division forming one apical progenitor and either one neuron (direct neurogenesis) or 
one basal progenitor (indirect neurogenesis) (Englund et al., 2005; Miyata et al., 2001; 
Götz et al., 1998). From approximately E11.5, basal progenitors are present and can 
be characterised by their expression of the transcription factor Tbr2. Whilst these 
progenitors are formed in the VZ from apical progenitors, they migrate radially to form 
another proliferative compartment dorsally to the VZ, known as the SVZ. By 
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approximately E14.5, basal progenitors overtake apical progenitors to become the 
predominant cortical progenitor subtype. Basal progenitors are more committed and 
are only able to undergo two modes of division: a small number of symmetrical 
divisions forming two basal progenitors, or more often, symmetrical division forming 
two neurons (Englund et al., 2005; Noctor et al., 2004) (figure 1.6).  
The mature cortex is a layered structure. The first-born neurons migrate away from 
the VZ along the radial fibres of RGCs, and subsequently born neurons migrate past 
these to more basal positions. The earliest-born neurons form a layer known the 
preplate at about E11.5 which is located basally to the VZ and eventually to the SVZ 
and consists of subplate neurons and CR cells. As more neurons are born, these 
migrate radially to form a new layer known as the cortical plate by about E12.5, which 
splits the preplate into the subplate layer, overlying the SVZ and below the cortical 
plate, and the marginal zone, overlying the cortical plate at the pial surface. Subplate 
neurons are confined to the subplate layer and CR cells to the marginal zone. As 
neurogenesis proceeds, the distinct cortical layers start to form beginning with the 
deep layer VI and finishing with the superficial layers II-III, with the marginal zone 
becoming layer I (Molyneaux et al., 2007), so that the cortex forms in an inside-out 
manner. Following neurogenesis, RGCs give rise to glial cells, first astrocytes followed 
by oligodendrocytes, and will eventually transform into ependymal cells (MuhChyi et 
al., 2013).   
The formation of the cortical layers is a complex, highly regulated process, and the 
birthdate of neurons corresponds with their final laminar position. As neurogenesis 
proceeds, cortical progenitors become more restricted so that they progress from 
being able to produce deep layer VI-V neurons before being able to produce only 
upper layer IV-II neurons. When progenitors harvested from young donors which were 
giving rise to deep layer neurons were transplanted into older host brains, they were 
able to switch to upper layer neuron production. However, when progenitors 
harvested from older donors which were giving rise to upper layer neurons were 
transplanted into younger host brains at the time of deep layer neuron production, 
they were unable to generate deep layer neurons, showing their commitment to upper 
layer neuron production (Frantz & McConnell, 1996; McConnell & Kaznowski, 1991). 
It was further demonstrated in vitro that this timing mechanism is cell intrinsic (Shen 





Figure 1.6: Cortical neurogenesis. Schematic showing the production of 
glutamatergic cortical neurons from neuroepithelial cells followed by apical 
progenitors, located in the VZ, and basal progenitors, located in the SVZ. Apical 
progenitors undergo symmetric division to form two new apical progenitors, symmetric 
division to form two basal progenitors, or asymmetrical division to form one apical 
progenitor and one basal progenitor or neuron. Basal progenitors undergo 
symmetrical division to form two new basal progenitors or symmetrical division to form 
two neurons. CP; cortical plate, IZ; intermediate zone, MZ; marginal zone, NE; 
neuroepithelium, SVZ; subventricular zone, VZ; ventricular zone. Modified schematic 






Aside from the age of the embryo, exposure to signalling molecules and the 
transcription factors expressed by a cell, and its position within the cortex, many 
factors can influence the mode of division a cortical progenitor will undergo. For 
example, post-translational gene modifications affect apical progenitor differentiation 
into basal progenitors via microRNA-92 silencing of Tbr2 (Nowakowski et al., 2013). 
Post mitotic neurons are also able to signal back to cortical progenitors and influence 
their division. The transcriptional repressor Sip1 is expressed in postmitotic neurons 
and signals via the neurotrophin Ntf3 to promote apical progenitor to basal progenitor 
and deep layer to upper layer fate changes (Parthasarathy et al., 2014; Seuntjens et 
al., 2009). Furthermore, epigenetic modifications can alter the balance between 
cortical progenitor proliferation and differentiation. For example, Pereira et al. (2010) 
deleted Ezh2, which represses transcription through histone H3 modification, in 
cortical progenitors before the beginning of cortical neurogenesis. This loss of function 
resulted in gene expression up-regulation which promoted cortical progenitor 
differentiation as opposed to proliferation, causing an overproduction of basal 
progenitors and neurons. In addition to these factors, the cell cycle of a progenitor has 
a large influence over the manner in which a progenitor will divide and will be 













1.5 Cell cycle   
  
The cortical progenitor cell cycle is a complex process beginning in a daughter cell 
following division of the parent cell. After mitosis and division of the parent, each 
daughter cell will enter gap 1-phase (G1-phase) of the cell cycle. Here, each cell is 
able to weigh up cell intrinsic and extrinsic signals, which will determine if the cell will 
continue on through the cell cycle as a progenitor and complete another round of cell 
division or if it will exit the cell cycle and differentiate, thereby entering gap 0-phase 
(G0-phase). If the cell is to continue on as a progenitor it must pass through the mid 
G1-restriction point, which is determined based on the level of cell cycle dependent 
protein expression. Once the checkpoint has been passed, the cell will then pass from 
G1-phase into synthesis phase (S-phase), during which DNA is replicated. After DNA 
replication, the cell will pass into gap 2-phase (G2-phase), where the cell prepares 
itself for mitosis through protein synthesis and rapid cell growth. A second checkpoint, 
the G2/M checkpoint, is reached just before the cell progresses from G2-phase into 
the final phase, mitosis (M-phase). Here, the level of DNA damage is assessed 
allowing a cell to repair damaged DNA before initiating mitosis. If damaged DNA is 
not allowed to repair before mitosis, the cell will undergo cell death following division. 
During the final phase, M-phase, the cell will divide to form two new progeny which 
will enter G1-phase and begin a new cell cycle.   
A number of protein families are key to either allowing or disallowing the cell to 
progress through the cell cycle. In general, cyclin-dependent kinases (Cdks) and their 
binding partners the cyclins cause progression through the cell cycle or through 
specific cell cycle phases. Conversely the Cdk inhibitors (CdkIs) act to inhibit Cdks 
and result in exit from the cell cycle or prevent a cell from progressing to the next cell 
cycle phase. With regard to G1-phase, there is sequential expression of Cdk6 and 
Cdk4 which bind to D-type cyclins, acting to progress the cell past the checkpoint, 
followed by Cdk2 binding to E-type cyclins to progress the cell from G1-phase into S-
phase. The Cdk/cyclin complex acts to hyperphosphorylate Rb, thereby preventing it 
from binding to and sequestering the E2F family of transcription factors (Dyson, 1998). 
These transcription factors promote transcription of genes which will cause 
progression into S-phase and ultimately DNA replication (Harbour & Dean, 2000). 
Progression through S-phase is mediated by Cdk2 binding with cyclin A, followed by 
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cyclin A and Cdk1 mediating progression through G2-phase. Finally, Cdk1 and cyclin 
B mediate progression through M-phase (Suryadinata et al., 2010) (figure 1.7). The 
levels of Cdks, cyclins and CdkIs are dependent on both intrinsic and extrinsic cell 
features. Intrinsic features include factors such as the size of the cell and the cell fate 
determinants inherited from the mother cell, which can influence if the cell will pass 
the checkpoint and continue to cell division, whilst extrinsic factors include 
proliferative or differentiative signals a cell receives from its environment. With regards 
to whether a progenitor will undergo proliferative or differentiation division, the most 
scrutinised cell cycle phase is G1-phase. During this phase, a cell will resolve the 
intrinsic and extrinsic factors acting upon it to determine the mode of division 
undertaken. The length of G1-phase has been shown to be critically important in the 
determination of which type of division will take place.  
With regards to cell intrinsic mechanisms, Calegari & Huttner (2003) used the 
pharmacological non-specific Cdk inhibitor olomoucine to lengthen G1-phase, 
resulting in an induction of cell differentiation at the expense of proliferation. From 
here they proposed the “cell cycle length” model, in which they suggested lengthening 
of G1-phase is sufficient to cause neurogenesis, as the cell has longer to respond to 
cell fate determinants and so cell fate will change. Lange et al. (2009) overexpressed 
Cdk4/cyclin D1 to promote progression from G1- into S-phase and a shortening of 
G1-phase, which resulted in an inhibition of neurogenesis leading to increased basal 
progenitor production and expansion. Furthermore, Pilaz et al. (2009) overexpressed 
either cyclin D1 or cyclin E1, also leading to a shorter G1-phase, promoting the 
proliferation of apical and basal progenitors at the expense of differentiation into 
neurons. Moreover, when G1-phase is shorter preceding a proliferative division, Cdk 
levels rise more quickly and are able to phosphorylate Ngn2, a regulator of neuronal 
differentiation, whilst at the same time p27Kip1, a CdkI, will be present at lower levels 
and therefore unavailable to stabilise Ngn2 (Nguyen et al., 2006). The result of this is 
an inability of Ngn2 to promote neuronal differentiation. When G1-phase is longer, 
there is less Ngn2 phosphorylation and CdkI levels are higher, resulting in an 
increased ability of Ngn2 to activate the expression of its target genes key to 
differentiation (Ali et al., 2011). Cell extrinsic factors which can affect the length of G1-
phase include exposure to signalling molecules such as Wnts. For example, 
Shtutman et al. (1999) and Tetsu & McCormick (1999) revealed cyclin D1 to be a 
direct target of the β-catenin/LEF-1 pathway, and β-catenin overexpression induced 





Figure 1.7: Cell cycle progression. Schematic showing progression through each 
phase of the cell cycle mediated by Cdks and cyclins. In G1-phase, Cdk4/6 in concert 
with D-type cyclins hyperphosphorylate pRb, easing repression of E2F transcription 
factors and allowing for transcription of phase progression genes. Cdk2 and Cyclin E 
then promote transition from G1-phase to S-phase, before Cdk2 and Cyclin A mediate 
progression through S-phase. Cdk1 and Cyclin A allow progression through G2-
phase, before finally Cdk1 and cyclin B progress the cell through M-phase.  
 
resulted in G1-phase arrest. Collectively, these studies provide evidence that the 
length of G1-phase is causal to the decision to proliferate or differentiate, with a 
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shorter G1-phase causing proliferative division and a longer G1-phase causing 
differentiative division.   
Conversely, a longer S-phase is considered to correlate with proliferative divisions, 
with S-phase becoming shorter as cells become more differentiated. Arai et al. (2011) 
compared the cell cycle phase lengths of Tis21+ and Tis21- progenitors. If a cell is to 
undergo a proliferative division, it will not express Tis21, but upon commitment to 
differentiation Tis21 expression is up-regulated during G1-phase (Iacopetti et al., 
1999). They revealed that S-phase length was significantly shorter in Tis21+ cells 
which are about to undergo differentiation, associated with a down-regulation of 
genes which would be expected to increase S-phase length in Tis21+ cells and an up-
regulation of genes which would reduce S-phase length in Tis21- cells. They propose 
the fidelity of DNA replication and time spent on DNA repair must be longer in 
proliferative cells which are expected to produce many more cells, than in 
differentiative cells which will produce comparatively less cells and so any mistakes 
will not be transmitted to as many progeny. In contrast to the Ali et al. (2011); Arai et 
al. (2011); Lange et al., (2009); Pilaz et al., (2009); Calegari & Huttner (2003) studies 
which were undertaken in mouse, Gonzales et al. (2015) investigated the role of 
different phase lengths in human embryonic stem cells (hESCs) in vitro. Here, they 
showed that in hESCS by decreasing S-phase length both genetically and 
pharmacologically, the pluripotent state is dissolved, meaning the cell will undergo 
differentiation. Building on the “cell cycle length” model of Calegari & Huttner (2003), 
they suggest that G1-phase is primed to respond to differentiation cues, whilst S-
phase is primed to respond to pluripotency maintenance. Taken together, whilst G1-
phase lengthens as cells differentiate, S-phase length is longer when a cell will 
undergo proliferative division and is shorter when a cell will undergo differentiative 
division.   
As to the final two phases, G2- and M-phase, much less is known about how the 
length of these phases may affect proliferation and differentiation. In the above study, 
Gonzales et al. (2015) also revealed that in hESCs G2-phase shortening may be 
linked to differentiation. The group undertook an RNAi screen in differentiating hESCs 
to identify pathways regulating dissolution of the pluripotent state. Cyclin B1 was 
identified in the screen, and when knocked down in hESCs led to pluripotency marker 
downregulation, indicating differentiation. Conversely when overexpressed, cyclin B1 
led to a delay in pluripotency state dissolution, indicating a maintenance of the 
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pluripotent state. Taken together, the study indicated that as with S-phase, G2-phase 
length may be longer when a cell will undergo proliferative division so the cell can 
respond to pluripotency maintenance.   
In a recent study, Pilaz et al. (2016) investigated the role of M-phase length on 
progenitor proliferation/differentiation using the Magoh+/- mutant mouse and two 
pharmacological inhibitors of M-phase. In the Magoh+/- mutant, microcephaly, a 
reduction in brain size, is exhibited due to defective mitosis resulting in basal 
progenitor depletion and neuronal apoptosis (Silver et al., 2010). Using live imaging, 
Pilaz et al. (2016) recorded that mitotic delay in the Magoh+/- mutant correlated with 
neuronal production at the expense of progenitor proliferation. To further investigate 
this finding, two pharmacological inhibitors of M-phase were employed, S-trityl-L-
cysteine (STLC) and nocodazole. E13.5 cortical brain slices incubated with both 
inhibitors showed a 50% increase in neurons compared to control and a 25% 
decrease in basal progenitors. Furthermore, slices incubated with STLC also showed 
a significant reduction in apical progenitors. Overall, this would indicate that a 
lengthening of M-phase length leads to decreased progenitor proliferation and 
increased progenitor differentiation, as has been reported for G1-phase length.   
In summary, proliferative division may correlate with a shorter G1-phase followed by 
longer S- and G2-phases and a shorter M-phase. On the contrary, differentiative 
division may correlate with a longer G1-phase followed by shorter S- and G2-phases 
and a longer M-phase. However, the evidence underlying the contribution of each 
phase length to the mode of division a progenitor will undergo varies greatly, and 
whilst there is good evidence that the length of G1-phase is critical, more research is 
required to establish the role of other phases in cortical progenitor division.  
 One factor shown to impact upon the cell cycle is Gli3. Besides regulating the 
development of the cortex, Gli3 also regulates development of the limbs. Vokes et al. 
(2008) conducted a genome-wide chromatin immunoprecipitation (ChIP)-on-chip 
analysis and transcriptional profiling for regulatory regions to which Gli3 binds and 
revealed a potential Gli3 binding site in the Cdk6 promoter. Building upon this, Lopez-
Rios et al. (2012) also conducted ChIP analysis using conditional Gli3 knockout limb 
buds. They showed that in vivo Gli3 binds to the Cdk6 promoter region with ~4-fold 
enrichment in wild-type limb buds and no interaction in conditional Gli3 knockout limb 
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buds. They suggested Gli3 acts as a negative regulator of the G1- to S-phase 
transition causing progenitors to cycle faster, likely through Cdk6 regulation.   
The role of Gli3 in cortical cell cycle regulation has also been investigated. Wang et 
al. (2011) used NestinCre to conditionally delete Gli3 in the cortex after patterning, 
with complete Gli3 deletion by E14.5. As described previously in other Gli3 mutants 
(Friedrichs et al., 2008; Theil, 2005; Tole et al., 2000), lamination was disrupted in the 
cortex of NestinCre conditional Gli3 knockouts. In these mutants, the loss of Gli3 led 
to an increased production of deeper layer neurons and decreased upper layer neuron 
production. Additionally, there was a decrease in apical progenitor proliferation and 
increased cell cycle exit of these progenitors, leading to a decreased basal progenitor 
population which also exited the cell cycle prematurely. The group suggested that Gli3 
is required to maintain progenitors in the cell cycle, and that as progenitors progress 
from apical to basal progenitors to neurons the level of Gli3 decreases, allowing them 
to become more differentiated. However, the role of Gli3 in early neurogenesis and 
particularly in apical progenitors is hard to assess from this study, due to the lateness 
at which Gli3 expression was deleted. Indeed, here the group reported that deletion 
was only complete by E14.5, whereas cortical neurogenesis begins at approximately 
E10. Further, they did not investigate the cell cycle, leaving an open question 
regarding the role of Gli3 in the cell cycle in cortical progenitors. Friedrichs et al. 
(2008) indicated a reduction in the Tbr1 expression domain dorsomedially at E12.5 in 
the Gli3Xt/Pdn mutant, indicating a disruption in neurogenesis prior to the time point 
reported by Wang et al. (2011).  
Whilst a link has been made already between Gli3, proliferation/differentiation of 
cortical progenitors, and the cell cycle in the limb bud and in late cortical 
neurogenesis, this has not yet been investigated for cortical progenitors at the onset 
of neurogenesis, nor has the role of the cell cycle in mutant cortical progenitors here. 
Therefore, due to the copious amount of evidence linking the cell cycle, and in 
particular G1-phase, to the proliferation/differentiation of cortical progenitors in early 






1.6 Aims and hypothesis of this thesis   
  
The focus of this thesis is the role Gli3 plays between E11.5-E12.5 in the developing 
dorsal telencephalon, and how its regulation of the cell cycle may impact upon apical 
and basal progenitor proliferation/differentiation, leading to alterations in the neuronal 
population. I hypothesise that early neurogenesis is disrupted in the Gli3Xt/Pdn mutant 
due to a disruption in the cell cycle, caused by a reduction in Gli3. The aims of this 
thesis were: 
1. To examine the expression of the Gli3 protein in apical and basal 
progenitors and assess the impact of reduced Gli3 expression levels on 
the apical and basal progenitor and early-born neuronal populations.   
2. To examine apical and basal progenitor cell cycle exit/re-entry in the 
Gli3Xt/Pdn dorsal telencephalon followed by detailed investigation of the 
individual cell cycle phase lengths in these progenitors.   
3. Using microarray analysis data from the Gli3Xt/Pdn mutant, identify 
potential candidate genes underlying Gli3's regulation of the cell cycle and 
to begin to investigate the mechanisms by which Gli3 may regulate the cell 












Chapter 2: Materials and Methods 
 
2.1 Animals  
 
2.1.1 Husbandry  
Procedures were carried out and mice kept in accordance with Home Office 
regulations and the University of Edinburgh’s Policy on the Use of Animals in 
Research.  
To obtain Gli3Xt/Pdn embryos, Gli3Xt/+ mice, maintained on a mixed C56Bl6 x C3H 
background, were interbred with Gli3Pdn/+ mice, maintained on a C3H background. 
Wild-type (wt), Gli3Pdn/+ and Gli3Xt/+ embryos were used as control as they exhibited 
no distinct phenotype. To obtain Emx1Cre;Gli3fl/fl embryos, Emx1Cre;Gli3fl/+ mice 
were mated with Gli3fl/fl mice, and Emx1Cre;Gli3+/+ and Emx1Cre;Gli3fl/+ embryos were 
used as control as no observable phenotype was displayed. Gli3-FLAG embryos were 
also used for antibody testing (Nishi et al., 2015). To obtain Gli3Xt/Pdn;Tis21GFP 
embryos, Gli3Xt+ animals were interbred with Tis21-GFP animals (Haubensak et al., 
2004) (a kind gift from W. Huttner). Gli3Xt/+;Tis21GFP animals were then interbred with 
Gli3Pdn/+ animals. Gli3+/+;Tis21GFP, Gli3Pdn/+;Tis21GFP and Gli3Xt/+;Tis21GFP were 
used as control.  
Food and water were available to all mice ad libitum, and mice were kept in a 14/10-
hour light/dark cycle. Timed matings occurred overnight, with E0.5 classified as the 
morning of vaginal plug discovery. For each experiment, between 3 and 5 embryos 
were analysed.  
 
2.1.2 Administration of BrdU and IdU  
10mg/ml 5-Bromo-2′-deoxyuridine (BrdU) (Sigma) or 5-Iodo-2′-deoxyuridine (IdU) 
(Sigma) were dissolved in 0.007M NaOH and 0.154M NaCl at 37°C (BrdU) and 70°C 
(IdU) with shaking in an Eppendorf Thermomixer at 1,400rpm for 20-30 mins just prior 
to use.  
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To calculate the length of S-phase and the length of the total cell cycle, 10mg/kg IdU 
was injected intraperitoneally (IP) into pregnant dams at E11.5 or E12.5. 1.5 hrs later, 
10mg/kg BrdU was injected IP into the dams, followed by sacrifice of the mice and 
harvesting of the embryos 30 mins after BrdU injection.  
To calculate the length of G2-phase, 10mg/kg BrdU was injected IP into pregnant 
dams at E11.5 or E12.5 1 hr, 1.5 hrs or 2 hrs before sacrifice and embryo isolation.  
To calculate cell cycle exit, 10mg/kg BrdU was injected IP into pregnant dams at 
E10.5 or E11.5, and embryos were collected 24 hrs later.  
 
2.1.3 Tissue preparation  
Pregnant dams were culled via anaesthetic overdose with IsoFlo 100% w/v isoflurane 
(Zoetis) followed by cervical dislocation when embryos reached E11.5 – E13.5. The 
uterus was dissected from the dams and transferred into ice cold 1x phosphate 
buffered saline (PBS) (table 2.6) except for during preparation for slice culture, in 
which uteri were transferred into ice cold 1x Krebs (table 2.6). Whole embryos were 
then dissected from the uterus, before the whole head was removed from the embryo. 
Heads to be used for histochemistry were transferred into 4% paraformaldehyde in 
PBS (PFA) (table 2.6) and fixed overnight at 4°C. For slice cultures, the brain was 
dissected from the embryos and embedded in 3-4% SeaKem LE agarose (Lonza) in 
sterile 1x PBS. Tail tips were removed from embryos and used for genotyping.  
 
2.1.4 Genotyping  
Tail tips were digested at 55°C and 1,400rpm for 2 hrs in a thermomixer (Eppendorf) 
with 100l DirectPCR lysis reagent (tail) (Viagen) containing 200g/ml proteinase K 
(Sigma). The enzyme was denatured following digestion at 85°C for 50 mins.  
Genotyping reactions were carried out in a total volume of 25l (except Xt which was 
carried out in a total volume of 50l) using the reagents and oligonucleotides shown 
in table 2.1 and table 2.2. PCRs were then performed using the programmes as 
shown in table 2.3.  
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PCR products were separated on 2% (w/v) agarose gels containing 1x TAE buffer 
(table 2.6) and GelRed Nucleic Acid Gel Stain (Biotium) or ethidium bromide (Sigma) 
(for Pdn reactions only) before visualisation with UV light.  
 
Table 2.1: PCR reaction mixtures  





















dH2O (l) DNA (l) 
Emx1Cre 5 0.5 1 0.1 16.4 1 
Gli3 Flox 5 0.5 0.75 0.1 16.9 1 
Pdn 5 1 0.75 0.2 15.55 1 

















Table 2.2: PCR primers 
Allele Primer Sequence (5’-3’) Band 
size 
(bp) 
Emx1Cre CreF -ACCTGATGGACATGTTCAGGGA- Cre: 
308 CreR -TCCGGTTATTCAACTTGCACCA- 















Xt C3f -GGCCCAAACATCTACCAACACATAG- Wt: 
180 C3r -GTTGGCTGCTGCATGAAGACTGAC- 
Xt580f -TACCCCAGCAGGAGACTCAGATTAG- Xt/+: 
580 Xt580r - AAACCCGTGGCTCAGGACAAG-  
 
Table 2.3: Genotyping programmes  
Genotype Reaction conditions 
Emx1Cre Maintained at 94°C for 5 mins, then 30 cycles were performed of 
94°C for 30 secs denaturing, 61°C for 45 secs annealing and 72°C 
for 45 secs extension. The reaction was then held 72°C for 5 mins. 
Flox Maintained at 95°C for 2 mins, then 30 cycles were performed of 
95°C for 30 secs denaturing, 61°C for 45 secs annealing and 72°C 
for 45 secs extension. The reaction was then held 72°C for 5 mins. 
Pdn Maintained at 95°C for 3 mins, then 30 cycles were performed of 
94°C for 1 min denaturing, 55°C for 1 min annealing and 72°C for 1 
min extension. The reaction was then held at 72°C for 7 mins. 
Xt Maintained at 94°C for 2 mins, then 35 cycles were performed of 
94°C for 15 secs denaturing, 62°C for 30 secs annealing and 72°C 
for 30 secs extension. The reaction was then held 72°C for 5 mins. 
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2.1.5 Tissue sectioning  
Cryostat  
Heads were washed in 1x PBS following overnight fixation before being transferred 
into 30% sucrose (Fischer Scientific) in 1x PBS (w/v) and stored on a rotator at 4°C 
overnight. Heads were then incubated in 30% sucrose/OCT (VWR) (1:1) for 30 mins 
before embedding in 30% sucrose/OCT (1:1) and stored at -80°C. 10m coronal 
sections were cut on a CM3050S cryostat (Leica) and adhered to Superfrost Plus 
slides (VWR). Slides were stored at 4°C overnight, with long-term storage at -20°C.  
Microtome  
Heads were washed in 1x PBS overnight following fixation, before being dehydrated 
in 70% ethanol (Fischer) and embedded in paraffin wax through an automated tissue 
processor (Tissue-Tek, VIP, Sakura). 10m coronal sections were cut on an RM2245 
microtome (Leica) and mounted on Superfrost Plus slides. Slides were incubated at 
37°C overnight before being stored at 4°C.  
Vibratome  
Heads were removed from embryos and from these the brains were dissected out in 
ice cold 1x Krebs + antibiotics (table 2.6). The brains were then transferred to molten 
LE agarose kept at 43°C, and stirred in the agarose for approximately 4-5 mins to 
allow for the tissue to adhere with the agarose. The agarose was then allowed to 
solidify on ice, and 300m coronal sections were cut on a Leica VT1000S vibratome 
in ice cold 1x Krebs. Sections were collected in 1x Krebs + antibiotics and kept on ice 
before being put into culture.   
 
2.2 Immunofluorescence  
 
2.2.1 Cryostat sections  
Slides were acclimatised to room temperature for approximately 30 mins before 
washing 3x 20 mins each on a rocker in 1x PBS to rehydrate the tissue. Sections 
being stained for primary antibodies which require antigen retrieval were rested in 
10mM sodium citrate buffer for 5 mins (pH6) (table 2.6) before being either 
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microwaved for 4x 5 mins each or incubated in a water bath at 80°C for 30 mins. The 
sections were rested in the sodium citrate buffer for approximately 20 mins, before 
being washed for 5 mins in 1x PBS. All slides were then encircled with an ImmEdge 
Hydrophobic Barrier Pen (Vector Laboratories), before blocking in 20% goat serum 
(Sigma) in 1x PBS for 2 hrs at room temperature. Subsequently, slides were incubated 
overnight at room temperature with primary antibodies (table 2.4) diluted in 10% goat 
serum. Slides were then washed 3x 10 mins each in 1x PBS, before secondary 
antibodies (table 2.5) and either TOPRO-3 (Invitrogen) or DAPI (Life Technologies) 
(table 2.5) were added to the sections for 2 hrs. Slides were again washed 3x 10 mins 
each in 1x PBS before mounting with mowiol (table 2.6).   
Amplification  
Slides were processed as above, however on the second day of the protocol after 
washing slides 3x 10 mins each in 1x PBS, slides were incubated for 1.5 hrs with a 
biotinylated secondary antibody (table 2.5) in 10% goat serum in 1x PBS with either 
TOPRO-3 or DAPI (table 2.5). Secondary antibodies required for primary antibodies 
which did not need amplification were included in this step. Slides were washed for 
3x 10 mins in 1x PBS, before incubation with a streptavidin-conjugated secondary 
antibody (table 2.5) diluted in 10% goat serum in 1x PBS for 30 mins. Slides were 
washed 3x 10 mins each in 1x PBS, before mounting with mowiol.   
 
2.2.2 Paraffin sections  
Dewaxing of paraffin sections was achieved by washing slides 3x 7 mins each in 
xylene (ThermoFisher Scientific), followed by 2 mins in EtOH (ThermoFisher 
Scientific)/xylene (1:1), 2x 2 mins each in 100% EtOH, and 1 min in each of 96% 
EtOH, 90% EtOH, 70% EtOH and 50% EtOH. Sections then underwent antigen 
retrieval by incubating the slides in 10mM sodium citrate buffer (pH6) for 5 mins at 
room temperature before microwaving 4x 5 mins each. Sections were then rested in 
the sodium citrate buffer for 20 mins at room temperature before washing in 1x PBST 
(table 2.6) for 5 mins. Sections were encircled with an ImmEdge Hydrophobic Barrier 
Pen and blocked for 2 hrs in blocking solution (20% goat serum in 1x PBST). Slides 
were incubated overnight at room temperature with primary antibodies (table 2.4) 
diluted in blocking solution. Slides were washed 3x 10 mins each in 1x PBST, followed 
by incubation for 2 hrs with secondary antibodies (table 2.5) diluted in 10% goat serum 
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in 1x PBST with TOPRO-3 or DAPI (table 2.5). Finally, slides were washed 3x 10 mins 
each in 1x PBST before mounting with mowiol.  
Amplification  
Slides were treated as above on the first day, however on the second day after 
washing 3x 10 mins each in 1x PBST, slides were incubated for 1.5 hrs with a 
biotinylated secondary antibody (table 2.5) in 10% goat serum in PBST with TOPRO-
3 or DAPI (table 2.5). Any other secondary antibodies required were included in this 
step. Slides were washed 3x 10 mins each in 1x PBST, followed by incubation for 30 
mins with a streptavidin-conjugated secondary antibody (table 2.5) diluted in 10% 
goat serum in PBST. Slides were washed again 3x 10 mins each in PBST and 
mounted with mowiol.  
 
 










BrdU 1:50 Required  - Rat Abcam 
GFP 1:1000 - Cryostat 
sections  
Chicken Abcam 




Goat R & D Systems  
IdU/BrdU 1:50 Required  - Mouse Becton 
Dickinson 
Pax6 1:400 - - Rabbit BioLegend 
PCNA 1:500 - - Mouse Santa-Cruz 
pHH3 1:100 - - Rabbit Millipore 
pRb S780 1:200 - - Rabbit Cell signalling  
Tbr1 1:400 Required Amplification  Rabbit Abcam 
Tbr2 1:1000 - - Rabbit Abcam 
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Table 2.5: Secondary antibodies  
Secondary 
antibody 
Dilution Origin Conjugated to Manufacturer  
Anti-chicken IgG 1:100 Donkey DyLight488 JacksonImmuno 
Research 
Anti-mouse IgG 1:200 Goat Alexa488 Invitrogen 
Anti-mouse IgG 1:100 Donkey Cy2 Jackson/Dianova 
Anti-rabbit IgG 1:200 Goat Alexa647 Invitrogen  
Anti-rabbit IgG 1:400 Goat Biotin DAKO 
Anti-rabbit IgG 1:100 Donkey Cy3 Jackson/Dianova 
Anti-rat IgG 1:100 Donkey Cy3 Jackson/Dianova 
DAPI 1:2000 - - Life Technologies 
Streptavidin  1:100 - AlexaFluorA568 ThermoFisher 
Scientific 

















2.3 Slice culture  
 
300m coronal vibratome slices of E11.5, E12.5 and E13.5 brains were cultured for 
24 hrs in 15mm centre well organ culture dishes (BD Falcon by Corning). The slices 
were cultured on 8m Whatman nucleopore track-etched membranes, on 1ml of pre-
warmed (37°C) Minimum Essential Medium (MEM) (Invitrogen) with serum (table 2.6).  
Slices were placed in a 37°C 5% CO2 Panasonic MCO-170AICUV-PE incubator for 1 
hr. MEM was removed, and 1ml of pre-warmed (37°C) neurobasal medium 
(Invitrogen) supplemented (table 2.6) was added. At this point, either palbociclib 
(Selleck Chemicals, varying concentrations, dissolved in DMSO (Sigma)) or DMSO 
were added to slices.  
The following day, the medium was removed and slices were fixed overnight with 4% 
PFA at 4°C. Slices were washed 3x 15 mins each with 1x PBS, before 30% sucrose 
in 1x PBS was added to the wells and left overnight at 4°C. The 30% sucrose solution 
was replaced with 30% sucrose/OCT (1:1) for approximately 30 mins, before slices 
were embedded in 30% sucrose/OCT (1:1) and stored at -80°C. Slices were then cut 
to 10m thick coronal sections via cryostat, as outlined in section 2.1.5.  
 
2.4 Microscopy  
 
Fluorescent images were captured with a Leica DMLB upright compound microscope 
fitted with a Leica DSC480 digital camera using 2.5x, 5x, 10x, 20x and 40x lenses. 
Bright field images were taken using a Leica M165C microscope with a Leica DFC420 
digital camera using 2.5x, 5x and 10x lenses. Images were processed with LAS AF 
Lite software and Adobe Photoshop CS6 software, adjusting images equally for 







2.5 Quantification and analysis  
 
2.5.1 Quantification of cells  
For all cell counts, cells within a 175m wide box parallel to the ventricular surface 
and spanning the width of the cortex (apical to basal surfaces) were counted (figure 
3.5). Three consecutive coronal sections were counted per embryo, at the level where 
the epithalamus first appeared. Both hemispheres were counted, and boxes were 
placed laterally across the cortex close to the pallial-subpallial boundary (PSPB) or 
medially close to the midline region.  
Cell counts were performed using the Cell Counter plugin in ImageJ. Statistical 
analyses were conducted and graphs produced using GraphPad Prism 6.   
 
2.5.2 Statistics  
Quantitative results are quoted throughout as mean ± 95% confidence interval. 
Graphs depict mean ± 95% confidence interval. Significance was calculated either via 
the Mann-Whitney U-test or, for slice culture only, the Kruskal-Wallis test followed by 
Dunn’s post-hoc test. A significance level of 0.05 was used, p<0.05 is indicated by 













Table 2.6: Solutions used in this thesis  
Solution Preparation 
10x Krebs (pH 7.2) To prepare 1l:  
• Dissolve dry ingredients in a small volume of 
dH2O, and once dissolved increase volume to 
1l with further dH2O:  
o 73.6g NaCl (ThermoFisher Scientific) 
o 1.87g KCl (ThermoFisher Scientific) 
o 1.66g NaH2PO4.H2O (ThermoFisher 
Scientific) 
o 2.44g MgCl2.6H2O (ThermoFisher 
Scientific) 
o 3.68g CaCl2.2H2O (ThermoFisher 
Scientific) 
• Adjust pH to 7.2 and autoclave  
1x Krebs + antibiotics  To prepare 50ml:  
• To 49ml 1x Krebs add:  
o 500l 1M HEPES buffer solution 
(Invitrogen) 
o 500l penicillin streptomycin 
(Invitrogen) 
o 100l 50mg/ml gentamicin (Gibco) 
• Can be stored at 4°C for up to 2 weeks  
MEM supplemented with 
serum 
To prepare 50ml:  
• To 44ml MEM (Invitrogen) add: 
o 5ml foetal calf serum (Sigma) 
o 500l D-(+)-glucose solution 45% 
(Sigma) 
o 500l penicillin streptomycin 
(Invitrogen) 
• Can be stored at 4°C for up to 2 weeks 
Mowiol To prepare 24ml: 
• Mix together overnight at room temperature: 
o 12ml dH2O 
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o 2.4g mowiol (Fluka Analytical) 
o 6g glycerol (Melford) 
• Heat for 1-2 hrs at 60°C with: 
o 12ml 0.2M Tris (pH8.5) (Sigma) 
• Centrifuge for 15 mins at 2,000rpm before 
adding: 
o 2.5% DABCO (Sigma) 
• Store at -20°C for long-term storage, store at 
4°C for short-term storage 
Neurobasal medium 
(supplemented) 
To prepare 50ml:  
• To 47.5ml neurobasal medium (Invitrogen) 
add: 
o 1ml B27 50x supplement (Invitrogen) 
o 500l D-(+)-glucose solution 45% 
(Sigma) 
o 500l penicillin streptomycin 
(Invitrogen) 
o 500l l-glutamine solution (Invitrogen) 
• Can be stored at 4°C for up to 2 weeks 
10x PBS (pH 7.4) To prepare 2l:  
• Dissolve dry ingredients in a small volume of 
dH2O, and once dissolved increase volume to 
2l with further dH2O:  
o 160.2g NaCl (ThermoFisher 
Scientific) 
o 4.0g KCl (ThermoFisher Scientific) 
o 4.0g KH2PO4 (ThermoFisher 
Scientific) 
o 23.2g Na2HPO4.2H2O (ThermoFisher 
Scientific) 
• Adjust pH to 7.4 before dilution to 1x working 
stock 
1x PBST (0.1% Triton-X) To prepare 1l: 
• To 1l 1x PBS add: 
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o 1ml Triton-X (Acros Organics) 
4% PFA To prepare 1l: 
• Heat together until dissolved: 
o 1l 1xPBS  
o 40g paraformaldehyde 
(ThermoFisher Scientific) 
• Store at -20°C for long-term storage, store at 
4°C for short-term storage 
100mM sodium citrate 
buffer (pH 6) 
To prepare 1l: 
• Dissolve dry ingredient in a small volume of 
dH2O and adjust pH to 6.0 with 1M citric acid, 
before increasing volume to 1l with further 
dH2O:  
o 29.4g C6H6Na3O7 (ThermoFisher 
Scientific) 
 50x TAE buffer To prepare 2l: 
• Dissolve dry ingredients in a small volume of 
dH2O before increasing volume to 2l with 
further dH2O:  
o 100ml 0.5M EDTA (pH8.0) 
(ThermoFisher Scientific) 
o 60ml acetic acid (ThermoFisher 
Scientific) 











Chapter 3: Gli3 is primarily expressed in apical progenitors of the 
developing neocortex, and reduction in Gli3 expression alters apical 
progenitor, basal progenitor and cortical neuron production  
 
 
3.1 Introduction   
 
Neurogenesis within the developing neocortex is a highly controlled process leading 
to the production of glutamatergic projection neurons. The layers of the mature cortex 
are formed in an inside-out manner, with the deeper layers being formed first from 
early-born neurons followed by the upper, more superficial layers being formed 
subsequently from later-born neurons. For this process to occur correctly, distinct 
subtypes of cortical progenitors must divide at the correct time and in the correct 
manner. In general, rodent cortical neurogenesis begins when neuroepithelial cells 
switch from self-renewing, proliferative divisions to asymmetric, differentiative 
divisions at approximately E10. These asymmetric divisions lead to the formation of 
apical progenitors and the earliest-born neurons (Haubensak et al., 2004; Noctor et 
al., 2004). In early neurogenesis apical progenitors are the predominant cortical 
progenitor subtype and are characterised by their expression of the paired 
homeodomain transcription factor Pax6. These progenitors reside in the ventricular 
zone (VZ) and undergo three types of division: symmetrical division to form two apical 
progenitors, symmetrical division to form two basal progenitors, or asymmetrical 
division to form one apical progenitor and either one basal progenitor or one neuron 
(Miyata et al., 2001; Götz et al., 1998). The second major subdivision of cortical 
progenitor are basal progenitors, which are formed from apical progenitors only and 
become the predominant cortical progenitor subtype later in neurogenesis, at 
approximately E14.5. Conversely, basal progenitors express the T-domain 
transcription factor Tbr2, reside in the subventricular zone (SVZ), and undergo two 
types of division: a limited number of symmetrical division to form two basal 
progenitors or, most commonly, symmetrical division to form two neurons (Englund et 
al., 2005; Noctor et al., 2004).  
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The manner in which apical and basal progenitors divide and the timing of these 
divisions is critical to the correct formation of the cortex. As such, it is a tightly 
controlled process involving the interaction of a number of different signalling 
molecules and transcription factors. Of note, mutations in the transcription factor Gli3 
have long been shown to result in severe developmental defects in the cortex, since 
Johnson (1967) first reported that the Gli3Xt/Xt null mutant exhibited small cerebral 
hemispheres and some animals were hydrocephalic.   
Gli3 mRNA expression is first detectable at E8.5 in the mouse, and expression 
continues until approximately E16.5. In general, it is expressed in a high-dorsal to low-
ventral pattern throughout the developing spinal cord and brain, in particular in the 
forebrain and hindbrain (Hui et al., 1994). In the presence of Shh, full length Gli3 
protein acts as a transcriptional activator, but in the absence of Shh, as in the dorsal 
telencephalon, Gli3 is proteolytically cleaved at the base of the primary cilium into a 
transcriptional repressor (Fotaki et al., 2006). In the dorsal telencephalon, Gli3 mRNA 
is expressed in the neocortex and cortical hem (Grove et al., 1998) and appears to 
be localised to the VZ (Amaniti et al., 2013; Hui et al., 1994), hinting at a role in 
mitotically active cells. Furthermore, single-cell mRNA sequencing of cells from the 
developing human telencephalon revealed GLI3 to be expressed in radial glial cells, 
a subset of apical progenitors (Pollen et al., 2014). Recently Yabut et al. (2016) 
described that at E16.5 Gli3 protein was localised in the VZ, but they also described 
expression in the SVZ. However, as they did not use markers of apical or basal 
progenitors, they were unable to say in which progenitor subtype(s) Gli3 was 
expressed. They noted that along the ventricular surface, Gli3 expression was largely 
cytoplasmic, yet expression was more localised to the nucleus as cells reached the 
SVZ. Neither the in situ nor immunofluorescence studies were able to reveal whether 
Gli3 protein is expressed within apical and/or basal progenitors, only that it is 
expressed in the progenitor zones.  
The functions in which Gli3 regulates the development of the dorsal telencephalon 
have primarily been evaluated through the use of Gli3 mutant mice. The focus of this 
thesis will be the Gli3Xt/Pdn mutant, a compound mutant formed by the crossing of the 
heterozygotes of the null Gli3Xt/Xt mutant and the hypomorphic Gli3Pdn/Pdn mutant 
(Kuschel et al., 2003). Gli3Xt/Pdn pups die shortly after birth and exhibit clear defects in 
the dorsal telencephalon. The signalling centres of the dorsal telencephalon are 
disrupted, leading to some dorsal progenitors implementing a ventral differentiation 
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programme in the rostral most telencephalon due to disruption of Fgf, BMP and Wnt 
signalling (Kuschel et al., 2003). Lamination of the cortex is disturbed in Gli3Xt/Pdn mice 
due to the loss of the cortical hem, a major source of Wnt signalling and a source of 
reelin, which is essential for lamination (Friedrichs et al., 2008). Furthermore, Magnani 
et al. (2013) demonstrated that subplate neurons are largely absent in these embryos. 
Subplate neurons are very early-born neurons produced mainly between E10.5 and 
E12.5 (Price et al., 1997), and the lack of subplate neurons in Gli3Xt/Pdn embryos 
indicates there may be a defect in cortical neurogenesis. Taken together, it is clear 
that Gli3 is required for the proper formation of the cortex.  
The focus of this chapter therefore will be the localisation of the Gli3 protein in the 
developing dorsal telencephalon as identified by immunofluorescence. I will show 
that, in alignment with mRNA sequencing, Gli3 protein is principally expressed in 
apical progenitors. I will then go on to evaluate the effect of Gli3 reduction on apical 


















3.2 Gli3 is primarily expressed in apical progenitors  
 
3.2.1 Specificity of the Gli3 antibody  
While Gli3 expression has been extensively studied at the mRNA level, there is very 
limited published data showing Gli3 protein expression in embryos in situ. At the 
protein level, only Yabut et al. (2016) have begun to elucidate where the protein is 
situated, however as stated above they only examined E16.5 and did not combine 
Gli3 with any other markers. I tested the specificity of a Gli3 antibody in 
immunofluorescence on cryostat sections of Emx1Cre;Gli3fl;/fl embryos and littermate 
controls at E12.5 and E17.5. In Emx1Cre;Gli3fl/fl embryos, Gli3 is inactivated in the 
cortex between E10.5 and E12.5 in a medial to lateral gradient (Amaniti et al., 2013). 
These embryos were used to examine the specificity of the antibody as Gli3 
expression is unaffected in the lateral ganglionic eminence (LGE), which served as a 
positive control. At E12.5, in control embryos Gli3 protein expression was clearly 
visible in the VZ of the cortex (figure 3.1 A-A”, B-B”), in agreement with published Gli3 
mRNA data (Amaniti et al., 2013; Hui et al., 1994). Gli3 is also expressed in the 
hippocampal primordium and in the cortical hem. As the antibody recognises the Gli3 
N-terminus, it recognises both the activator and repressor forms, hence it detects Gli3 
expression in the LGE (figure 3.1 E-E”, 3.2 A-A”, C-C”, E-E”, G-G”). However, in 
Emx1Cre;Gli3fl;/fl embryos Gli3 protein was greatly reduced in neocortex (figure 3.1 C-
C”, D-D”), consistent with the loss of Gli3 mRNA (Amaniti et al., 2013). This specific 
loss of Gli3 protein was also observed in E17.5 Gli3 conditional mutants. In E17.5, in 
control embryos Gli3 was still expressed in the cortex and LGE (figure 3.1 E-E”, F-F”) 
yet it was absent in the cortex of Emx1Cre;Gli3fl;/fl embryos (figure 3.1 G-G”, H-H”). 
In both control and mutant embryos at E12.5, Gli3 appeared to be mostly localised to 
the nucleus with some cytoplasmic staining visible along the very edge of the ventricle 
(figure 3.1 A-D”), in agreement with the observations of Yabut et al. (2016) at E16.5. 
However, at E17.5 Gli3 expression appeared to be more diffuse and showed more 
cytoplasmic staining (figure 3.1 E-H”). This is noteworthy, as although Gli3 functions 
as a transcription factor and so expression would be primarily expected in the nucleus, 
it is processed in and at base of the primary cilium, and so higher resolution images 
are needed to further resolve where the protein is localised. Overall though, the 
antibody showed good protein specificity and was clear at the cellular level, and so 






Figure 3.1: Gli3 and TOPRO-3 expression in the E12.5 and E17.5 cortex. 
Comparison between control and Emx1Cre;Gli3fl/fl embryos showing the specificity of 
the Gli3 antibody. Boxes on A, C, E, G represent area shown in B, D, F, H, 
respectively. A-D”. Gli3/TOPRO-3 immunofluorescence on coronal sections of E12.5 
cortex from control and Emx1Cre;Gli3fl/fl telencephalon. E-H”. Gli3/TOPRO-3 
immunofluorescence on coronal sections of E17.5 cortex from control and 
Emx1Cre;Gli3fl/fl telencephalon. Ctx; cortex, LGE; lateral ganglionic eminence. Scale 
bars = 25m (B”, F”, D”, H”), 100m (A”, C”), 500m (E”, G”).  
 
 
3.2.2 Gli3 is expressed in apical progenitors with minimal expression in basal 
progenitors in the early developing dorsal telencephalon   
Several groups have reported Gli3 mRNA to be expressed in the VZ in the mouse 
(Amaniti et al., 2013; Grove et al., 1998; Hui et al., 1994), and in humans, GLI3 mRNA 
was found to be co-expressed with PAX6 in radial glia cells (Pollen et al., 2014). I 
therefore examined Gli3 protein distribution between apical and basal progenitors in 
E11.5 and E12.5 control embryos to determine if Gli3 was expressed in apical and/or 
basal progenitors. At E11.5, Gli3 showed expression in the VZ of the cortex and there 
was clear coexpression with Pax6, used as a marker of apical progenitors (figure 3.2 
A-B”). However, there was very little expression outside of the VZ and little overlap 
between Gli3 and Tbr2, which labels basal progenitors (figure 3.2 C-D”). There were 
a few cells which did express both Gli3 and Tbr2 (marked by arrows, figure 3.2 D-D”), 
and it is possible that these were newly formed basal progenitors which had not yet 
fully switched off Gli3 expression. At E12.5, Gli3 expression was clear in the VZ and 
overlapped with Pax6 as shown at E11.5 (figure 3.2 E-F”). There was less overlap 
between Gli3 and Tbr2 than Pax6, although it was not as clear as at E11.5. There 
were more basal progenitors expressing both Gli3 and Tbr2 at E12.5, and these 
Gli3+Tbr2+ cells were mainly located in the VZ, lending credence to the hypothesis 
that these cells were newly formed basal progenitors which may not have 
downregulated Gli3 expression completely or may have inherited Gli3 protein from 
their parent cell (arrows, figure 3.2 H-H”). The expression of Gli3 protein mimics that 







Figure 3.2: Gli3, Pax6 and Tbr2 expression in E11.5 and E12.5 wild-type cortex. 
Boxes on A, C, E, G represent area shown in B, D, F, H, respectively. White arrows 
denote co-labelled cells. A-B”. Gli3 and Pax6 expression in the E11.5 cortex. C-D”. 
Gli3 and Tbr2 expression in the E11.5 cortex. E-F”. Gli3 and Pax6 expression in the 
E12.5 cortex. G-H”. Gli3 and Tbr2 expression in the E12.5 cortex. Ctx; cortex, LGE; 




3.2.3 Gli3 protein is reduced in Gli3Xt/Pdn embryos at E11.5 and E12.5  
Gli3Xt/Pdn embryos are a widespread tool for evaluating the result of reduced Gli3 
function on the development of the telencephalon. I used the Gli3 antibody to assess 
protein levels and distribution at E11.5 and E12.5 in these embryos. 
Immunofluorescence was carried out together with either Pax6 or Tbr2 to assess if 
the Gli3 expression pattern remained the same in these embryos.  
At E11.5, Gli3 was expressed in the VZ of the cortex of control embryos in apical 
progenitors (figure 3.3 A-B”) but in only a few basal progenitors (figure 3.3 C-D”). In 
Gli3Xt/Pdn mutant embryos, some Gli3 expression was still visible in the cortex but with 
a much reduced intensity. In the mutants, Gli3 expression again overlapped with Pax6 
in apical progenitors (figure 3.3 E-F”), but very little with Tbr2 in basal progenitors 
(figure 3.3 G-H”).   
At E12.5, Gli3 expression was visible in the VZ of the cortex in control embryos and 
overlapped with Pax6 in apical progenitors (figure 3.4 A-B”) but with only a few Tbr2+ 
basal progenitors (figure 3.4 C-D”). In the Gli3Xt/Pdn embryos, Gli3 was expressed at a 
reduced level in the VZ overlapping with Pax6 in apical progenitors (figure 3.4 E-F”). 
There appeared to be more Gli3 expression in E12.5 mutant basal progenitors (figure 
3.4 G-H”) than at E11.5.  
Overall, the immunofluorescent analyses reflected prior analyses of Gli3 mRNA 
expression in Gli3Xt/Pdn embryos and support that there were reduced Gli3 mRNA and 
Gli3 protein levels present in the cortex (Magnani et al., 2013; Friedrichs et al., 2008), 







Figure 3.3: Gli3 protein is reduced in Gli3Xt/Pdn embryos at E11.5. Boxes on A, C, 
E, G represent area shown in B, D, F, H, respectively. White arrows denote co-
labelled cells. A-B”. Gli3 and Pax6 expression in the E11.5 wild-type cortex. C-D”. 
Gli3 and Tbr2 expression in the E11.5 wild-type cortex. E-F”. Gli3 and Pax6 
expression in the E11.5 Gli3Xt/Pdn cortex. G-H”. Gli3 and Tbr2 expression in the E11.5 












Figure 3.4: Gli3 protein is reduced in Gli3Xt/Pdn embryos at E12.5. Boxes on A, C, 
E, G represent area shown in B, D, F, H, respectively. White arrows denote co-
labelled cells. A-B”. Gli3 and Pax6 expression in the E12.5 wild-type cortex. C-D”. 
Gli3 and Tbr2 expression in the E12.5 wild-type cortex. E-F”. Gli3 and Pax6 
expression in the E12.5 Gli3Xt/Pdn cortex. G-H”. Gli3 and Tbr2 expression in the E12.5 
Gli3Xt/Pdn cortex. Ctx; cortex, LGE; lateral ganglionic eminence. Scale bars = 25m 

























Figure 3.5: Location of cell counts. Placement of lateral and medial boxes for 
counting in E11.5 wild-type embryos (A), E11.5 Gli3Xt/Pdn embryos (B), E12.5 wild-
type embryos (C) and E12.5 Gli3Xt/Pdn embryos (D). Boxes were 175m wide and 
spanned the ventricular to pial cortical surface and were aligned parallel with the 
cortical ventricular surface. Analyses in this thesis were conducted on three adjacent 
sections per embryo in both hemispheres. Ctx; cortex, LGE; lateral ganglionic 








3.3 Reduction in Gli3 results in an increased apical progenitor population in 
Gli3Xt/Pdn embryos at E11.5 and a decreased apical progenitor population in 
Gli3Xt/Pdn embryos at E12.5 
 
My Gli3 protein expression analyses revealed that Gli3 was primarily expressed in 
apical progenitors, and so the effect of reducing Gli3 levels on the formation of apical 
progenitors was examined. Immunofluorescence was carried out against Pax6 and 
PCNA, a marker of proliferating cells (Hall et al., 1990), and the proportion of apical 
progenitors to the total number of progenitors was calculated. As described in section 
2.5.1 and as shown in figure 3.5, as neurogenesis progresses from lateral to medial 
cell counts were performed in boxes placed across the lateral and medial neocortex 
to compare the cortex in two slightly different stages of neurogenesis. These boxes 
were placed at the level where the epithalamus first appeared, to avoid the partial 
ventralisation of the rostral most Gli3Xt/Pdn dorsal telencephalon. Laterally, the 
proportion of apical progenitors was increased 1.16-fold in Gli3Xt/Pdn embryos from 
74.65±1.57% in control to 86.76±2.40% in mutants (n=4, p<0.05) (figure 3.6 A, B, E). 
However, medially the proportion of apical progenitors was unchanged and remained 
relatively similar at 92.69±1.55% in control and 89.79±0.85% in mutant (n=4, p>0.05) 
(figure 3.6 C, D, E). This clearly indicated that the reduction in Gli3 expression had an 
effect on the proportion of apical progenitors laterally where neurogenesis was more 
advanced.  
The effect on apical progenitor formation was also evaluated at E12.5 in the same 
manner as at E11.5 to assess if the defect remained 24 hrs later. At E12.5, laterally 
there was no difference in the proportion of apical progenitors between control and 
Gli3Xt/Pdn (71.34±1.58% in control and 68.49±2.69% in mutant, n=4, p<0.05) (figure 
3.7 A, B, E). However, medially there was a 1.22-fold decrease in the proportion of 
apical progenitors in the Gli3Xt/Pdn mutant compared to control (89.98±1.56% in control 
and 74.05±4.13% in mutant, n=4, p<0.05) (figure 3.7 C, D, E). 
Combined with the data from E11.5, over the course of 24 hrs the proportion of apical 
progenitors decreased. Laterally, there was an increased proportion at E11.5 but no 
difference between control and mutant at E12.5, and medially there was no difference 
between control and mutant at E11.5 to a decreased apical progenitor proportion at 
E12.5, which may have reflected the lateral to medial transmission of neurogenesis. 






Figure 3.6: Reduction in Gli3 resulted in an increased proportion of lateral apical 
progenitors in Gli3Xt/Pdn embryos at E11.5. A-D. Pax6/PCNA immunofluorescence 
on sections of E11.5 cortex from control and Gli3Xt/Pdn embryos. E. Reduced Gli3 
significantly increased the proportion of lateral apical progenitors in Gli3Xt/Pdn mutants, 
whereas there was no effect on the proportion of medial apical progenitors. All 
statistical data represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-
Whitney U-test. Scale bars = 100m.  
 
 
(2003) who reported that expression of Pax6 was unaffected prior to E12.5, but was 






















Figure 3.7: Reduction in Gli3 resulted in a decreased proportion of medial apical 
progenitor in Gli3Xt/Pdn embryos at E12.5. A-D. Pax6/PCNA immunofluorescence 
on sections of E12.5 cortex from control and Gli3Xt/Pdn embryos. E. Reduced Gli3 
significantly decreased the proportion of medial apical progenitors in Gli3Xt/Pdn 
mutants, whereas there was no effect on the proportion of lateral apical progenitors. 
All statistical data represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-
Whitney U-test. Scale bars = 100m.  
 
 
3.4 Gli3 reduction results in a reduced basal progenitor population in Gli3Xt/Pdn 
embryos at E11.5 and an increased basal progenitor population at E12.5  
 
As basal progenitors are formed via the asymmetric divisions of apical progenitors, 
the proportion of basal progenitors present in the Gli3Xt/Pdn mutant was assessed to 
see if it was altered along with the proportion of apical progenitors. PCNA 
immunofluorescence was carried out alongside Tbr2 immunofluorescence and the 
proportion of basal progenitors present at E11.5 was calculated. Laterally, as opposed 
to Pax6, there was a 1.36-fold decrease in the proportion of basal progenitors formed 
in the mutant (29.72±3.59% in control and 21.91±1.34% in mutant, n=4, p<0.05) 
(figure 3.8 A, B, E). However medially, as with Pax6, there was no statistically 
significant difference in the proportion of basal progenitors (13.43±1.29% in control 
and 14.55±1.15% in mutant, n=4, p>0.05) (figure 3.8 C, D, E). It is evident that the 
Gli3 reduction caused disruption to the normal formation of basal progenitors, possibly 
as a consequence of the disruption in the apical progenitor population.  
The same analyses on basal progenitors were repeated at E12.5 to measure if the 
disruption in basal progenitor production at E11.5 had a consequent effect 24 hrs 
later. Laterally, there was a 1.47-fold increase in the proportion of basal progenitors 
in the mutant compared to control (30.15±1.79% in control and 44.21±3.35% in 
mutant, n=4, p<0.05) (figure 3.9 A, B, E), and a 2.01-fold increase in basal progenitor 
proportion medially (14.45±2.86% in control and 30.04±3.79% in mutant, n=4, p<0.05) 
(figure 3.9 C, D, E). Taken together, the decreased proportion of basal progenitors 






Figure 3.8: Reduction in Gli3 resulted in a decreased proportion of lateral basal 
progenitors in Gli3Xt/Pdn embryos at E11.5. A-D. Tbr2/PCNA immunofluorescence 
on sections of E11.5 cortex from control and Gli3Xt/Pdn embryos. E. Reduced Gli3 
significantly decreased the proportion of lateral basal progenitors in Gli3Xt/Pdn mutants, 
whereas there was no effect on the proportion of medial basal progenitors. All 
statistical data represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-
Whitney U-test. Scale bars = 100m.  
 
 























Figure 3.9: Reduction in Gli3 resulted in increased proportions of lateral and 
medial basal progenitors in Gli3Xt/Pdn embryos at E12.5. A-D. Tbr2/PCNA 
immunofluorescence on sections of E12.5 cortex from control and Gli3Xt/Pdn embryos. 
E. Reduced Gli3 significantly increased the proportions of lateral and medial basal 
progenitors in Gli3Xt/Pdn mutants. All statistical data represents mean ± 95% 
confidence interval; n=4; * = p<0.05; Mann-Whitney U-test. Scale bars = 100m.  
 
 
3.5 Gli3 reduction results in a decreased neuronal population in Gli3Xt/Pdn 
embryos at E11.5 and an increased neuronal population at E12.5  
 
Due to the alterations in apical and basal progenitor proportions, the proportions of 
early-born neurons formed in the E11.5 and E12.5 neocortex were assessed. 
Immunofluorescence against Tbr1 was carried out using TOPRO-3 as a nuclear 
counterstain to determine the proportion of neurons compared to the total number of 
cells. At E11.5, laterally there was a nearly two-fold decrease in the proportion of 
neurons formed in the mutant compared to control (19.55±1.78% in control and 
9.97±1.90% in mutant, n=4, p<0.05) (figure 3.10 A, B, E). This was in alignment with 
the increased proportion of apical progenitors which seemed to have reduced 
differentiation rates into basal progenitors and neurons. However, medially, following 
the same pattern as with apical progenitors and basal progenitors, there was no 
difference in neuron formation (8.44±1.08% in control and 8.87±1.92% in mutant, n=4, 
p>0.05) (figure 3.10 C, D, E).  
The proportion of neurons formed was also assessed at E12.5 using Tbr1 and 
TOPRO-3. In the lateral cortex, the proportion of neurons formed in Gli3Xt/Pdn embryos 
was increased 1.16-fold compared to control (19.45±1.73% in control and 
22.52±2.33% in mutant, n=4, p<0.05) (figure 3.11 A, B, E). Medially, there was a 
larger increase in neuron proportion in the mutant compared to control of 1.52-fold 
(9.40±0.64% in control and 14.30±2.56% in mutant, n=4, p<0.05) (figure 3.11 C, D, 
E). The differences in neuron formation again align with the differences in basal 







Figure 3.10: Reduction in Gli3 resulted in a decreased proportion of lateral 
early-born neurons in Gli3Xt/Pdn embryos at E11.5. A-D. Tbr1/TOPRO-3 
immunofluorescence on sections of E11.5 cortex from control and Gli3Xt/Pdn embryos. 
E. Reduced Gli3 significantly decreased the proportion of lateral early-born neurons 
in Gli3Xt/Pdn mutants, whereas there was no effect on the proportion of medial early-
born neurons. All statistical data represents mean ± 95% confidence interval; n=4; * 


























Figure 3.11: Reduction in Gli3 resulted in increased proportions of lateral and 
medial early-born neurons in Gli3Xt/Pdn embryos at E12.5. A-D. Tbr1/TOPRO-3 
immunofluorescence on sections of E12.5 cortex from control and Gli3Xt/Pdn embryos. 
E. Reduced Gli3 significantly increased the proportions of lateral and medial early-
born neurons in Gli3Xt/Pdn mutants. All statistical data represents mean ± 95% 























3.6 Discussion  
 
Gli3 protein is clearly expressed in the developing dorsal telencephalon at time points 
critical to the development of the cortex. The majority of Gli3 was expressed 
overlapping with Pax6 in apical progenitors, however there was also some expression 
in Tbr2+ basal progenitors. There was a reduction in the intensity of the Gli3 staining 
in the E11.5 and E12.5 cortex of Gli3Xt/Pdn embryos, and these were used to further 
examine the role of Gli3 on neuron formation in the developing cortex.  
At E11.5 in the lateral telencephalon, there was a larger proportion of apical 
progenitors to total progenitors in the Gli3Xt/Pdn mutant compared to control. At the 
same time, there was a smaller proportion of basal progenitors and a smaller 
proportion of neurons. By E12.5, the proportion of apical progenitors in the mutant 
was not significantly different to the proportion in control, effectively showing a 
decrease in the proportion of apical progenitors from E11.5 to E12.5 in the mutant. 
Conversely, the proportions of basal progenitors and neurons had both increased in 
the mutant. In the medial telencephalon at E11.5, there was no significant difference 
in the proportion of apical progenitors, basal progenitors or neurons in the mutant 
compared to control. However, by E12.5, there was a significantly smaller proportion 
of apical progenitors in the mutant, and significantly larger proportions of basal 
progenitors and neurons. At E11.5 there were differences measured in the progenitor 
and neuronal proportions laterally yet there were no differences measured medially. 
This may have been due to the progression of neurogenesis from lateral to medial, 
but it cannot be ruled out that altered signalling within the Gli3Xt/Pdn dorsal 
telencephalon may also have contributed, or possibly a mixture of both. However, the 
rostro-caudal level examined was chosen to minimise the impact of disrupted 
signalling centres. Taken together, the general trend for increased apical progenitors 
and decreased basal progenitors and neurons at E11.5 followed by decreased apical 
progenitors and increased basal progenitors and neurons at E12.5 would indicate an 
early delay in neurogenesis. As Gli3 showed the greatest expression in apical 
progenitors, it is likely that this delay was due to a cell-autonomous effect on the 





3.6.1 Gli3 protein is primarily expressed in apical progenitors 
Loss of Gli3 has been linked with disruptions to the developing telencephalon since 
Johnson (1967) described the extra-toes (Gli3Xt/Xt) mouse, which carries a deletion of 
the 3’ end of Gli3 resulting in a null mutation. Gli3 mRNA has been shown to be 
expressed in the dorsal telencephalon, particularly in the VZ at E11.5 and E12.5 
(Amaniti et al., 2013; Hui et al., 1994), close to the beginning of neurogenesis in the 
cortex and important time points for the development of the final structure and function 
of the cortex (Martynoga et al., 2012). Furthermore, it has been confirmed by western 
blot that Gli3 is expressed in the developing telencephalon (Magnani et al., 2013; 
Fotaki et al., 2006), but there is little published data showing the cellular location of 
the Gli3 protein in dorsal telencephalon at different ages. Here, in alignment with 
mRNA in situ (Amaniti et al., 2013), it was confirmed via immunofluorescence that 
Gli3 is expressed mostly in the VZ at E11.5 and E12.5 of the developing neocortex, 
showing mainly concomitant expression with Pax6 and so in apical progenitors. 
Indeed, in the developing human telencephalon, Pollen et al. (2014) carried out single-
cell mRNA sequencing and also revealed that GLI3 clusters with PAX6 and is a 
marker of radial glial cells. Due to its high expression in apical progenitors, which are 
the source of basal progenitors and during early neurogenesis the main source of 
neurons, Gli3 is therefore in a prime position to regulate early neurogenesis.  
There was much less overlap between Gli3 expression and Tbr2. The basal 
progenitors in which Gli3 expression was the most intense were located within the 
VZ, presumably moving basally on route to the forming SVZ. Englund et al. (2005) 
reported Tbr2+ progenitors in the VZ commonly expressed Pax6 as well, although 
both were at lower levels than when either was expressed alone. It is likely that these 
progenitors which express both Pax6 and Tbr2 are newly formed basal progenitors 
moving from the ventricular surface through the VZ to the SVZ. Pax6 transcription has 
likely stopped but inherited mRNA and protein from the parent cell has not yet been 
fully broken down, and Tbr2 expression has already begun, resulting in dual 
expression. Based on their location, it is likely that the basal progenitors expressing 
Gli3 also belong to this population of basal progenitors newly formed from apical 
progenitors, and Gli3 has not fully cleared yet.  
On a subcellular level, the localisation of Gli3 is interesting. Based on its role as a 
transcription factor, clearly expression would be expected in the nucleus. Indeed, I 
saw clear nuclear overlap between Gli3 and TOPRO-3 (figure 3.1). However it was 
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also abundantly evident that there was cytoplasmic expression which was particularly 
obvious at E17.5 (figure 3.1 E-H”), and which was also reported at E16.5 by Yabut et 
al. (2016), who described Gli3 expression to be cytoplasmic along the edge of the VZ. 
In the absence of Shh, the full-length Gli3 protein translocates to the base of the 
primary cilium, where it undergoes PKA phosphorylation triggering further 
phosphorylation by GSK3 and CK1. These phosphorylated residues result in a 
TrCP binding site and subsequent SCFTrCP ubiquitination (Tempe et al., 2006). Via 
this mechanism, the C-terminus is cleaved from the full-length Gli3 protein via the 
ubiquitin-proteasome pathway and targeted for degradation. It is hypothesised that 
the N-terminus repressor form of Gli3 then translocates to the nucleus where it 
undertakes its role as a transcriptional repressor (Wen et al., 2010). Clearly, there 
would be some cytoplasmic Gli3 expression expected, however it would be expected 
predominantly in the region of the primary cilium. Whilst in figure 3.1 F there appeared 
to be a band of stronger expression along the very edge of the ventricle where the 
primary cilium is located, Gli3 expression was widespread throughout the whole 
cytoplasm. It is possible that this expression is due to the processing and translocation 
of the protein from the cilium to the nucleus, however this may also indicate control 
over the nuclear localisation of Gli3 as a mechanism to regulate Gli3 repression. As 
stated before, higher resolution images of Gli3 expression are required, and it would 
be interesting to combine Gli3 staining with ciliary markers, such as Arl13b and 
gamma-tubulin.  
Gli3 expression was also evaluated in the Gli3Xt/Pdn mutant embryo at E11.5 and 
E12.5. At E11.5, there was expression of Gli3 in the mutant dorsal telencephalon, 
however it was at a lower level than in control. Gli3 was chiefly expressed in the Pax6+ 
apical progenitors of the mutant but was also expressed in some basal progenitors 
within the VZ as in control. At E12.5, again Gli3 was expressed in the dorsal 
telencephalon of the mutant in the VZ, but at a lower level than in control. Gli3 
expression was more predominant in apical progenitors as opposed to basal 
progenitors. Whilst the intensity of the Gli3 staining in the Gli3Xt/Pdn dorsal 
telencephalon at E11.5 and E12.5 was reduced, quantification of the amount of Gli3 
protein is still required, either by western blot or by measuring fluorescence levels.  
In figure 3.3 it is also clear how the reduction in Gli3 affects the size and shape of the 
dorsal telencephalon. At E11.5, the cortex becomes thinner and longer in the mutants 
with expanded ventricles and obvious reduction in the size of the midline structures, 
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as has been reported previously (Friedrichs et al., 2008; Kuschel et al., 2003). At 
E12.5, there is again a reduction of the midline structures, with a longer and thinner 
dorsal telencephalon. At both ages, the LGE is reduced in size.  
Altogether, Gli3 protein expression was evident in the dorsal telencephalon at E11.5 
and E12.5, coinciding mostly with Pax6 expression in apical progenitors. As shown 
here, in the Gli3Xt/Pdn embryo the pattern of Gli3 expression remains the same as in 
control embryos although at a lower level. It is clear that a reduction in Gli3 affects 
both the size and shape of the dorsal telencephalon, making it evident that the level 
of Gli3 expression is critically important in the proper development of the cortex. 
 
3.6.2 Gli3 reduction leads to alterations in the apical progenitor, basal 
progenitor and early neuronal populations 
Due to the abundance of Gli3 protein in the VZ of the E11.5 and E12.5 Gli3Xt/Pdn 
embryos, I assessed how the reduction of Gli3 in these mutant embryos would affect 
progenitors and subsequent cortical neurons. As stated, overall at E11.5 there was 
an increased apical progenitor proportion and decreased basal progenitor and 
neuronal proportion in the lateral cortex, whilst the medial cortex was unaffected. By 
E12.5, the apical progenitor proportions both laterally and medially had decreased 
compared to control with respect to the E11.5 measurements, and the basal 
progenitor and neuronal proportions had increased. Taken together, one possible 
explanation for the disruption to the progenitor and neuronal proportions at E12.5, is 
that the system attempted to rectify the increased proportion of apical progenitors 
present at E11.5 by differentiating a large proportion of them into basal progenitors 
and neurons in the 24 hrs between analyses, but did this overzealously, thereby 
surpassing the control levels of progenitors and neurons. In this scenario, these 
analyses could suggest that the timing of asymmetrical, differentiative divisions has 
been disrupted in the Gli3Xt/Pdn embryo, ultimately leading to a delay in neuron 
formation.  
Haubensak et al. (2004) used Tis21-GFP knock-in mice to highlight the proportion of 
progenitors in the neocortex dividing asymmetrically to form more differentiated cells. 
They showed that at the beginning of neurogenesis at approximately E10.5, apical 
progenitors in the VZ were dividing asymmetrically and had already formed basal 
progenitors which were translocating basally and also expressing Tis21, indicating 
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they were ready to begin differentiative division. The larger proportion of apical 
progenitors present in Gli3Xt/Pdn embryos at E11.5 and concomitant smaller 
proportions of basal progenitors and neurons may indicate that there was a delay in 
the timing of when apical progenitors should begin to divide differentiatively into basal 
progenitors and neurons. At E12.5, the smaller proportion of apical progenitors and 
larger proportions of basal progenitors and neurons in the mutant may indicate the 
system attempting to overcome the delay by pushing for more asymmetrical, 
differentiative divisions of apical progenitors into basal progenitors and neurons in the 
24 hrs between measurements, depleting the apical progenitor pool. One way to 
further examine this would be to look at Tis21 expression in Gli3Xt/Pdn embryos, which 
was carried out and will be discussed in section 5.6.  
Another possible explanation for the decreased basal progenitor proportion observed 
laterally at E11.5 could be a decrease in basal progenitor proliferation, although the 
concomitant increase in apical progenitor proportion would argue for an alteration in 
asymmetric division of apical progenitors. Furthermore, as Gli3 protein was primarily 
expressed in apical progenitors, I would argue that it was more likely that Gli3 had a 
direct effect on apical progenitors, altering their balance between differentiative and 
proliferative division and therefore the amount of basal progenitors formed, rather 
than an effect on basal progenitor proliferation itself. Indeed, there was also a 
decrease in neuronal proportion at E11.5, which can only be attributed to alterations 
in neurogenic progenitor division, so if basal progenitors at E11.5 were failing to 
proliferate and differentiating instead, I would not have expected to see a nearly two-
fold decrease in the proportion of neurons.  
As well as Gli3 cell intrinsic effects on apical progenitors, the contribution from 
alterations to signalling in the Gli3Xt/Pdn dorsal telencephalon cannot be ruled out. 
Kuschel et al. (2003) revealed that in the rostral-most Gli3Xt/Pdn dorsal telencephalon 
there was ectopic activation of Fgf8 expression. Furthermore, due to the reduction in 
the cortical hem, Wnt2b, Wnt3a and Bmp4 expression are abolished. Although the 
rostro-caudal level at which the analyses were performed was carefully selected to 
minimise the impact of the disruption in signalling, it is likely that it still influenced the 
cell populations.  
One caveat of using Pax6 and Tbr2 as markers of apical and basal progenitors is that 
there is not completely exclusive expression of the two markers between the two 
populations. The sum of Pax6+ and Tbr2+ cells across the four conditions examined 
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(E11.5 lateral and medial and E12.5 lateral and medial) totalled between 101% and 
112%. However, as mentioned above, this is in line with previous studies which also 
found some double expression of the two proteins in single cells (Englund et al., 
2005), which were suggested to be newly formed basal progenitors which had 
inherited Pax6 protein from their parent cell. I would suggest that the Gli3 expression 
seen in a number of Tbr2+ basal progenitors (section 3.2.2) reflects the same 
situation. It should also be noted that Tbr2 is expressed in some preplate neurons, 
including postmitotic Cajal-Retzius (CR) cells (Englund et al., 2005). However, as 
PCNA was used in conjunction with Tbr2, only those Tbr2+ cells which were 
progenitors were counted. 
Another caveat of the above experiments was the use of Tbr1 to measure the 
proportion of early-born neurons. In addition to being expressed in early-born neurons 
generated from apical and basal progenitors and which will populate layer VI, Tbr1 is 
also expressed in the marginal zone in CR cells, cells which are born outwith the 
cortex and so not from cortical apical and basal progenitors. In the lateral 
telencephalon CR cells derive from the ventral pallium, which is slightly expanded in 
Gli3Xt/Pdn embryos (Friedrichs et al., 2008). One would expect therefore to see an 
increase in the proportion of Tbr1+ cells in the lateral measurements undertaken 
above, however, I observed a decrease at E11.5. This could indicate that the delay in 
neurogenesis is greater than was measured. Medially, CR cells derive from the 
cortical hem, which is severely reduced in the Gli3Xt/Pdn mutant, however at E11.5 
there was no difference between the proportion of Tbr1+ neurons in the mutant and 
control, and an increased proportion of neurons in the mutant compared to control at 
E12.5. Therefore, it is likely that the Tbr1+ neurons counted at the level used here 
reflect early-born neurons derived from apical progenitors. However, in the future it 
may be important to repeat these counts using a different neuronal marker, or to carry 
out immunofluorescence against Tbr1 and reelin, to rule out the contribution from any 








3.7 Summary  
 
It has been shown here that Gli3 protein expression aligns with Gli3 mRNA expression 
patterns, and that Gli3 is expressed in the dorsal telencephalon at E11.5 and E12.5. 
Gli3 is primarily expressed in Pax6+ apical progenitors, with co-expression in a very 
small subset of likely newly differentiated Tbr2+ basal progenitors. Furthermore, Gli3 
is greatly reduced in the neocortex of Gli3Xt/Pdn embryos. As Gli3 was shown to be 
primarily expressed in apical progenitors which give rise to basal progenitors and 
early-born cortical neurons, the impact of the reduction of Gli3 to these populations 
was assessed. In the lateral cortex of E11.5 Gli3Xt/Pdn embryos, there was an 
increased proportion of apical progenitors alongside decreased proportions of basal 
progenitors and neurons. By E12.5 in the lateral cortex, the proportion of apical 
progenitors in the mutant compared to control was unaltered, yet the proportions of 
basal progenitors and neurons were increased. In the medial cortex, at E11.5 the 
apical and basal progenitor and neuronal populations were unchanged, but by E12.5 
there was a decreased apical progenitor proportion and increased basal progenitor 
and neuronal proportions. These analyses revealed a delay in neurogenesis at E11.5 
in the Gli3Xt/Pdn dorsal telencephalon which was overcome by E12.5. As Gli3 
expression was mostly confined to apical progenitors, it is likely that this delay was 
the result of cell intrinsic properties of Gli3 mutant apical progenitors, altering the 
proliferative/differentiative balance of these progenitors. However, as signalling is also 
altered in the Gli3Xt/Pdn dorsal telencephalon, it cannot be ruled out that alterations in 











Chapter 4: Reduction in Gli3 results in major alterations to cell cycle 
kinetics in the Gli3Xt/Pdn neocortex 
 
4.1 Introduction  
 
As revealed in chapter 3, Gli3 protein was primarily expressed in apical progenitors 
of the early developing cortex, with little expression in basal progenitors. In the 
Gli3Xt/Pdn cortex, Gli3 was expressed in apical progenitors but was reduced. In these 
embryos, the proportion of apical progenitors was increased at E11.5 in the lateral 
cortex, whilst the proportions of basal progenitors and early-born neurons were 
decreased. However, in the medial cortex the proportions of all three progenitor 
populations were unaltered. At E12.5, in the mutant lateral cortex, the proportion of 
apical progenitors was unchanged compared to control, yet the proportions of basal 
progenitors and early-born neurons were increased. By E12.5 in the medial cortex, 
the apical progenitor proportion was decreased compared to control whereas the 
basal progenitor and early-born neuron proportions were increased compared to 
control. In this chapter, I will explore the cell cycle as a mechanism through which the 
progenitor populations may have been altered, leading to a delay in neurogenesis in 
the lateral cortex.  
In order for the adult brain to form appropriately, the correct number of neurons must 
be produced at the correct time. Glutamatergic projection neurons of the murine 
cortex are mainly formed from apical and basal cortical progenitors, which must exit 
the cell cycle at the appropriate time to correctly form the required number of neurons 
for each cortical layer. If there is an increase in the differentiative capacity of a 
progenitor population, despite an initial increase in the production of neurons, the 
progenitor population will become depleted. This will ultimately lead to a reduction in 
the total number of neurons formed compared to control as the progenitors are 
exhausted. Conversely, if there is an increase in the proliferative capacity of a 
progenitor population, whilst there will be an initial decrease in the number of neurons 
formed due their delayed production, the larger progenitor pool will ultimately give rise 
to a larger population of neurons as compared to control (Dehay & Kennedy, 2007). 
A delay in the division of progenitors at the appropriate time can result in neurons 
from the incorrect layer being produced, resulting in the over-proliferation of one layer 
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at the expense of another, and leading to cytoarchitectural differences in the adult 
brain (Lange et al., 2009; Pilaz et al., 2009). In a number of seminal studies performed 
over the last few decades, the importance of the cell cycle in the decision of 
proliferative versus differentiative division has become apparent. 
When a daughter cell is produced from a dividing mother cell, the daughter will enter 
G1-phase. G1-phase is a growth phase, during which the cell makes the decision as 
to whether it will leave the cell cycle or if it will remain in the cell cycle and divide 
again. During G1-phase, a restriction point is reached. If the retinoblastoma (Rb) 
family of proteins are hypophosphorylated the cell will not progress past the 
checkpoint, in which case it will differentiate or remain in G1-phase. Upon Rb 
hyperphosphorylation, the cell will progress past the checkpoint and genes required 
for transition into the next phase of the cell cycle will be up-regulated (Blagosklonny 
& Pardee, 2002). The following stage, S-phase, sees replication of the DNA. From 
here, cells will progress into a second growth phase, G2-phase, followed by 
undergoing mitosis during M-phase.  
When each cortical progenitor divides, it may undergo either proliferative or 
differentiative division. When apical and basal progenitors undergo proliferative 
division, they produce two new apical or two new basal progenitors, respectively. 
When apical progenitors undergo differentiative division, they produce either one 
apical progenitor and one basal progenitor or neuron, or two neurons. When basal 
progenitors undergo differentiative division, they may produce one basal progenitor 
and one neuron, or more commonly two neurons.  
The length of G1-phase has been shown to have a tight correlation with whether a 
progenitor will undergo proliferative or differentiative division. A shorter G1-phase has 
been shown to correlate with proliferative division (Lange et al., 2009; Pilaz et al., 
2009), whilst G1-phase lengthening is required for differentiative division (Calegari & 
Huttner, 2003). The “cell cycle length” model suggests that a longer G1-phase allows 
for progenitors to receive and respond to differentiative signals (Calegari & Huttner, 
2003). Conversely, S-phase has been suggested to be longer when a progenitor will 
undergo proliferative division, allowing for extra time to be spent checking the fidelity 
of DNA replication (Gonzales et al., 2015; Arai et al., 2011). S-phase then gets shorter 
as progenitors undergo differentiative division. As with S-phase, G2-phase has been 
reported to be shorter during proliferative division, so that longer S- and G2-phases 
allow for progenitors to respond to proliferative signals (Gonzales et al., 2015). Finally, 
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Pilaz et al. (2016) revealed that lengthening of M-phase results in a decrease in 
progenitor proliferation and an increase in neuron formation, altering the balance in 
apical progenitor division. Altogether, a shorter G1-phase, longer S- and G2-phases, 
followed by a shorter M-phase appear to correlate with a proliferative division. 
However, a longer G1-phase, shorter S- and G2-phases, and longer M-phase appear 
to correlate with a differentiative division, with varying degrees of evidence to support 
the effect of altering each phase length.  
Clearly, cell cycle length is important in the decision of proliferative or differentiative 
division. In the E11.5 and E12.5 Gli3Xt/Pdn cortex, I reported alterations to the apical 
and basal progenitor and early-born neuron populations, likely in part caused by 
differences in the proliferative and differentiative divisions of the progenitors. By 
deleting Gli3 in the dorsal telencephalon later in neurogenesis using a NestinCre 
driver line, Wang et al. (2011) reported that basal progenitors were depleted due to a 
reduction of apical progenitor proliferation and increased differentiation of the basal 
progenitors themselves. Meanwhile, in the limb bud, Gli3 has been shown to promote 
differentiation at the expense of proliferation by negatively regulating the G1- to S-
phase promoting Cyclin dependent kinase 6, Cdk6 (Lopez-Rios et al., 2012). This 
raises the possibility that Gli3 also regulates the cell cycle in cortical progenitors, 
which will in turn influence its effect over proliferative and differentiative division.  
This chapter will address if reducing Gli3 in the Gli3Xt/Pdn cortex affects the cell cycle. 
Firstly, I measured if there was an alteration in cell cycle re-entry/cell cycle exit at 
E11.5 and E12.5 in the lateral and medial cortex. Following this, I measured the length 
of each phase of the cell cycle in the total progenitor population to determine if cell 
cycle length was altered in the mutant. I found that it was reduced at both E11.5 and 
E12.5, and as Gli3 was primarily expressed in apical progenitors, I then measured 
each phase length in both apical and basal progenitors separately. In the Gli3Xt/Pdn 
neocortex, there was a decrease in the total cell cycle length, and in particular a 
shortening of both G1- and S-phases in apical progenitors, with very little effect on 







4.2 Cell cycle exit is decreased in the Gli3Xt/Pdn mutant at E11.5 but increased at 
E12.5  
 
At E11.5, in the Gli3Xt/Pdn lateral cortex there was an increased apical progenitor 
proportion and decreased basal progenitor and neuronal proportions, whilst these 
remained unchanged in the medial cortex. Laterally, basal progenitors and neurons 
may have undergone apoptosis, and/or apical progenitors may have divided 
proliferatively, re-entering the cell cycle to produce new apical progenitors at the 
expense of basal progenitors and neurons. By E12.5, the apical progenitor proportion 
was unchanged and the basal progenitor and neuronal proportions were increased 
laterally, whilst medially there was a decrease in apical progenitor proportion and 
increased basal progenitor and neuronal proportions. Here both laterally and medially, 
apical progenitors may have undergone cell death and/or there was an increase in 
apical and basal progenitor cell cycle exit, followed by differentiation of both apical 
and basal progenitors into neurons.  
I therefore examined progenitor cell cycle exit at these time points in the Gli3Xt/Pdn 
neocortex. In order to assess cell cycle exit, pregnant females were injected 
intraperitoneally (IP) with BrdU and sacrificed 24 hrs later. BrdU is a thymidine 
analogue which is incorporated into synthesising DNA, and so labels proliferating cells 
in S-phase of the cell cycle (Gratzner, 1982). Immunofluorescence against BrdU and 
PCNA was carried out, and the proportions of BrdU+/PCNA+ and BrdU+/PCNA- cells 
were counted. Cells which were in S-phase at the time of BrdU injection became 
BrdU+, and would also be PCNA+ if, 24 hrs later, these cells had not exited the cell 
cycle and so remained as progenitors. In contrast, if they had exited the cell cycle and 
differentiated into neurons, they would be PCNA-. Embryos were dosed with BrdU at 
E10.5 and sacrificed at E11.5 to assess the cell cycle exit of progenitors in the 24 hrs 
preceding E11.5, and dosed with BrdU at E11.5 before sacrifice at E12.5 to assess 
cell cycle exit in the 24 hrs preceding E12.5. As with previous analyses, the lateral 
and medial neocortex were examined (figure 4.1 A).  
In the lateral E11.5 neocortex, the proportion of BrdU+/PCNA- neurons that had 
formed following a differentiative division, was decreased in the Gli3Xt/Pdn embryo 
compared to control (15.77±0.86% in control and 7.20±1.13% in mutant, n=4, p<0.05) 
(figure 4.1 B, C, F), indicating mutant progenitor cell cycle re-entry. This agrees with 






























Figure 4.1: Cell cycle exit was decreased laterally in the Gli3Xt/Pdn mutant at 
E11.5. A. Schematic depicting the experimental BrdU paradigm used to measure cell 
cycle exit. BrdU was injected into pregnant dams at either E11.5 or E12.5 and 
embryos were harvested 24 hrs later. B-E. BrdU/PCNA immunofluorescence on 
sections of E11.5 cortex from control and Gli3Xt/Pdn embryos. F. The proportion of 
BrdU+/PCNA- cells was significantly decreased in the Gli3Xt/Pdn lateral cortex. There 
was no significant difference between control and mutant in the medial cortex. All 
statistical data represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-
Whitney U-test. Scale bars = 100m.  
 
 
larger apical progenitor population and smaller basal progenitor and early-born 
neuron populations, indicating a delay in the onset of differentiative divisions. In the 
medial neocortex, there was no change between the proportion of BrdU+/PCNA- cells 
in the mutant compared to control (4.55±0.86% in control and 4.13±1.13% in mutant, 
n=4, p>0.05) (figure 4.1 D, E, F). Indeed, the analyses of apical and basal progenitors 
and early-born neurons also did not show any differences in the medial E11.5 cortex.  
This analysis was repeated at E12.5. At this timepoint in the lateral neocortex, there 
was an increase in the proportion of BrdU+/PCNA- cells in the Gli3Xt/Pdn embryo 
compared to control (12.03±2.05% in control and 18.56±2.75% in mutant, n=4, 
p<0.05) (figure 4.2 A, B, E), indicating a shift towards differentiative divisions and cell 
cycle exit at the expense of proliferative divisions in the mutant in the 24 hrs time 
interval. In the medial neocortex at E12.5, again there was an increase in the 
proportion of differentiative to proliferative divisions in the mutant compared to control 
(11.25±1.25% in control and 15.27±1.32% in mutant, n=4, p<0.05) (figure 4.2 C, D, 
E). Further, this was reflected as a decreased proportion of apical progenitors and 
increased proportions of basal progenitors and neurons. Altogether, there was an 
increase in cell cycle re-entry in the E11.5 lateral cortex, followed by increased cell 









Figure 4.2: Cell cycle exit was increased in the Gli3Xt/Pdn mutant at E12.5. A-D. 
BrdU/PCNA immunofluorescence on sections of E12.5 cortex from control and 
Gli3Xt/Pdn embryos. E. The proportion of BrdU+/PCNA- cells was significantly increased 
in the Gli3Xt/Pdn lateral and medial cortex. All statistical data represents mean ± 95% 
confidence interval; n=4; * = p<0.05; Mann-Whitney U-test. Scale bars = 100m.  
 
 
4.3 Cell cycle phase lengths are altered in the total cortical progenitor 
population of E11.5 and E12.5 Gli3Xt/Pdn embryos  
 
As mentioned before, the cell cycle is critical to the decision of which mode of division 
a progenitor will undertake. Cdk6, a gene critical to the progression of progenitors 
from G1-phase into S-phase, is directly regulated by Gli3 (Lopez-Rios et al., 2012; 
Vokes et al., 2008). As cell cycle re-entry/exit were shown to be disrupted in the 
Gli3Xt/Pdn cortex at E11.5 and E12.5, resulting in an alteration in 
proliferative/differentiative division, the length of the cell cycle was examined. 
Decreased G1- and M-phases and increased S- and G2-phases would indicate 
increased progenitor proliferation, whilst longer G1- and M-phases and shorter S- and 
G2-phases would indicate increased differentiative division. Before undertaking 
extensive analyses of the cell cycle in apical and basal progenitors separately, I 
examined both progenitor populations together. Cell cycle phase lengths were found 
to be altered, and as Gli3 expression is mainly restricted to apical progenitors, I 
examined both populations separately to determine if Gli3 acted cell-autonomously.    
 
4.3.1 Determination of the length of each phase of the cell cycle 
To begin with, S-phase length was measured and from here total cell cycle length was 
calculated. IdU, a thymidine analogue distinguishable from BrdU (Gratzner, 1982), 
was injected IP into E11.5 and E12.5 pregnant females, followed by IP injection of 
BrdU 1.5 hrs later. Females were sacrificed 30 mins after BrdU injection, and embryos 
were harvested (figure 4.3 A). IdU and BrdU were used as they label cells in S-phase 
at the time of administration of each substance. The fraction of cells in S-phase 
compared to the total number of proliferative cells within the population measured, is 
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proportional to the length of S-phase (TS) as compared to the length of the total cell 
cycle (TC), according to Nowakowski et al. (1989). As the progenitors of a population 
exhibit asynchronous progression through the cell cycle, by administering IdU and 
BrdU sequentially it is to possible to distinctly label different proportions of the 
progenitors. A small proportion will be labelled with IdU only; those cells were in S-
phase at the time of IdU administration but have progressed into G2-phase by the 
time of BrdU administration. These cells are referred to as “leaving-cells”, or “L-cells”. 
The majority of cells which are labelled following this protocol will be in S-phase at the 
time of IdU administration and will still be in S-phase at the time of BrdU 
administration, and so become double-labelled by both substances. These cells are 
referred to the “staying-cells”, or “S-cells” (Martynoga et al., 2005). Therefore, 
following the logic of Nowakowski et al. (1989) above and as determined by Shibui et 
al. (1989) and Martynoga et al., (2005), the ratio of L-cells to S-cells is equal to the 
ratio of the length of time allowed for IdU incorporation (TI here equal to 1.5 hrs) 
compared to TS:  
TI / TS = L-cells / S-cells 
Therefore:  
TS = TI / (L-cells / S-cells)  
Furthermore, the same concept can be extrapolated to calculate TC using TS and the 
total number of proliferative cells within the population under measure (P-cells):  
TS / TC = S-cells / P-cells  
Therefore:  
TC = TS / (S-cells / P-cells)  
In the data presented in chapter 4, TS and TC were first calculated for all cortical 
progenitors combined. Therefore, the number of P-cells was determined by counting 
the number of TOPRO-3+ cells within the ventricular zone, as Caviness et al. (1995) 
and Estivill-Torrus et al. (2002) estimated that between 98% and 100% of progenitors 
located here at the ages examined are proliferative.  
In order to calculate G2-phase length (TG2), BrdU was administered to pregnant dams 































Figure 4.3: S-phase and total cell cycle length were decreased in the Gli3Xt/Pdn 
total cortical progenitor population at E11.5. A. Schematic depicting the 
experimental BrdU/IdU injection paradigm used to measure S-phase and total cell 
cycle length. B-E. BrdU/IdU/TOPRO-3 immunofluorescence on sections of E11.5 
cortex from control and Gli3Xt/Pdn embryos. White arrows depict IdU/TOPRO-3 co-
labelled L-cells, yellow arrows depict BrdU/IdU/TOPRO-3 co-labelled S-cells. F. S-
phase and total cell cycle length were significantly decreased in the lateral Gli3Xt/Pdn 
cortex. G. Total cell cycle length was significantly decreased in the medial Gli3Xt/Pdn 
cortex whilst there was no effect on S-phase length. All statistical data represents 
mean ± 95% confidence interval; n=4; * = p<0.05; Mann-Whitney U-test. Scale bars 
= 100m.   
 
 
Sections from the embryos were stained for BrdU as a marker of S-phase and pHH3 
as a marker of M-phase. The number of double-labelled cells was quantified and 
plotted as a fraction of the total number of pHH3+ cells against the defined time-points. 
TG2 was designated as the time at which 50% of cells in M-phase were in S-phase at 
the time of BrdU administration and so were BrdU+ (Arai et al., 2011). To calculate 
TG2 for all progenitors combined, all pHH3+ cells were counted together irrespective 
of their position at the ventricular surface or in an aventricular position.  
To calculate the length of M-phase (TM), sections from embryos were stained with 
pHH3 and PCNA. Thereby, the proportion of cells in M-phase compared to the total 
proliferative population could be calculated, and extrapolating from the method used 
to calculate TS as above, TM could be calculated from TC:  
TM = TC (pHH3+ cells / PCNA+ cells) 
To calculate TM for all progenitors combined, the total number of pHH3+ cells present 
in the box counted was used. 
Finally, the length of G1-phase has been shown to be critically important in the 
decision of a progenitor to divide proliferatively or differentiatively (Calegari & Huttner, 
2003). In the Gli3Xt/Pdn mutant, a disruption in proliferative/differentiative division may 
have, at least in part, underlaid the disruption in both cell cycle exit and apical/basal 






Figure 4.4: S-phase and total cell cycle length were decreased in the Gli3Xt/Pdn 
total cortical progenitor population at E12.5. A-D. BrdU/IdU/TOPRO-3 
immunofluorescence on sections of E12.5 cortex from control and Gli3Xt/Pdn embryos. 
White arrows depict IdU/TOPRO-3 co-labelled L-cells, yellow arrows depict 
BrdU/IdU/TOPRO-3 co-labelled S-cells.  E. S-phase and total cell cycle length were 
significantly decreased in the lateral Gli3Xt/Pdn cortex. F. S-phase and total cell cycle 
length were significantly decreased in the medial Gli3Xt/Pdn cortex.  All statistical data 
represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-Whitney U-test. 
Scale bars = 100m.   
 
 
G1-phase length (TG1). It was not possible to directly measure TG1 in these embryos, 
but as TC, TS, TG2 and TM had already been measured, it was possible to indirectly 
calculate TG1 by subtracting the sum of TS, TG2 and TM from TC. Again, this 
measurement was carried out at E11.5 and E12.5, both laterally and medially for all 
cortical progenitors combined.  
 
4.3.2 G1-, S- and M-phase and total cell cycle length were reduced in the total 
progenitor population in the Gli3Xt/Pdn cortex at E11.5 and E12.5  
In the E11.5 lateral neocortex, TC was shortened in the Gli3Xt/Pdn mutant compared to 
control, from 12.83±0.70 hrs in the control to 9.33±0.28 hrs in the mutant (n=4, 
p<0.05) (figure 4.3 B, C, F). Furthermore, TS was also shortened in the mutant from 
6.48±0.40 hrs in control to 4.93±0.37 hrs in the mutant (n=4, p<0.05) (figure 4.3 B, C, 
F). In the control medial neocortex TC was 11.91±0.83 hrs, yet it was shorter in the 
mutant at only 9.56±0.87 hrs (n=4, p<0.05) (figure 4.3 D, E, G). However, TS was 
unaffected in the mutant medial neocortex (5.80±0.46 hrs in control and 5.28±0.77 
hrs in mutant, n=4, p>0.05) (figure 4.3 D, E, G).  
At E12.5, in the lateral neocortex TC was again shorter in the mutant than in control 
(13.51±0.56 hrs in control and 10.08±0.40 hrs in mutant, n=4, p<0.05) (figure 4.4 A, 
B, E), as was TS (6.84±0.27 hrs in control and 4.68±0.11 hrs in mutant, n=4, p<0.05) 
(figure 4.4 A, B, E). Medially, TC was also shorter in the mutant compared to control 






Figure 4.5: G2-phase was unaltered in the Gli3Xt/Pdn total cortical progenitor 
population at E11.5. A-L. pHH3/BrdU immunofluorescence on sections of E11.5 
cortex from control and Gli3Xt/Pdn embryos. Solid yellow arrows depict BrdU single-
labelled apical progenitors, solid white arrows depict pHH3/BrdU co-labelled apical 
progenitors, empty yellow arrows depict BrdU single-labelled basal progenitors, and 
empty white arrows depict pHH3/BrdU co-labelled basal progenitors. M. There was 
no effect on G2-phase length in the lateral (M) or medial (N) Gli3Xt/Pdn cortex. Error 




D, F), as was TS (7.50±0.45 hrs in control and 4.98±0.35 hrs in mutant, n=4, p<0.05) 
(figure 4.4 C, D, F). Taken together, the reduction in Gli3 at both E11.5 and E12.5 
resulted in a decrease in S-phase and total cell cycle length.  
At E11.5, TG2 was of similar length in the mutant compared to control both laterally 
and medially (lateral: 1.31 hrs in control and 1.27 hrs in mutant, medially: 1.29 hrs in 
control and 1.29 hrs in mutant, n=11) (figure 4.5 M, N). Moreover, TG2 was also largely 
unaffected at E12.5 both laterally and medially (lateral: 1.28 hrs in control and 1.31 
hrs in mutant, medially: 1.29 hrs in control and 1.29 hrs in mutant, n=12 in control and 
n=11 in mutant) (figure 4.6 M, N). As TG2 was calculated from a curve containing 
multiple embryos from multiple litters, statistical analyses were not conducted. 
However, it is clear that the reduction in Gli3 had very little if any effect on the length 
of G2-phase. 
Both laterally and medially at E11.5 TM was unaffected in the mutant compared to 
control (lateral: 0.89±0.09 hrs in control and 0.81±0.03 hrs in mutant, n=4, p>0.05, 
medially: 0.90±0.08 hrs in control and 0.80±0.04 hrs in mutant, n=4, p>0.05) (figure 
4.7 E). However, by E12.5 in the lateral neocortex, TM was shorter in the mutant 
compared to control (1.10±0.05 hrs in control and 0.93±0.09 hrs in mutant, n=5, 
p<0.05) (figure 4.8 A, B, E). Likewise, medially TM was reduced in the mutant 
compared to control (1.09±0.11 hrs in control and 0.77±0.08 hrs in mutant, n=4, 
p<0.05) (figure 4.8 C, D, E). Altogether, the reduction in Gli3 had little effect on M-






Figure 4.6: G2-phase was unaltered in the Gli3Xt/Pdn total cortical progenitor 
population at E12.5. A-L. pHH3/BrdU immunofluorescence on sections of E12.5 
cortex from control and Gli3Xt/Pdn embryos. Solid yellow arrows depict BrdU single-
labelled apical progenitors, solid white arrows depict pHH3/BrdU co-labelled apical 
progenitors, empty yellow arrows depict BrdU single-labelled basal progenitors, and 
empty white arrows depict pHH3/BrdU co-labelled basal progenitors. M. There was 
no effect on G2-phase length in the lateral (M) or medial (N) Gli3Xt/Pdn cortex. Error 
bars represent mean ± 95% confidence interval; n=12 in control and n=11 in mutant. 
Scale bars = 100m.   
 
 
With respect to all progenitors combined, in the lateral neocortex at E11.5 TG1 was 
shortened in Gli3Xt/Pdn mutants compared to control (4.14±0.80 hrs in control and 
2.33±0.21 hrs in mutant, n=4, p<0.05) (figure 4.9). In the medial neocortex, TG1 was 
also shorter in the mutant compared to control (3.93±0.83 hrs in control and 2.19±0.51 
hrs in mutant, n=4, p<0.05) (figure 4.9).  
At E12.5, in the lateral cortex, TG1 was unaltered in the mutant compared to control 
(4.29±0.66 hrs in control and 3.17±0.46 hrs in mutant, n=4, p>0.05) (figure 4.10). In 
the medial cortex, TG1 was decreased in the mutant (3.58±0.14 hrs in control and 
2.79±0.20 hrs in mutant, n=4, p<0.05) (figure 4.10). This would indicate that Gli3 
regulates G1-phase length at both E11.5 and E12.5. A summary of the length of each 





























 Cell cycle phases 
TG1 TS TG2 TM  TC 
E11.5 Lateral Control 4.14 6.48 1.31 0.89  12.83 
Gli3Xt/Pdn 2.33 4.93 1.27 0.81  9.33 
 
Medial Control 3.93 5.80 1.29 0.90  11.91 
Gli3Xt/Pdn 2.19 5.28 1.29 0.80  9.56 
 
E12.5 Lateral Control 4.29 6.84 1.28 1.10  13.51 
Gli3Xt/Pdn 3.17 4.68 1.31 0.93  10.08 
 
Medial Control 3.58 7.50 1.29 1.09  13.46 







Figure 4.7: M-phase length was unaltered in the Gli3Xt/Pdn total cortical 
progenitor population at E11.5. A-D. pHH3/PCNA immunofluorescence on sections 
of E11.5 cortex from control and Gli3Xt/Pdn embryos. White arrows depict apical 
progenitors, yellow arrows depict basal progenitors E. There was no effect on M-
phase length in the lateral and medial Gli3Xt/Pdn cortex. All statistical data represents 
mean ± 95% confidence interval; n=4; * = p<0.05; Mann-Whitney U-test. Scale bars 


























Figure 4.8: M-phase length was reduced in the Gli3Xt/Pdn total cortical progenitor 
population at E12.5. A-D. pHH3/PCNA immunofluorescence on sections of E12.5 
cortex from control and Gli3Xt/Pdn embryos. White arrows depict apical progenitors, 
yellow arrows depict basal progenitors E. M-phase length was significantly decreased 
in the lateral and medial Gli3Xt/Pdn cortex. All statistical data represents mean ± 95% 
confidence interval; n=5 in control and n=4 in mutant; * = p<0.05; Mann-Whitney U-


























Figure 4.9: G1-phase length was reduced in the lateral and medial Gli3Xt/Pdn total 
cortical progenitor population at E11.5. Schematics showing the length of each cell 
cycle phase and total cell cycle length in lateral control (A), lateral Gli3Xt/Pdn (B), medial 
control (C) and medial Gli3Xt/Pdn (D) embryos. In B and D significantly altered phase 
lengths are shown in bold purple text and note reduced total circle size representing 
reduced total cell cycle length. All statistical data represents mean; n=4; * = p<0.05; 











Figure 4.10: G1-phase length was reduced in the medial Gli3Xt/Pdn total cortical 
progenitor population at E12.5. Schematics showing the length of each cell cycle 
phase and total cell cycle length in lateral control (A), lateral Gli3Xt/Pdn (B), medial 
control (C) and medial Gli3Xt/Pdn (D) embryos. In B and D significantly altered phase 
lengths are shown in bold purple text and note reduced total circle size representing 
reduced total cell cycle length. All statistical data represents mean; n=4; * = p<0.05; 







4.4 G1-, S- and M-phase and total cell cycle length were reduced in apical 
progenitors of E11.5 and E12.5 Gli3Xt/Pdn embryos 
 
The reduction in Gli3 resulted in a shortening of the total cell cycle length and of G1-
, S- and M-phase in the Gli3Xt/Pdn mutant, when examining the total cortical progenitor 
population. At E11.5 and E12.5, apical progenitors are the main progenitor subtype, 
and Gli3 expression is mainly confined to this population. Therefore, the analyses of 
cell cycle lengths outlined above were repeated in the apical progenitor population 
alone.  
To calculate TS and TC, the same analyses on cell cycle parameters as carried out on 
all progenitors were conducted. Using BrdU and IdU as described in section 4.3.1 the 
length of S-phase and the total cell cycle length were measured in E11.5 and E12.5 
apical progenitors in the lateral and medial cortex, however the number of P-cells was 
determined based on the number of apical progenitors expressing Pax6 within the 
area counted.  
At E11.5 in the lateral cortex, TS was significantly shorter in the Gli3Xt/Pdn mutant as 
compared to control (5.08±0.21 hrs in control and 4.61±0.21 hrs in mutant, n=4, 
p<0.05) (figure 4.11 A, B, E), as was TC (8.28±0.27 hrs in control and 6.87±0.14 hrs 
in mutant, n=4, p<0.05) (figure 4.11 A, B, E). In the medial cortex, TS was unaltered 
in the mutant compared to control (4.09±0.66 hrs in control and 4.23±0.60 hrs in 
mutant, n=4, p>0.05) (figure 4.11 C, D, F), as was TC (6.79±0.54 hrs in control and 
6.41±0.59 hrs in mutant, n=4, p>0.05) (figure 4.11 C, D, F).  
In the E12.5 lateral neocortex, TS was significantly shorter in the mutant compared to 
control (5.82±0.37 hrs in control and 4.80±0.34 hrs, n=4, p<0.05) (figure 4.12 A, B, E) 
and TC was also significantly reduced (12.71±0.61 hrs in control and 9.48±0.29 hrs in 
mutant, n=4, p<0.05) (figure 4.12 A, B, E). Medially, TS was shorter in the mutant 
compared to control (6.03±0.53 hrs in control and 4.78±0.61 hrs in mutant, n=4, 
p<0.05) (figure 4.12 C, D, F) along with TC (12.71±0.61 hrs in control and 9.48±0.29 
hrs in mutant, n=4, p<0.05) (figure 4.12 C, D, F). Taken together, the reduction in Gli3 
in apical progenitors in Gli3Xt/Pdn mutants reduced both S-phase and total cell cycle 
laterally at E11.5 and both laterally and medially at E12.5.   
As with all progenitors combined, the length of G2-phase was measured in the apical 






Figure 4.11: S-phase and total cell cycle length were reduced in lateral Gli3Xt/Pdn 
apical progenitors at E11.5. A-D. BrdU/IdU/Pax6 immunofluorescence on sections 
of E11.5 cortex from control and Gli3Xt/Pdn embryos. White arrows depict IdU/Pax6 co-
labelled L-cells, yellow arrows depict BrdU/IdU/Pax6 co-labelled S-cells.  E. S-phase 
and total cell cycle length were significantly decreased in the lateral Gli3Xt/Pdn cortex. 
F. S-phase and total cell cycle length were unaltered in the medial Gli3Xt/Pdn cortex. All 
statistical data represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-
Whitney U-test. Scale bars = 100m.   
 
 
and only pHH3+ cells along the ventricular zone were counted. In the E11.5 lateral 
neocortex the length of G2-phase was very similar in the Gli3Xt/Pdn mutant compared 
to control (1.31 hrs in control and 1.26 hrs in mutant, n=11) (figure 4.13 M), and TG2 
was also unaltered in the medial cortex (1.29 hrs in control and 1.29 hrs in mutant, 
n=11) (figure 4.13 N).  
At E12.5, TG2 was a similar length in both the mutant and control in the lateral cortex 
(1.27 hrs in control, n=12, and 1.31 hrs in mutant, n=11) (figure 4.14 M), and was 
unaltered in the medial cortex (1.29 hrs in control, n=12, and 1.29 hrs in mutant, n=11) 
(figure 4.14 N). Overall, it appears that Gli3 has little impact on the length of G2-phase 
in apical progenitors.  
M-phase length was also measured as described in section 4.3.1 but in the apical 
progenitor population alone, using the proportion of pHH3+ cells located along the 
edge of the ventricle. At E11.5 in the lateral cortex, TM was unaltered in the Gli3Xt/Pdn 
mutant compared to control (0.76±0.05 hrs in control and 0.62±0.03 hrs in mutant, 
p=4, p>0.05) (figure 4.15 A, B, E). In the medial cortex, the length of M-phase was 
also unchanged in the mutant compared to control (0.86±0.07 hrs in control and 
0.70±0.07 hrs in mutant, n=4, p>0.05) (figure 4.15 C, D, E).  
In the E12.5 lateral neocortex, TM was shorter in mutant apical progenitors than in 
control (0.82±0.03 hrs in control and 0.69±0.07 hrs in mutant, n=5, p<0.05) (figure 
4.16 A, B, E). Furthermore, TM was also shorter in the medial mutant cortex compared 
to control (1.04±0.11 hrs in control and 0.66±0.08 hrs in mutant, n=4, p<0.05) (figure 
4.16 C, D, E). Combined, Gli3 reduction in the mutant did not alter M-phase length 






Figure 4.12: S-phase and total cell cycle length were reduced in Gli3Xt/Pdn apical 
progenitors at E12.5. A-D. BrdU/IdU/Pax6 immunofluorescence on sections of 
E12.5 cortex from control and Gli3Xt/Pdn embryos. White arrows depict IdU/Pax6 co-
labelled L-cells, yellow arrows depict BrdU/IdU/Pax6 co-labelled S-cells.  E. S-phase 
and total cell cycle length were significantly decreased in the lateral Gli3Xt/Pdn cortex. 
F. S-phase and total cell cycle length were significantly decreased in the medial 
Gli3Xt/Pdn cortex. All statistical data represents mean ± 95% confidence interval; n=4; 
* = p<0.05; Mann-Whitney U-test. Scale bars = 100m.   
 
 
cortex, indicating that Gli3 may regulate the length of M-phase in apical progenitors 
at E12.5 but not E11.5.  
Finally, due the reported significance of the length of G1-phase in the decision for a 
progenitor to divide either proliferatively or differentiatively, as described for the total 
progenitor population (section 4.3.1) TG1 was calculated from TS, TG2, TM and TC for 
apical progenitors alone. In the lateral cortex of E11.5 embryos TG1 was significantly 
shortened in Gli3Xt/Pdn mutant compared to control (1.13±0.17 hrs in control and 
0.37±0.08 hrs in mutant, n=4, p<0.05) (figure 4.17). In the medial neocortex, TG1 was 
0.55±0.13 hrs in control embryos but could not be calculated in the mutant (figure 
4.17). Due to inaccuracies in the measurements of TS, TG2, TM and TC, the length of 
TG1 was calculated as 0 hrs in the mutant. It is very unlikely that medial mutant apical 
progenitors did not have a G1-phase, and so due to imprecision in the measurements 
of the other phases I was unable to calculate the correct length of G1-phase.  
24 hrs later, in the E12.5 lateral neocortex, TG1 was significantly shorter in Gli3Xt/Pdn 
compared to control (4.82±0.33 hrs in control and 2.67±0.34 hrs in mutant, n=4, 
p<0.05) (figure 4.18). Medially, there was no significant difference between TG1 in 
control and mutant (2.21±0.57 hrs in control and 1.59±0.40 hrs in mutant, n=4, 
p>0.05) (figure 4.18). Taken together, Gli3 had an influence on the length of G1-phase 
in the apical progenitor population at both E11.5 and E12.5, acting to shorten it. A 























 Cell cycle phases 
TG1 TS TG2 TM  TC 
E11.5 Lateral Control 1.13 5.08 1.31 0.76  8.28 
Gli3Xt/Pdn 0.37 4.61 1.27 0.62  6.87 
 
Medial Control 0.55 4.09 1.29 0.86  6.76 
Gli3Xt/Pdn ND 4.43 1.29 0.70  6.41 
 
E12.5 Lateral Control 4.82 5.82 1.27 0.80  12.71 
Gli3Xt/Pdn 2.67 4.80 1.31 0.69  9.46 
 
Medial Control 2.21 6.03 1.29 1.04  10.56 







Figure 4.13: G2-phase was unaltered in the Gli3Xt/Pdn apical progenitor 
population at E11.5. A-L. pHH3/BrdU immunofluorescence on sections of E11.5 
cortex from control and Gli3Xt/Pdn embryos. Yellow arrows depict BrdU single-labelled 
apical progenitors, white arrows depict pHH3/BrdU co-labelled apical progenitors. M. 
There was no effect on G2-phase length in the lateral (M) or medial (N) Gli3Xt/Pdn 
cortex. Error bars represent mean ± 95% confidence interval; n=11. Scale bars = 


























Figure 4.14: G2-phase was unaltered in the Gli3Xt/Pdn apical progenitor 
population at E12.5. A-L. pHH3/BrdU immunofluorescence on sections of E12.5 
cortex from control and Gli3Xt/Pdn embryos. Yellow arrows depict BrdU single-labelled 
apical progenitors, white arrows depict pHH3/BrdU co-labelled apical progenitors. M. 
There was no effect on G2-phase length in the lateral (M) or medial (N) Gli3Xt/Pdn 
cortex. Error bars represent mean ± 95% confidence interval; n=12 in control and 


























Figure 4.15: M-phase length was unaltered in the Gli3Xt/Pdn apical progenitor 
population at E11.5. A-D. pHH3/PCNA immunofluorescence on sections of E11.5 
cortex from control and Gli3Xt/Pdn embryos. Arrows depict pHH3/PCNA co-labelled 
apical progenitors. E. There was no effect on M-phase length in the lateral and medial 
Gli3Xt/Pdn cortex. All statistical data represents mean ± 95% confidence interval; n=4; 


























Figure 4.16: M-phase length was shorter in the Gli3Xt/Pdn apical progenitor 
population at E12.5. A-D. pHH3/PCNA immunofluorescence on sections of E12.5 
cortex from control and Gli3Xt/Pdn embryos. Arrows depict pHH3/PCNA co-labelled 
apical progenitors. E. There was a significant reduction in M-phase length in the lateral 
and medial Gli3Xt/Pdn cortex. All statistical data represents mean ± 95% confidence 


























Figure 4.17: G1-phase length was reduced in the lateral Gli3Xt/Pdn apical 
progenitor population at E11.5. Schematics showing the length of each cell cycle 
phase and total cell cycle length in lateral control (A), lateral Gli3Xt/Pdn (B), medial 
control (C) and medial Gli3Xt/Pdn (D) embryos. In B and D significantly altered phase 
lengths are shown in bold purple text and note reduced total circle size (B) 
representing reduced total cell cycle length. All statistical data represents mean; n=4; 










Figure 4.18: G1-phase length was reduced in the Gli3Xt/Pdn apical progenitor 
population at E12.5. Schematics showing the length of each cell cycle phase and 
total cell cycle length in lateral control (A), lateral Gli3Xt/Pdn (B), medial control (C) and 
medial Gli3Xt/Pdn (D) embryos. In B and D significantly altered phase lengths are shown 
in bold purple text and note reduced total circle size representing reduced total cell 







4.5 S- and M-phase length and total cell cycle length were altered in basal 
progenitors of the E11.5 and E12.5 Gli3Xt/Pdn neocortex 
 
As above, analyses of the cell cycle phase lengths and of total cell cycle length were 
conducted in the basal progenitor population alone. Due to the lack of expression of 
Gli3 in these progenitors, any alterations to the cell cycle were thought unlikely. In the 
medial Gli3Xt/Pdn cortex at E11.5 and E12.5, there were too few basal progenitors 
present, and so analyses of the cell cycle were only conducted laterally.  
Total cell cycle length and the length of S-phase were calculated using BrdU and IdU 
as described in section 4.3.1 using Tbr2 to define the number of P-cells. At E11.5 in 
the lateral cortex, TS was significantly shorter in Gli3Xt/Pdn embryos compared to control 
(8.52±1.23 hrs in control and 5.82±0.48 hrs in mutant, n=4, p<0.05) (figure 4.19 A, B, 
C), as was TC (16.35±1.08 hrs in control and 13.65±0.73 hrs in mutant, n=4, p<0.05) 
(figure 4.19 A, B, C).  
At E12.5, TS was unchanged in the mutant compared to control (7.47±0.97 hrs in 
control and 7.25±0.84 hrs in mutant, n=4, p>0.05) (figure 4.20 A, B, C), as was TC 
(17.00±2.16 hrs in control and 16.79±1.32 hrs in mutant, n=4, p>0.05) (figure 4.20 A, 
B, C). As in the lateral cortex at E11.5, the reduction in Gli3 affected both S-phase 
and total cell cycle length of basal progenitors as it did in apical progenitors, however 
24 hrs later it appears that the reduction in Gli3 did not affect TS and TC.  
TG2 of basal progenitors was measured at both E11.5 and E12.5 in the lateral cortex 
as described in section 4.3.1, using only pHH3+ cells in an aventricular position. At 
E11.5, there was little difference in TG2 in the Gli3Xt/Pdn embryo compared to control 
(1.34 hrs in control and 1.26 hrs in mutant, n=11) (figure 4.21 G). 24 hrs later, TG2 was 
similar to E11.5 and unchanged between control and mutant (1.31 hrs in control, 
n=12, and 1.31 hrs in mutant, n=11) (figure 4.22 G). Therefore, as in the apical 
progenitor population, Gli3 reduction had little effect on the length of G2-phase.  
As described in section 4.3.1, M-phase length was measured in the basal progenitor 
population at both E11.5 and E12.5 by counting the pHH3+ cells away from the 
ventricular surface. At E11.5, TM was unchanged in Gli3Xt/Pdn basal progenitors 
compared to control (0.13±0.04 hrs in control and 0.19±0.01 hrs in mutant, n=4, 
p>0.05) (figure 4.23 A, B, C). At E12.5, surprisingly there was a 2.55-fold increase in 






















Figure 4.19: S-phase and total cell cycle length were reduced in lateral Gli3Xt/Pdn 
basal progenitors at E11.5. A, B. BrdU/IdU/Tbr2 immunofluorescence on sections 
of E11.5 cortex from control and Gli3Xt/Pdn embryos. White arrows depict IdU/Tbr2 co-
labelled L-cells, yellow arrows depict BrdU/IdU/Tbr2 co-labelled S-cells.  C. S-phase 
and total cell cycle length were significantly decreased in the lateral Gli3Xt/Pdn cortex. 
All statistical data represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-
Whitney U-test. Scale bars = 100m.   
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mutant, n=5, p<0.05) (figure 4.24 A, B, C). Altogether, as in apical progenitors, Gli3 
had no effect on TM at E11.5. However, in apical progenitors at E12.5 the reduction in 
Gli3 resulted in a shortened TM, yet in E12.5 basal progenitors the reduction in Gli3 
resulted in a statistically significant lengthening of TM.  
The length of G1-phase was calculated as in section 4.3.1 from the measurements of 
the other phase lengths and total cell cycle length in basal progenitors. In the lateral 
E11.5 cortex, the TG1 was unaltered in mutant basal progenitors compared to control 
(6.35±0.81 hrs in control and 6.38±0.65 hrs in mutant, n=4, p>0.05) (figure 4.25), as 
was TG1 24 hrs later in the E12.5 cortex (8.13±1.53 hrs in control and 8.00±1.34 hrs 
in mutant, n=4, p>0.05) (figure 4.26). Unlike in apical progenitors TG1 was unchanged 
in basal progenitors at both E11.5 and E12.5. Shown below in table 4.3 is a summary 
of the cell cycle phase lengths of basal progenitors.  
 









 Cell cycle phases 
TG1 TS TG2 TM  TC 
E11.5 Lateral Control 6.35 8.52 1.34 0.13  16.35 
Gli3Xt/Pdn 6.37 5.82 1.26 0.19  13.65 
 
E12.5 Lateral Control 8.13 7.47 1.31 0.09  17.00 























Figure 4.20: S-phase and total cell cycle length were unaltered in lateral Gli3Xt/Pdn 
basal progenitors at E12.5. A, B. BrdU/IdU/Tbr2 immunofluorescence on sections 
of E12.5 cortex from control and Gli3Xt/Pdn embryos. White arrows depict IdU/Tbr2 co-
labelled L-cells, yellow arrows depict BrdU/IdU/Tbr2 co-labelled S-cells.  C. S-phase 
and total cell cycle length were unaffected in the lateral Gli3Xt/Pdn cortex. All statistical 
data represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-Whitney U-






Figure 4.21: G2-phase was unaltered in the lateral Gli3Xt/Pdn basal progenitor 
population at E11.5. A-F. pHH3/BrdU immunofluorescence on sections of E11.5 
cortex from control and Gli3Xt/Pdn embryos. Yellow arrows depict BrdU single-labelled 
basal progenitors, white arrows depict pHH3/BrdU co-labelled basal progenitors. G. 
There was no effect on G2-phase length in the lateral Gli3Xt/Pdn cortex. Error bars 





Figure 4.22: G2-phase was unaltered in the lateral Gli3Xt/Pdn basal progenitor 
population at E12.5. A-F. pHH3/BrdU immunofluorescence on sections of E12.5 
cortex from control and Gli3Xt/Pdn embryos. Yellow arrows depict BrdU single-labelled 
basal progenitors, white arrows depict pHH3/BrdU co-labelled basal progenitors. G. 
There was no effect on G2-phase length in the lateral Gli3Xt/Pdn cortex. Error bars 






















Figure 4.23: M-phase length was unaltered in the lateral Gli3Xt/Pdn basal 
progenitor population at E11.5. A, B. pHH3/PCNA immunofluorescence on 
sections of E11.5 cortex from control and Gli3Xt/Pdn embryos. Arrows depict 
pHH3/PCNA co-labelled basal progenitors. C. There was no effect on M-phase length 
in the lateral Gli3Xt/Pdn cortex. All statistical data represents mean ± 95% confidence 






Figure 4.24: M-phase length was increased in the lateral Gli3Xt/Pdn basal 
progenitor population at E12.5. A, B. pHH3/PCNA immunofluorescence on 
sections of E12.5 cortex from control and Gli3Xt/Pdn embryos. Arrows depict 
pHH3/PCNA co-labelled basal progenitors. C. There was a significant increase in M-
phase length in the lateral Gli3Xt/Pdn cortex. All statistical data represents mean ± 95% 







Figure 4.25: G1-phase length was unaltered in the lateral Gli3Xt/Pdn basal 
progenitor population at E11.5. Schematics showing the length of each cell cycle 
phase and total cell cycle length in lateral control (A) and lateral Gli3Xt/Pdn (B) embryos. 
In B significantly altered phase lengths are shown in bold purple text and note reduced 
total circle size representing reduced total cell cycle length. All statistical data 













Figure 4.26: G1-phase length was unaltered in the lateral Gli3Xt/Pdn basal 
progenitor population at E12.5. Schematics showing the length of each cell cycle 
phase and total cell cycle length in lateral control (A) and lateral Gli3Xt/Pdn (B) embryos. 
In B significantly increased M-phase length is shown in bold purple text. All statistical 















4.6 Discussion  
 
The aim of this chapter was to begin to understand why the proportions of apical and 
basal progenitors and early-born neurons were altered in the Gli3Xt/Pdn cortex. One 
major factor known to impact upon the proliferation and differentiation of progenitors, 
which can alter progenitor and neuronal proportions, is the cell cycle (Lange et al., 
2009; Pilaz et al., 2009). Here, exit from the cell cycle and therefore differentiation into 
neurons was evaluated in the Gli3Xt/Pdn mutant, followed by examination of the length 
of each phase in the progenitor populations. I shall first discuss the lateral cortex, 
starting with apical progenitors at E11.5 and E12.5, then basal progenitors at E11.5 
and E12.5.  I will then discuss the medial cortex, focussing on apical progenitors at 
E11.5 and E12.5. As I was unable to make measurements in the medial basal 
progenitor population due to the low number of cells present at both E11.5 and E12.5, 
I will not discuss this population. I will consider how the changes observed in cell cycle 
re-entry/exit and in cell cycle phase lengths may have affected the 
proliferation/differentiation defects observed.  
 
4.6.1 In Gli3Xt/Pdn lateral apical progenitors, cell cycle phase lengths were 
reduced at E11.5 and E12.5, whilst cell cycle exit was reduced at E11.5 and 
increased at E12.5  
At E11.5 in the lateral cortex, cell cycle re-entry for the total progenitor population was 
increased 2.19-fold in the Gli3Xt/Pdn mutant, indicating a tip towards proliferative 
divisions at the expense of differentiative divisions. Indeed, here apical progenitors, 
the largest progenitor population, showed an increased proportion whilst there were 
decreases in the proportions of basal progenitors and early-born neurons. This would 
indicate that the increase in cell cycle re-entry measured reflected an increase in 
apical progenitor proliferation instead of differentiation.  
Concurrently, in the apical progenitor population, G1-phase, S-phase and total cell 
cycle length were shorter in the mutant compared to control. G2- and M-phase were 
unaltered in the mutant, suggesting Gli3 does not regulate these phases here. The 
“cell cycle length” model proposes that G1-phase lengthening is required for 
progenitors to act upon differentiation cues (Calegari & Huttner, 2003). Here, as G1-
phase length was shorter in the mutant apical progenitors, it would suggest a drive 
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towards proliferative divisions at the expense of differentiative divisions. Indeed, this 
was also suggested by the increase in cell cycle re-entry. Furthermore, the larger 
apical progenitor proportion and smaller basal progenitor and early-born neuron 
proportions also indicated that apical progenitors had undergone proliferative, self-
renewing divisions to increase their pool instead of differentiating into basal 
progenitors and neurons. As Gli3 expression was primarily confined to this progenitor 
population, Gli3’s regulation of G1-phase was likely direct. A likely candidate by which 
Gli3 regulates G1-phase length is Cdk6, as it has been shown to bind to the Cdk6 
promoter and thereby negatively regulate the cell cycle (Lopez-Rios et al., 2012; 
Vokes et al., 2008).  
Whilst a lengthening of G1-phase has been shown to be required for progenitors to 
switch from proliferative to differentiative division (Lange et al., 2009; Pilaz et al., 
2009; Calegari & Huttner, 2003), shortening of S-phase length has been associated 
with the switch from proliferative to differentiative division (Gonzales et al., 2015; Arai 
et al., 2011). Therefore, it was surprising to find a shortening of G1-phase length and 
simultaneous shortening of S-phase length. As these analyses were conducted at the 
population level instead of an individual cell level, there may have been a larger 
proportion of progenitors undergoing differentiative division. This was unlikely 
however, based on the measurements of apical and basal progenitor and early-born 
neuron proportions and cell-cycle exit, which pointed to increased proliferative division 
at E11.5. To directly examine the proportion of progenitors which were undergoing 
proliferative versus differentiative division, Tis21 expression was examined. When a 
progenitor will undergo differentiative division, Tis21 mRNA is up-regulated during 
G1-phase, and protein expression continues throughout S-, G2- and M-phases 
(Iacopetti et al., 1999). As I will show in section 5.6.1, the proportion of Tis21+ apical 
progenitors was unaltered in the mutant compared to control in the E11.5 lateral 
cortex.  
Taken together, perhaps Gli3 regulates S-phase length directly, acting to shorten it, 
yet the length of G1-phase is a more critical factor regulating proliferative versus 
differentiative division in E11.5 lateral apical progenitors. Unlike G1-phase 
lengthening, S-phase shortening has not been shown to be causative in the switch 
from proliferative to differentiative division in the mouse.  Furthermore, cell cycle 
length is not the only element influencing mode of division, and the impact of these 
other elements likely contribute to the decision of how to divide.  
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In the Gli3Xt/Pdn mutant, there are many defects contributing to the alteration in cortical 
development, such as alterations in signalling (Kuschel et al., 2003), all of which 
complicate the analyses of these embryos. In order to assess if and how Gli3 
regulates the cell cycle directly, examination of cell cycle phase lengths was also 
undertaken in the Emx1Cre;Gli3fl;/fl embryo in the rostro-medial telencephalon 
(Hasenpusch-Theil et al., 2018). At E11.5, there were few Tbr2+ basal progenitors, 
and so analyses were conducted at the total progenitor population level which 
primarily reflected the apical progenitor population. Here, G1- and S-phase and total 
cell cycle length were also decreased in the Emx1Cre;Gli3fl;/fl mutant compared to 
control. As Gli3 has only recently been deleted here (Amaniti et al., 2013), it is likely 
that Gli3 therefore directly regulates both G1- and S-phase length.  
In the E12.5 lateral cortex of the Gli3Xt/Pdn mutant, there was a 1.54-fold increase in 
cell cycle exit. Here, the apical progenitor population still made up the majority of 
cortical progenitors. As opposed to E11.5, the proportion of apical progenitors was 
unchanged in the mutant compared to control at E12.5, and there were larger 
proportions of basal progenitors and neurons. This would suggest that in the time 
interval between analyses, there was a switch from apical progenitor proliferative 
division to differentiative division into neurons, decreasing their proportion from E11.5 
to E12.5, and increasing the proportion of early-born neurons.  
As at E11.5, G1-phase length was significantly shorter in the E12.5 mutant apical 
progenitors, implying Gli3 directly affects G1-phase length. The analyses of apical 
and basal progenitors and early-born neurons outlined before suggests there was an 
early delay in neurogenesis at E11.5 caused by an increase in proliferative divisions 
that was overcome at E12.5, due to an increase in differentiative division. Therefore, 
the question is raised in that if there was a decrease in proliferative divisions and an 
increase in differentiative divisions between E11.5 and E12.5 in the mutant, why was 
G1-phase length shorter in the mutant at E12.5? Factors other than the cell cycle are 
known to regulate neurogenesis, and so it is possible that at E12.5, the length of G1-
phase is less important in the mutant. For example, Wnt and Fgf signalling are 
disrupted in the Gli3Xt/Pdn mutant (Kuschel et al., 2003), although these are more 
influential in the medial cortex. It is also conceivable that Gli3 regulates factors which 
inhibit proliferation. RNA sequencing was performed in the E11.5 and E12.5 
Emx1Cre;Gli3fl;/fl dorsal telencephalon. In these embryos, at E11.5 the Cdk inhibitors 
Cdkn1a, b and c were down-regulated at E11.5 yet were unaltered at E12.5 
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(Hasenpusch-Theil et al., 2018). In these mutants, G1-phase length was reduced 
compared to control at E11.5, yet unaffected at E12.5.  
In the Gli3Xt/Pdn mutant, at E12.5 S-phase was also shorter compared to control in 
apical progenitors. As a shortened S-phase has been shown to correlate with 
differentiative division as opposed to proliferative division (Gonzales et al., 2015; Arai 
et al., 2011), at E12.5 this links to the alterations in progenitor and neuronal 
proportions. Three possible explanations could be suggested to explain why both S-
phase and G1-phase were reduced in mutant apical progenitors compared to control 
at E12.5, although it is likely other factors also contribute to these observations. 
Firstly, the length of S-phase may be more critical to the mode of division which 
mutant apical progenitors will undertake than the length of G1-phase. Secondly, the 
reduced S-phase length measured at E11.5 might already indicate a switch towards 
apical progenitor differentiative division in the mutant, the result of which (a relative 
reduction in apical progenitor proportion and increase in neuronal proportion from 
E11.5 to E12.5), was only obvious 24 hrs later. Thirdly, it is possible that G1-phase 
lengthening is required for the switch from proliferative to differentiative division, yet it 
was artificially blocked possibly due to a reduction in Cdk6 inhibition by the reduction 
in Gli3 in the mutant. S-phase shortening may then have occurred to compensate for 
the block on G1-phase lengthening.  
Unlike at E11.5, M-phase length was shorter in Gli3Xt/Pdn lateral apical progenitors at 
E12.5, where there was an increase in cell cycle exit indicating an increase in 
differentiation. However, Pilaz et al. (2016) reported that a longer M-phase length 
correlates with an increase in neurogenesis. As was seen with G1-phase, perhaps 
the length of M-phase was not as critical to the decision to undergo proliferative as 
opposed to differentiative division in these progenitors at this time.  
 
4.6.2 In lateral basal progenitors of the Gli3Xt/Pdn mutant, S-phase and total cell 
cycle length were reduced at E11.5, whilst M-phase was increased at E12.5  
Cell cycle was also examined in basal progenitors to reveal if there were any cell non-
autonomous effects of the reduction of Gli3 in the Gli3Xt/Pdn mutant. As before, cell 
cycle re-entry/exit was evaluated at the total progenitor population level. In the E11.5 
lateral cortex, there was an increase in cell cycle re-entry. Whilst there was an 
increased apical progenitor proportion, there were decreased basal progenitor and 
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neuronal proportions. The decreased basal progenitor proportion may have been due 
to decreased basal progenitor production from apical progenitors or increased basal 
progenitor cell death. I suggest that the increased cell cycle re-entry measured 
indicated an increase in apical progenitor proliferation, at the expense of 
differentiation into basal progenitors, but cannot rule out that there was decreased 
basal progenitor apoptosis. It would therefore be important to examine cell death in 
the Gli3Xt/Pdn cortex. Furthermore, these analyses were conducted at the total 
progenitor population level by combining BrdU with PCNA. In the future, cell cycle re-
entry/exit should be examined at the apical and basal progenitor levels by combining 
BrdU with Pax6 and Tbr2. This would confirm if the alterations seen in the total 
progenitor population reflects primarily the apical progenitor proportion, and/or if the 
basal progenitor proportion was also affected.  
In E11.5 lateral basal progenitors, S-phase was significantly shorter in the mutant 
compared to control, resulting in a significantly reduced total cell cycle length. As in 
the apical progenitors, G2- and M-phase were unaltered, suggesting Gli3 does not 
regulate these phase lengths in the E11.5 lateral cortex. However, unlike apical 
progenitors G1-phase was unaltered, indicating as hypothesised above that Gli3 
directly regulates the length of G1-phase in the lateral cortex. The change in S-phase 
length could reflect indirect regulation of Gli3 over this phase length, or possibly an 
increase in the differentiation of basal progenitors. Tis21 immunostaining revealed a 
small, yet significant 1.09-fold increase in basal progenitor differentiation here (section 
5.6.2). However, it is unlikely this accounted for the 1.46-fold decrease in S-phase 
length, so arguably Gli3 regulates S-phase length on a cell non-autonomous level 
also.  
By E12.5 in the lateral neocortex, there had been a switch from cell cycle re-entry in 
the mutant to increased cell cycle exit. Whilst the mutant apical progenitor proportion 
was unchanged in comparison with control, the basal progenitor and early-born 
neuron proportions were increased. The switch from cell cycle re-entry to cell cycle 
exit therefore likely reflected either an increase in apical progenitor differentiation into 
neurons and/or an increase in basal progenitor differentiation into neurons. If there 
had been a considerable increase in basal progenitor differentiation, I would suggest 
that the basal progenitor proportion would not have been so significantly increased 
(by 1.47-fold) compared to control in the mutant. Therefore, the increased cell cycle 
exit recorded at the total progenitor population level probably indicated an alteration 
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in apical progenitors, highlighting the need to repeat cell cycle exit analyses with Pax6 
and Tbr2 instead of PCNA.  
Unexpectedly in the E12.5 lateral basal progenitor population all cell cycle length 
measurements including total cell cycle length were unaltered in the Gli3Xt/Pdn mutant 
compared to control, apart from M-phase. As the total cell cycle length of basal 
progenitors was unaffected yet these cells appeared to spend more time in M-phase, 
this reflects a larger proportion of basal progenitors in mitosis. The increased basal 
progenitor proportion measured here may therefore be due to an increase in basal 
progenitor production from apical progenitors differentiating between E11.5 and 
E12.5, combined with a larger proportion of basal progenitors dividing proliferatively. 
Eventually, this would be expected to lead to an increase in basal progenitors followed 
by an increase in subsequently born deeper-layer neurons when these basal 
progenitors divide differentiatively, resulting in disruption to the cortical layers. 
Friedrichs et al. (2008) reported that in newborn P0 Gli3Xt/Pdn animals, ER81 (layer V) 
and ROR (layer IV) neurons were scattered throughout the cortical layers in the 
lateral neocortex, including near to the ventricular surface, indicating disruption to the 
generation of these neurons.  
Together, the reduction in Gli3 had little effect on the cell cycle of the basal progenitor 
population at both ages. This was unsurprising, as Gli3 was primarily expressed in 
apical progenitors. Therefore, Gli3 likely primarily regulates the cell cycle directly, 
although alterations to the cell cycle and to the balance between proliferative and 
differentiative division also probably occurred due to alterations in signalling and other 
factors disrupted in the Gli3Xt/Pdn mutant. 
 
4.6.3 In the Gli3Xt/Pdn medial apical progenitor population, cell cycle exit and cell 
cycle phase lengths were unaffected at E11.5, yet cell cycle exit was increased 
and cell cycle phase lengths were shorter at E12.5  
In the medial neocortex, there were very few Tbr2+ basal progenitors at both E11.5 
and E12.5, thereby skewing the calculation of the length of each phase of the cell 
cycle. As such, I did not measure the cell cycle phase lengths of medial basal 




In the E11.5 medial mutant cortex, the proportions of apical and basal progenitors and 
early-born neurons were unaltered. In conjunction, cell cycle exit was also unaffected, 
indicating that at this early age medially the reduction in Gli3 had little effect on 
progenitor division.  
S-, G2- and M-phase of the cell cycle, as well as total cell cycle length, were unaltered 
in the mutant compared to control at this time. However, I was unable to accurately 
measure G1-phase length and so cannot comment on whether or not G1-phase was 
altered in mutant medial apical progenitors. It is unlikely that these cells did not have 
a G1-phase, as an extremely short, negligible G1-phase is associated with embryonic 
stem cells, which are much less differentiated than apical progenitors (Soufi & Dalton, 
2016). A calculated length of 0 hrs for G1-phase of these cells is likely due to 
inaccurate measurement of the other cell cycle phase lengths, particularly an 
overestimation of G2-phase length. However, using this methodology to indirectly 
measure G1-phase length made this error unavoidable. In the future, measurement 
of G1-phase length directly would be valuable. As apical progenitors comprised the 
majority of progenitors, the reduction seen in G1-phase length when apical and basal 
progenitors were combined was likely due to a reduction of G1-phase length in apical 
progenitors. This would indicate increased apical progenitor proliferative division and 
reduced differentiative division, although these changes were not recognised in the 
progenitor and neuronal proportions. As neurogenesis progresses from lateral to 
medial, the decrease in G1-phase length may precede alterations in the progenitor 
and neuronal proportions.  
Although I was unable to determine if G1-phase length was significantly altered in the 
apical progenitor population, it was reduced in the E11.5 Gli3Xt/Pdn medial cortex when 
all progenitors were examined together. A shorter G1-phase is associated with 
proliferative division (Lange et al., 2009; Pilaz et al., 2009), yet there were no 
alterations in the apical and basal progenitor and neuronal proportions. This indicates 
that although G1-phase was reduced, it did not have a substantial effect on the cell 
populations.   
All other phase lengths were unaltered in the mutant E11.5 medial cortex compared 
to control. This reflects the lack of alteration to the neuronal and progenitor 
proportions, suggesting that in the E11.5 medial cortex Gli3 has little effect on this 
very early stage of neurogenesis. This is in contrast to the lateral cortex, where the 
reduction in Gli3 has a significant effect on the mutant cell cycle, as well as on the 
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progenitor and neuronal proportions. Perhaps as neurogenesis in the lateral cortex is 
more advanced than in the medial cortex, this underlies the importance of Gli3 to 
neurogenesis as the reduction of it in the Gli3Xt/Pdn mutant results in increasing 
disruption to the cortex following the progression of neurogenesis. 
By E12.5, the apical progenitor proportion had decreased in the mutant compared to 
control, and the basal progenitor and early-born neuron proportions had increased. In 
the medial E12.5 cortex in both control and mutant embryos, apical progenitors still 
represented the largest progenitor population, and there was a 1.36-fold increase in 
cell cycle exit. Therefore, here the reduction in Gli3 caused an increase in apical 
progenitor differentiation into early-born neurons, as was happening in the lateral 
cortex, although possibly basal progenitor differentiation into neurons also occurred. 
Here in the apical progenitor population, S-phase, M-phase and total cell cycle length 
were reduced in the mutant compared to control. A shorter S-phase length correlates 
with differentiative division (Gonzales et al., 2015; Arai et al., 2011), which would fit 
with the increase seen in apical progenitor differentiation into basal progenitors and 
neurons observed between E11.5 and E12.5 in the mutant. A reduction in Gli3 
resulting in a shorter S-phase may therefore contribute to the mutant phenotype, but 
it is likely that factors other than cell cycle length, such as alterations in signalling, 
also contributed to the changes in progenitor and neuronal proportions. One major 
factor likely to have had a large impact in the Gli3Xt/Pdn mutant is alterations in 
signalling. In the medial cortex, Wnt2b and Wnt3a gene expression is abolished in the 
mutant (Kuschel et al., 2003). Wnt signalling has been shown to delay basal 
progenitor formation by encouraging proliferative division (Wrobel et al., 2007), and 
so the abolition of Wnt signalling in the medial cortex may contribute to apical 
progenitor differentiative division and basal progenitor formation at E12.5.  
Finally, as in the lateral cortex, M-phase length was also reduced in the medial 
Gli3Xt/Pdn apical progenitor population compared to control. Again, this contradicts the 
report from (Pilaz et al., 2016) who stated that a longer M-phase is associated with 
increased neurogenesis, as I measured a shorter M-phase whilst the early-born 
neuronal proportion was increased. This could indicate that Gli3 regulates M-phase 
length, yet the decrease in M-phase length was not influential enough to prolong the 
delay in neurogenesis observed at E11.5. Instead, the reduction in S-phase length 
and differences in signalling led to the increased basal progenitor and early-born 
neuron proportions.   
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Altogether, Gli3 clearly plays a role in the regulation of the cell cycle, which likely 
contributes to the alterations observed in the progenitor and neuronal proportions, 
although these alterations are complex. At E11.5, the reduction in G1-phase in the 
mutant apical progenitors correlates with the “cell cycle length” model, as I reported a 
larger proportion of apical progenitors and concomitant smaller proportions of basal 
progenitors and neurons. Therefore, the reduced G1-phase length would indicate that 
apical progenitors are undergoing increased self-renewing divisions, reflecting their 
larger proportion, at the expense of differentiative divisions, reflecting the smaller 
basal progenitor and neuronal proportions. Conversely, shorter S-phase length is 
linked with differentiative division, yet S-phase length was shorter in the mutant 
compared to control. It would seem in the E11.5 cortex, G1-phase length was critically 
important in the decision as to which mode of division to undergo. However, by E12.5, 
both G1-phase and S-phase length were still reduced in the mutant yet the progenitor 
and neuronal proportions would indicate a switch in apical progenitors from 
proliferative to differentiative division. Thus, at E12.5, G1-phase length seemed to be 
less critical, and S-phase length more critical in the Gli3Xt/Pdn cortex, in order to correct 
the delay in neurogenesis. Overall, I hypothesise that in the Gli3Xt/Pdn mutant, 
particularly in the lateral cortex, there is competition between the influence of G1-
phase shortening and S-phase shortening, with G1-phase length more important at 
E11.5 whilst S-phase length is more important at E12.5.  
In the future, it would be useful to directly measure the length of G1-phase to avoid 
the complication observed in the E11.5 medial G1-phase measurement. It is now 
possible to do this with the use of transgenic mouse mutants such as FUCCI mice. In 
these mice, for example, Cdt1 is tagged to a red fluorescent marker thereby labelling 
progenitors only when they are in G1-phase, and Geminin is tagged to a green 
fluorescent marker and is only expressed when those same progenitors are in 
S/G2/M-phase (Roccio et al., 2013). Using time lapse microscopy or live imaging, it 
is possible to directly measure how long individual cells remain in G1-phase, and it 
would be very interesting to cross these into Gli3Xt/Pdn embryos to give a more accurate 
measurement of the length of G1-phase.  
Furthermore, when measuring the length of M-phase, I classified pHH3+ cells along 
the ventricular edge as apical progenitors and those away from the ventricular edge 
as basal progenitors, yet I used PCNA as a progenitor marker against which to 
compare these cells. In the future, it would be advantageous to repeat these 
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experiments using pHH3 and either Pax6 or Tbr2, to assess the proportion of mitotic 
apical or basal progenitors against their own progenitor population, giving a more 
accurate measurement of M-phase length. This would also indirectly result in a more 

























4.7 Summary  
 
In this chapter, the role of Gli3 in cell cycle exit and therefore the formation of neurons 
close to the beginning of neurogenesis has been evaluated. At E11.5 in the lateral 
cortex, a reduction in Gli3 resulted in increased cell cycle re-entry, coinciding with an 
increased apical progenitor proportion at the expense of a decreased neuronal 
proportion. Furthermore, the basal progenitor proportion was also reduced, indicating 
not just a failure in apical progenitors to leave the cell cycle but also to form basal 
progenitors. Here, G1-phase was significantly shorter in the apical progenitor 
population but unaltered in the basal progenitor population, suggesting Gli3 directly 
regulates G1-phase length and cell-autonomously controls the mode of division apical 
progenitors will undertake. At E12.5, cell cycle exit was increased in the Gli3Xt/Pdn 
lateral cortex, alongside a reduced apical progenitor proportion compared to E11.5 
and increased neuronal proportion. G1-phase, S-phase and M-phase lengths were 
shorter in the mutant amongst apical progenitors indicating faster cycling through the 
cell cycle, whilst the mitotic index of basal progenitors was increased, indicating more 
basal progenitors actively dividing. In the E11.5 medial cortex, cell cycle exit was 
unchanged in the mutant, as were the proportions of apical and basal progenitors and 
neurons. Although based on these measurements I am unable to say if G1-phase was 
significantly altered in the apical progenitor population, G1-phase length was shorter 
in the total progenitor population, indicating that Gli3 regulated the cell cycle here but 
possibly not strongly enough to have a resulting effect on the progenitors and 
subsequent neurons. By E12.5 in the mutant medial cortex, cell cycle exit was 
increased and the apical progenitor proportion was decreased whilst the neuronal 
proportion had increased. G1-phase, S-phase, M-phase and total cell cycle length 
were reduced in the mutant compared to control, as was seen in the lateral cortex. 
Therefore, whilst Gli3 reduction resulted in a shortening of the cell cycle coinciding 
with increased cell cycle re-entry at E11.5, at E12.5 the reduction in Gli3 still resulted 
in a shorter cell cycle whilst cell cycle exit was increased. Additional factors, then, 
regulating progenitor proliferation or differentiation must surpass the control of the cell 






Chapter 5: A preliminary investigation into the cellular mechanisms 
through which Gli3 may regulate the cell cycle 
 
5.1 Introduction  
 
In chapter 4, I showed that the reduction in Gli3 in Gli3Xt/Pdn embryos results in an 
increase in cell cycle re-entry in the E11.5 lateral cortex, whilst cell cycle exit is 
increased laterally and medially at E12.5. Cell cycle lengths were also altered in the 
mutant, with most often a reduction in G1-, S- and M-phase length as well as total cell 
cycle length, at both E11.5 and E12.5. In this chapter, I will explore possible 
mechanisms by which G1-phase and S-phase length were altered.  
The mammalian neural progenitor cell cycle is complex. When a parent cell divides, 
the two progeny enter G1-phase. Here each cell is able to integrate extra- and intra-
cellular signals, indicating if it should differentiate and leave the cell cycle, entering 
G0-phase, or if it should continue on to S-phase and divide again. If the cell is to 
continue to S-phase, the cyclin-dependent kinases Cdk4 and Cdk6 form a complex 
with the D-type cyclins, predominantly cyclin-D1 in apical progenitors and cyclin-D2 
in basal progenitors (Glickstein et al., 2007). The Cdk4/6-cyclin D complex 
hyperphosphorylates pRb, thereby changing the pRb/E2F complex conformation and 
preventing pRb from actively repressing transcription by the E2F transcription factors. 
This then allows the cell to progress past the mid G1-restriction point. Cyclin E and 
Cdk2 expression are then up-regulated, in part by the unrestricted E2Fs, and in 
complex contribute to further hyperphosphorylation of pRb. This frees the E2F 
transcription factors from being bound to pRb, enabling transcription of genes 
required for DNA replication and so transitioning the cell from G1-phase into S-phase 
(Harbour et al., 1999; Sherr, 1996).  
In the Gli3Xt/Pdn dorsal telencephalon I reported a reduction in G1-phase length. 
Cdk4/6 and cyclin D1 are key regulators of progression through G1, and for example 
when Cdk4 and cyclin D1 were overexpressed in cortical progenitors, G1-phase 
lengthening was inhibited (Lange et al., 2009). Although Cdk6 has been recently 
reported to have effects out with its association with the D-type cyclins, for example it 
can regulate transcription of the Cdk inhibitor p16INK4a (Kollmann et al., 2013), with 
regards to progression past the mid G1-restriction point and into S-phase Cdk6 and 
Cdk4 act in the same way.  In the mouse limb bud, a whole-genome chromatin 
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immunoprecipitation (ChIP)-on-chip identified potential Gli3 binding sites in the Cdk6 
promoter (Vokes et al., 2008). From here, Lopez-Rios et al. (2012) conducted further 
ChIP analysis on control and conditional Gli3 knockout limb buds and found that 
endogenous Gli3 binds to the Cdk6 promoter region in vivo. 
I hypothesise, therefore, that the reduction in Gli3 may result in a dysregulation of 
Cdk6 in the developing cortex, promoting faster progression through G1-phase. 
Indeed, several Gli3 binding sites were identified up-stream of the Cdk6 transcription 
start site, and these were verified in vitro through luciferase assay to be functional 
(Hasenpusch-Theil et al., 2018). Under normal physiological conditions, Cdk inhibitors 
such as p16INK4a and the Cip/Kip families of proteins would be responsible for limiting 
the activity of Cdks. This allows G1-phase lengthening to take place, and cortical 
progenitors are able to withdraw from the cell cycle and differentiate into neurons. In 
recent years, Cdks have become a major focus in cancer therapy, leading to the 
development of Cdk pharmacological inhibitors. Palbociclib has been identified as a 
specific inhibitor of Cdk4/6 that shows no significant activity against other Cdks ( Sherr 
et al., 2016). When used at a high concentration it prevents cells from leaving G1-
phase, but at lower concentrations slows progression through G1-phase thereby 
lengthening it (Toogood et al., 2005; Fry et al., 2004). It therefore represents a useful 
tool for the artificial lengthening of G1-phase in a Cdk4/6-orientated manner.  
Following G1-phase, progenitors enter S-phase where DNA replication takes place to 
ready the cell for division into two new progeny. Whilst it known that progression 
through S-phase is mediated by Cdk2-cyclin A, the regulation of S-phase length 
presents a more complicated picture than that of G1-phase. This is primarily as less 
is known about its regulation and how dysregulation of S-phase length contributes to 
the way in which a progenitor will divide. In human ESCs, down-regulation of S-phase 
progression genes prevented pluripotency marker down-regulation (Gonzales et al., 
2015). Additionally, treatment of human ESCs with aphidicolin, an inhibitor of DNA 
replication, resulted in a lengthening of S-phase and an up-regulation of active TGF 
signalling. This is known to promote the pluripotent state in human ESCs and prevent 
differentiation (Gonzales et al., 2015). Furthermore, in the mouse dorsal 
telencephalon, proliferative cortical progenitors exhibit a longer S-phase length than 
differentiative progenitors (Arai et al., 2011). As no obvious candidate genes by which 
Gli3 may regulate S-phase length have been identified by ChIP analysis (Lopez-Rios 
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et al., 2012; Vokes et al., 2008), it is possible that the shortening of S-phase length 
measured here represented an increased proportion of differentiative progenitors.  
In this chapter, I will begin by analysing microarray analysis data from the E10.5 
Gli3Xt/Pdn dorsal telencephalon, to look for any obvious candidate genes which may 
have contributed to the defects in G1- and S-phase length. As alluded to, Cdk6 was 
identified in the screen as up-regulated in the Gli3Xt/Pdn mutant. I then performed pRb 
expression analysis at E11.5 and E12.5 to assess if the up-regulation of Cdk6 had a 
functional effect on pRb hyperphosphorylation, and found that it was increased. I 
followed this analysis by culturing control and Gli3Xt/Pdn cortical slices in vitro for 24 hrs 
in the presence of palbociclib or DMSO as control to see if G1-phase lengthening 
could be achieved, and if it would rescue the defect in neuron formation reported at 
E11.5 in the mutant. However, the culture conditions used were not conducive to 
cortical slice growth, and so I could not assess the effect of palbociclib on slices. 
Finally, as no candidate genes for the dysregulation of S-phase length were identified 
in the microarray screen, I examined Tis21 expression in apical and basal progenitors 
of Gli3Xt/Pdn;Tis21GFP embryos to measure the proportion of differentiative divisions. 
Tis21 is up-regulated during G1-phase when a progenitor commits to undergoing a 
differentiative division; apical progenitors into basal progenitors or neurons and basal 













5.2 Gene expression profiling of Gli3 mutants revealed dysregulation of cell 
proliferation/differentiation genes  
 
In order to investigate how Gli3 may have regulated cell cycle length in the Gli3Xt/Pdn 
embryo, I examined microarray data from the E10.5 Gli3Xt/Pdn dorsal telencephalon, 
carried out by Thomas Theil and Kerstin Hasenpusch-Theil. E10.5 was used as an 
early time point preceding the defects observed at E11.5, particularly the reduction in 
G1- and S-phase and total cell cycle length. Microarray analysis allowed for evaluation 
of changes in mRNA expression resulting from reduced Gli3, which may have resulted 
in alteration to the cell cycle and ultimately differences in progenitor 
proliferation/differentiation.   
To conduct the microarray analysis, the complete dorsal telencephalon was dissected 
from E10.5 control and Gli3Xt/Pdn embryos. The dorsal telencephalons from two to 
three littermate embryos were pooled together to form each sample, and three control 
and mutant littermate samples were compared. The RNAeasy Micro Kit (Qiagen) was 
used to extract and isolate RNA from the samples, before microarray analysis was 
performed using Affymetrix GeneChip Mouse Genome 430 2.0 arrays. Analysis of the 
raw data output from the array was performed at the Sir Henry Wellcome Functional 
Genomics Facility (Institute of Biomedical and Life Science, University of Glasgow). 
A cut off value of p<0.05 was employed, revealing a total of 262 genes as 
dysregulated in the Gli3Xt/Pdn mutant compared to control, 78 up-regulated and 184 
down-regulated. 
In support of the reliability of the microarray analyses, a number of genes previously 
identified as dysregulated in the Gli3Xt/Pdn dorsal telencephalon were identified in this 
screen. In situ hybridisation performed by Kuschel et al. (2003) revealed an abolition 
of Emx1 expression and severe reduction in Emx2 expression at E10.5. The 
microarray screen revealed a down-regulation of Emx1 of 2.94-fold, and a down-
regulation of Emx2 of 2.05-fold. With regards to signalling molecules, Kuschel et al. 
(2003) reported an inability to detect Wnt3a and Bmp6 transcripts via in situ, and these 
showed 2.23-fold and 2.03-fold down-regulations, respectively, in the microarray. At 
E12.5, Hasenpusch-Theil et al. (2015) revealed expanded Fgf15 and Fgf17 
expression in the Gli3Xt/Pdn mutant, transcripts which were up-regulated 1.82-fold and 
2.21-fold in the microarray analysis, respectively. Furthermore, in the E11.5 lateral 





Figure 5.1: Gene Ontology (GO) analysis of up-regulated genes. Genes identified 
as up-regulated by microarray analysis in the E10.5 Gli3Xt/Pdn dorsal telencephalon, 
based on the biological processes associated with each gene. Terms were ranked 
based upon GO term usage in the list.  
 
 
progenitors and a 1.98-fold decrease in the proportion of Tbr1+ early-born neurons. 
The microarray analysis revealed a 1.95-fold down-regulation of Tbr2 and a 2.36-fold 
down-regulation of Tbr1 at E10.5. Pax6 was not identified in the microarray screen, 
although it may have been dysregulated but not identified due to the cut-off value for 
fold change used.  
To evaluate the microarray data, I conducted Gene Ontology (GO) analysis looking 
specifically at biological processes. In this analysis, the dysregulated genes are 
ranked based on the processes in which they have been implicated. The output 
reveals the number of genes from the submitted gene list which coincide with the total 
number of genes linked to each process. The Generic Gene Ontology Term Finder 
tool from Princeton University (Boyle et al., 2011) was used to perform GO analysis 

















Figure 5.2: Gene Ontology (GO) analysis of down-regulated genes.  Genes 
identified as down-regulated in the E10.5 Gli3Xt/Pdn dorsal telencephalon, based on the 
biological processes associated with them. Terms were ranked based upon GO term 
usage in the list.  
 
 
identified as linked to each gene set were ranked based on GO term usage in each 
gene list.  
Figures 5.1 and 5.2 show the top 10 results received for up-regulated and down-
regulated genes, respectively. Some of the processes identified amongst the up-
regulated genes included “regulation of cell proliferation” and “cell proliferation”, whilst 
the down-regulated processes included “neurogenesis”, “generation of neurons” and 
“neuron differentiation”. In the E11.5 Gli3Xt/Pdn lateral cortex, I reported an increase in 
cell cycle re-entry and increased apical progenitor proportion with decreased basal 
progenitor and early-born neuron proportions. I suggested the apical progenitor 
population was proliferating and re-entering the cell cycle at this age, at the expense 
of differentiation into neurons. The GO analysis supports this, revealing that 24 hrs 
before I conducted my immunofluorescent analyses there was already an up- 
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Figure 5.3: Cdk6 expression. In situ hybridisation revealing Cdk6 expression in the 
E12.5 wild-type cortex. Cdk6 was expressed in the proliferating zone of the cortex. 
Image supplied by Kerstin Hasenpusch-Theil. Scale bar = 250m. 
 
 
regulation of genes regulating proliferative division at the expense of genes regulating 
differentiative division.  
In regard to the cell cycle length defect observed at E11.5 in the Gli3Xt/Pdn cortex, Cdk6 
was identified in the microarray screen as up-regulated 1.59-fold in the mutant 
compared to control. Cdk6 is a cyclin dependent kinase which is up-regulated in G1-
phase, and in combination with D-type cyclins, progresses a progenitor past the G1 
restriction point thereby allowing entry into S-phase (Lim & Kaldis, 2013). The 
microarray was conducted at the total cell level in the dorsal telencephalon, and G1-
phase length was reduced in the Gli3Xt/Pdn mutant at the total progenitor level. Figure 
5.3 shows Cdk6 expression in the control E12.5 telencephalon, where it is expressed 
in the proliferative zone of the cortex (image supplied by Kerstin Hasenpusch-Theil). 
Cdk6 therefore represented an interesting candidate gene which may have 
contributed to the reduction in G1-phase length. Additionally, when this microarray 
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was conducted, analysis was also carried out on the E10.5 Gli3Pdn/Pdn mutant. In this 
mutant between E11.5 and E12.5, there was no delay in neurogenesis as seen in the 
lateral Gli3Xt/Pdn cortex (Magnani et al., 2010) and no differential expression of Cdk6, 
further suggesting Cdk6 as a potential candidate gene altering G1-phase length in 
Gli3Xt/Pdn.   
 
5.3 pRb expression was increased in apical and basal progenitors of the E11.5 
lateral Gli3XtPdn cortex, whilst at E12.5 it was increased in lateral and medial 
basal progenitors only 
 
Before focussing on Cdk6 as a candidate gene reducing the length of G1-phase, I 
assessed if the up-regulation in Cdk6 had a consequential effect on the actions of 
Cdk6. When bound to its catalytic binding partners D-type cyclins, Cdk6 
hyperphosphorylates Rb (pRb), releasing its inhibition on the E2F transcription factors 
and allowing transcription of phase progression genes. I therefore examined pRb 
expression in the E11.5 and E12.5 Gli3Xt/Pdn cortex. As with Pax6 and Tbr2, pRb 
expression was compared with PCNA expression to give the proportion of progenitors 
expressing it. Apical and basal progenitors were identified separately based on the 
position of the pRb+ cells, with those along the ventricular surface classified as apical 
progenitors and those in an aventricular position classified as basal progenitors.  
At E11.5, the proportion of pRb+ apical progenitors was increased in the Gli3Xt/Pdn 
lateral neocortex compared to control, yet remained unaffected in the medial cortex 
(lateral: 4.69±0.30% in control and 5.59±0.54% in mutant, n=4, p<0.05, medial: 
5.05±0.95% in control and 5.99±0.45% in mutant, n=4, p>0.05) (figure 5.4 A–E, yellow 
arrows). In the basal progenitor population, the proportion of pRb+ cells was increased 
laterally but unaltered medially (lateral: 0.33±0.09% in control and 0.91±0.15% in 
mutant, n=4, p<0.05, medial: 0.26±0.18% in control and 0.65±0.36% in mutant, n=4, 
p>0.05) (figure 5.4 A–D, F, white arrows). 
At E12.5, the proportion of pRb+ apical progenitors in the Gli3Xt/Pdn cortex was no 
different from control in both the lateral and medial cortex (lateral: 4.12±0.55% in 
control and 5.31±1.07% in mutant, n=4, p>0.05, medial: 4.71±0.70% in control and 
4.91±0.39% in mutant, n=4, p>0.05) (figure 5.5 A–E, yellow arrows). However, the 
proportion of pRb+ basal progenitors was increased in the mutant compared to control 
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both laterally and medially (lateral: 0.58±0.13% in control and 1.01±0.18% in mutant, 
n=4, p<0.05, medial: 0.13±0.08% in control and 0.74±0.19% in mutant, n=4, p<0.05) 
(figure 5.5 A–D, F, white arrows). Taken together, the reduction in Gli3 in the mutant 
cortex did result in an increase in pRb hyperphosphorylation, potentially due to an 







Figure 5.4: pRb S780 expression was increased in the E11.5 lateral cortex. A-D. 
pRb/PCNA immunofluorescence on sections of E11.5 cortex from control and 
Gli3Xt/Pdn embryos. Yellow arrows denote apical progenitors, white arrows denote 
basal progenitors. E. The proportion of pRb+ cells was increased in the Gli3Xt/Pdn apical 
progenitor population compared to control in the lateral cortex. There was no 
significant difference between control and mutant in the medial cortex. F. The 
proportion of pRb+ cells was significantly increased in the Gli3Xt/Pdn basal progenitor 
population in the lateral cortex. There was no significant difference in the pRb 
expression between control and mutant in the medial cortex. All statistical data 
represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-Whitney U-test. 





















Figure 5.5: pRb S780 expression was increased in basal progenitors of the 
E12.5 cortex. A-D. pRb/PCNA immunofluorescence on sections of E12.5 cortex from 
control and Gli3Xt/Pdn embryos. Yellow arrows denote apical progenitors, white arrows 
denote basal progenitors. E. In the lateral cortex, there was no significant difference 
in the proportion of pRb+ apical progenitors in the Gli3Xt/Pdn mutant compared to 
control. Likewise, there was no significant difference between control and mutant in 
the medial cortex. F. The proportion of pRb+ cells was significantly increased in the 
Gli3Xt/Pdn basal progenitor population in the lateral cortex. The proportion of pRb+ basal 
progenitors was also increased in the medial mutant cortex compared to control. All 
statistical data represents mean ± 95% confidence interval; n=5; * = p<0.05; ** = 
p<0.01; Mann-Whitney U-test. Scale bars = 100m.  
 
 
5.4 Palbociclib increased pRb expression in E13.5 CD1 organotypic slice 
culture 
 
To investigate the link between increased Cdk6 expression in the E10.5 Gli3Xt/Pdn 
dorsal telencephalon and the reduction in G1-phase length measured at E11.5 and 
E12.5, a Cdk4/6 specific inhibitor was used to promote rescue of the neurogenesis 
delay. Developed as a chemotherapy drug, palbociclib specifically inhibits the action 
of Cdk6 and its counterpart Cdk4. In tumour cell lines, treatment with palbociclib 
reduces expression of the proliferation marker Ki67 and down-regulated E2F target 
genes (Sherr et al., 2016). To test the efficacy of palbociclib in cortical slice culture, 
CD1 embryos were used due to the large litter size of CD1 mice compared to Gli3Xt/+ 
and Gli3Pdn/+ mice. This facilitated evaluation of the concentration of palbociclib to be 
used in Gli3Xt/Pdn slice cultures. The brain was dissected from E13.5 CD1 embryos 
and embedded in agarose for vibratome sectioning. 300m coronal sections were 
incubated for 24 hrs in the presence of either DMSO (control) or palbociclib dissolved 
in DMSO. Three different concentrations of palbociclib were compared, 1.5g/ml, 
0.75g/ml and 0.38g/ml (Fry et al., 2004). After culture, the slices were further 
cryosectioned to 10m to allow for immunofluorescent analysis. As above, pRb 






Figure 5.6: pRb S780 expression in the lateral cortex of E13.5 CD1 organotypic 
slice cultures after exposure to DMSO or palbociclib. A-D. pRb/PCNA 
immunofluorescence on slice cultures of E13.5 cortex from CD1 embryos. Yellow 
arrows denote apical progenitors, white arrows denote basal progenitors. E. In the 
apical progenitor population, administration of 1.5g/ml palbociclib significantly 
reduced the proportion of pRb+ cells in comparison with DMSO administration.  F. In 
the basal progenitor population, administration of all concentrations of palbociclib did 
not significantly reduced the proportion of pRb+ cells in comparison to DMSO. All 
statistical data represents mean ± 95% confidence interval; n=4; ** = p<0.01; Kruskal-
Wallis test followed by Dunn’s post-hoc test. Scale bars = 100m.  
 
 
activity. Apical and basal progenitor expression was examined as outlined in the 
Gli3Xt/Pdn cortex, and the lateral and medial cortex were compared. 
In the lateral cortex, the proportion of pRb+ apical progenitors was significantly 
reduced in the presence of 1.5g/ml palbociclib compared to control, yet 0.75g/ml 
and 0.38g/ml palbociclib did not significantly reduce the proportion of pRb+ apical 
progenitors (DMSO: 2.46±0.52%, 1.5ml: 0.26±0.14%, 0.75g/ml: 0.63±0.37%, 
0.38g/ml: 0.71±0.37%. DMSO vs. 1.5g/ml p<0.01, DMSO vs. 0.75g/ml p>0.05, 
DMSO vs. 0.38g/ml p>0.05, n=4 per condition. Kruskal-Wallis test followed by 
Dunn’s post-hoc test) (figure 5.6 A-E, yellow arrows). In the basal progenitor 
proportion, the Kruskal-Wallis test revealed there was a significant difference between 
palbociclib and DMSO treatment, yet the Dunn’s post-hoc test was unable to identify 
between which drug treatment group(s) the significance lay probably due to 
insufficient power. Subsequent power analysis (conducted using G*Power) revealed 
a power of 0.43, and a sample size of 12 slices per group would have been required 
to attain a power of >0.80 (DMSO: 0.62±0.31%, 1.5ml: 0.09±0.05%, 0.75g/ml: 
0.16±0.23%, 0.38g/ml: 0.19±0.14%. DMSO vs. 1.5g/ml p>0.05, DMSO vs. 
0.75g/ml p>0.05, DMSO vs. 0.38g/ml p>0.05, n=4 per condition) (figure 5.6 A-D, F, 
white arrows).  
In the medial cortex, 1.5g/ml and 0.38g/ml palbociclib significantly reduced the 






Figure 5.7: pRb S780 expression in the medial cortex of E13.5 CD1 organotypic 
slice cultures after exposure to DMSO or palbociclib. A-D. pRb/PCNA 
immunofluorescence on slice cultures of E13.5 cortex from CD1 embryos. Yellow 
arrows denote apical progenitors, white arrows denote basal progenitors. E. In the 
apical progenitor population, administration of 1.5g/ml and 0.38g/ml palbociclib 
significantly reduced the proportion of pRb+ cells in comparison to DMSO.  F. In the 
basal progenitor population, administration of all concentrations of palbociclib did not 
significantly reduced the proportion of pRb+ cells in comparison to DMSO. All 
statistical data represents mean ± 95% confidence interval; n=4; * = p<0.05; Kruskal-
Wallis test followed by Dunn’s post-hoc test. Scale bars = 100m.  
 
 
expression (DMSO: 2.41±0.69%, 1.5ml: 0.50±0.15%, 0.75g/ml: 1.18±0.74%, 
0.38g/ml: 0.67±0.79%. DMSO vs. 1.5g/ml p<0.05, DMSO vs. 0.75g/ml p>0.05, 
DMSO vs. 0.38g/ml p<0.05, n=4 per condition) (figure 5.7 A-E, yellow arrows). In the 
medial cortex, no concentration of palbociclib significantly reduced the proportion of 
pRb+ basal progenitors (DMSO: 0.50±0.29%, 1.5ml: 0.06±0.08%, 0.75g/ml: 
0.05±0.10%, 0.38g/ml: 0.22±0.09%. DMSO vs. 1.5g/ml p>0.05, DMSO vs. 
0.75g/ml p>0.05, DMSO vs. 0.38g/ml p>0.05, n=4 per condition) (figure 5.7 A-D, F, 
white arrows). Together, palbociclib was able to decrease pRb expression in 
organotypic cortical slice culture, and so its effect was evaluated in the Gli3Xt/Pdn 
cortex, which showed an increase in pRb expression.  
 
5.5 Organotypic slice culture was not conducive to in vitro Gli3Xt/Pdn cortical 
growth 
 
5.5.1 E11.5 Gli3Xt/Pdn and littermate control slices failed to grow correctly during 
24 hrs in vitro 
At E11.5 in the Gli3Xt/Pdn lateral cortex, there was a decrease in the proportion of early-
born neurons and an increase in apical progenitor proportion, alongside increased 
cell cycle re-entry. Here, G1-phase length was shorter in the apical progenitor 
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population alongside an increase in pRb expression, whilst in the basal progenitor 
population pRb was increased yet G1-phase length was unaltered. Cdk6 expression 
was increased in the E10.5 mutant dorsal telencephalon, which could be 
hypothesised to reduce G1-phase length. Thus the effect of inhibiting the action of 
Cdk6 and thereby prolonging G1-phase length at this age was evaluated, in order to 
assess if the reduction in neurogenesis could be rescued. 
A concentration of 0.38g/ml palbociclib was used as it had been shown to decrease 
pRb expression, and it was very important to prolong G1-phase length whilst not 
blocking progenitors in G1-phase and causing a failure to progress through the cell 
cycle. Indeed, the primary use of palbociclib is in breast cancer treatment, where it is 
used to block tumour cells in G1-phase (DiPippo et al., 2016). To confirm if palbociclib 
was still able to decrease pRb expression 24 hrs after E11.5 cortical slices had been 
put into culture, pRb/PCNA expression was evaluated. Telencephalic sections of both 
control and Gli3Xt/Pdn embryos were cultured in the presence of DMSO or 0.38g/ml 
palbociclib dissolved in DMSO, with cortical slices from the same embryo used to 
compare the effects of DMSO and palbociclib.  
Under control DMSO conditions, it was apparent that the cortical slices of both control 
and mutant embryos had failed to grow properly during the 24 hrs in culture. In the 
control slice shown in figure 5.8 A, whilst most of the midline of the telencephalon has 
been disrupted, the cortex was still visible at the top of the slice (figure 5.8 A, white 
arrow). However, the ventricles became filled with tissue which fused in places with 
the cortical ventricular surface (figure 5.8 A’). Presumably, during culture the slice had 
flattened and spread outwards, so the ventricular zone either rostral or caudal to the 
section shown in the figure had fused with that shown. This precluded examination of 
the slices as it was not clear which cells should be counted. It should also be noted 
that the images shown in the figures represent the most successful slice cultures. In 
the Gli3Xt/Pdn slices as shown figure 5.8 B, the majority of the midline structures 
became unidentifiable. It was still possible to identify some cortical tissue, shown on 
the left of the image, yet clearly growth had been disturbed (figure 5.8 B’). It became 
difficult to discern a continuous ventricular surface where counting could be 
conducted.  
When cultured in the presence of 0.38g/ml palbociclib, surprisingly the morphology 
of the control slice was more recognisable (figure 5.8 C). However, upon closer 






Figure 5.8: pRb S780 expression in the cortex of E11.5 control and Gli3Xt/Pdn 
organotypic slice cultures after exposure to DMSO, palbociclib, or neither. 
pRb/PCNA immunofluorescence on slice cultures after 24hrs in vitro. Boxes in A, B, 
C, D, E represent area shown in A’, B’, C’, D’, E’, respectively. A, A’, B, B’. Control 
(A, A’) and Gli3Xt/Pdn (B, B’) slices after 24hrs in culture in the presence of DMSO. C, 
C’, D, D’. Control (C, C’) and Gli3Xt/Pdn (D, D’) slices after 24hrs in culture in the 
presence of 0.38g/ml palbociclib. E, E’. Control slice after 24hrs in culture with 
neither DMSO or palbociclib. Scale bars = 200m.  
 
 
There were clumps of cells growing inside the ventricle attached to the ventricular 
surface (figure 5.8 C, white arrow). pRb+ cells also formed clusters (figure 5.8 C’), 
instead of lining the ventricle regularly. In the Gli3Xt/Pdn slice in the presence of 
palbociclib, the ventricles had shrunk dramatically in the region of the cortex, so that 
the presumed ventral and dorsal telencephalon appeared to be in contact (figure 5.8 
D’) and rosette-like structures formed where the ventricular surface became folded. It 
therefore became impossible to identify the lateral and medial areas of the cortex.  
Collectively, both control and Gli3Xt/Pdn cortical slices failed to grow properly in culture 
when taken at E11.5 and left for 24 hrs, in the presence of either DMSO or palbociclib. 
The disruption to the cortex meant it was not possible to accurately identify the lateral 
and medial cortex for counting, and so the effect of palbociclib on pRb expression 
could not be evaluated.  
In order to determine if the presence of DMSO had contributed to the disruption in 
growth, control cortical slices were cultured without DMSO or palbociclib present 
(figure 5.8 E). Even when cultured in only supplemented neurobasal medium (table 
2.6), growth in the cortex was disturbed. Rosette-like structures formed (figure 5.8 E’), 
and the regular pattern of pRb+ cells lining the ventricular surface as seen in figure 
5.4 was lost. Therefore, at this early stage, the organotypic culture environment was 
not permissive to the regular growth of the cortex, and so the effect of palbociclib on 




5.5.2 E12.5 Gli3Xt/Pdn cortical slices failed to grow properly during 24 hrs in 
culture 
In the E12.5 Gli3Xt/Pdn dorsal telencephalon, the proportion of neurons compared to 
control was increased in both the lateral and medial cortex. This coincided with 
increased cell cycle exit, indicating progenitor differentiation into neurons. Yet, when 
the length of G1-phase was measured in the apical progenitor population laterally and 
the total progenitor population medially, it was reduced in the mutant. 
Pharmacological G1-phase lengthening has been reported to promote progenitor 
differentiation (Calegari & Huttner, 2003), and so the effect of artificially lengthening 
G1-phase in the E12.5 cortex was assessed. E12.5 embryos were harvested and 
cultured as above for 24 hrs in the presence of either DMSO or 0.38g/ml palbociclib 
in DMSO. Control and Gli3Xt/Pdn littermate embryos were used, with one slice from 
each embryo being exposed to DMSO and another slice from the same embryo being 
exposed to palbociclib. As before, pRb expression was used as a measure of Cdk6 
activity to assess the effect of the palbociclib.  
When slices from control embryos were exposed to DMSO, the structure of the 
telencephalon remained recognisable (figure 5.9 A). However as with E11.5 slices, 
rosette-like structures formed albeit to a lesser extent (figure 5.9 A’), and the normally 
continuous expression of pRb along the ventricular surface was disrupted. In the 
mutant, the overall structure of the dorsal and ventral telencephalon was again 
recognisable, but upon closer inspection the cortex displayed severe growth 
problems. The cortex and LGE/MGE fused at one point (figure 5.9 B’), and the 
ventricle appeared to become compartmentalised to form multiple smaller ventricles 
(figure 5.9 B, arrows). The expression of pRb along the ventricular surface was also 
disrupted, and it was not possible to distinguish where the lateral and medial cortex 
lay for comparison.  
In the presence of palbociclib, slices from control embryos remained identifiable in 
terms of the dorsal and ventral telencephalon (figure 5.9 C). However, as when 
exposed to DMSO only, rosettes formed in the cortex and the expression of pRb along 
the ventricular surface was discontinuous (figure 5.9 C’). In the example slice shown 
in figure 5.9 C, there was a huge expansion of PCNA+ cells basal to the ventricular 
zone (figure 5.9 C, arrow). Clearly, growth of the cortex was disturbed here. When 
Gli3Xt/Pdn slices were exposed to palbociclib, the cortex became thinner (figure 5.9 D). 










Figure 5.9: pRb S780 expression in the cortex of E12.5 control and Gli3Xt/Pdn 
organotypic slice cultures after exposure to DMSO or palbociclib. pRb/PCNA 
immunofluorescence on slice cultures after 24hrs in vitro. Boxes in A, B, C, D 
represent area shown in A’, B’, C’, D’, respectively. A, A’, B, B’. Control (A, A’) and 
Gli3Xt/Pdn (B, B’) slices after 24hrs in culture in the presence of DMSO. C, C’, D, D’. 
Control (C, C’) and Gli3Xt/Pdn (D, D’) slices after 24hrs in culture in the presence of 
0.38g/ml palbociclib. Scale bars = 250m.  
 
 
proliferative cells with pRb+ cells in the middle. This splitting/duplication of the 
ventricular zone is likely due to flattening of the slice during the culture (figure 5.9 D’).  
In summary, as with E11.5 slices, at E12.5 slices showed marked disturbance in their 
growth after 24 hrs of culture. The expression pattern of pRb along the ventricular 
surface was altered and the formation of rosette-like structures meant a reliable 
proportion of pRb+/PCNA+ cells could not be calculated. The position of the medial 
and lateral cortex was also unclear, particularly in the mutant slice exposed to DMSO.   
 
5.5.3 At E13.5, growth of Gli3Xt/Pdn cortical slices in vitro was defective  
Slice cultures of E13.5 CD1 telencephalon were successful in the presence of either 
DMSO or palbociclib. In contrast, the uncoordinated growth of E11.5 and E12.5 
Gli3Xt/Pdn and littermate control slices in culture precluded analysis of the effect of 
palbociclib. Potentially, the earlier ages were not conducive to this culture technique, 
or differences between the Gli3Xt/Pdn background and CD1 embryos resulted in the 
ability to study pRb expression in one circumstance but not the other. Therefore, I 
harvested E13.5 Gli3Xt/Pdn and control embryos and cultured cortical slices from them 
as I did with E13.5 CD1 embryos.  
Control cortical slices cultured in the presence of DMSO retained the morphology of 
the dorsal and ventral telencephalon (figure 5.10 A), although occasionally there was 
growth of additional cortical-like tissue in the ventricles (figure 5.10 A, arrow). 
However, importantly, the positioning of pRb+ and PCNA+ progenitors within the 
cortex replicated that of CD1 embryos in culture and of control embryos that had not 








Figure 5.10: pRb S780 expression in the cortex of E13.5 control and Gli3Xt/Pdn 
organotypic slice cultures after exposure to DMSO or palbociclib. pRb/PCNA 
immunofluorescence on slice cultures after 24hrs in vitro. Boxes in A, B, C, D 
represent area shown in A’, B’, C’, D’, respectively. A, A’, B, B’. Control (A, A’) and 
Gli3Xt/Pdn (B, B’) slices after 24hrs in culture in the presence of DMSO. C, C’, D, D’. 
Control (C, C’) and Gli3Xt/Pdn (D, D’) slices after 24hrs in culture in the presence of 
0.38g/ml palbociclib. Scale bars = 500m.  
 
 
morphology of Gli3Xt/Pdn slices put into culture at E13.5 with DMSO. Nevertheless, 
there was some compartmentalisation of the ventricle (figure 5.10 B, arrow), and 
some additional tissue growing inside the ventricle (figure 5.10 B’, arrow). The 
expression pattern of pRb and PCNA appeared mostly normal except where the 
additional tissue was present in the ventricle.  
When palbociclib was added to the cultures, control cortical slices retained the shape 
of a conventional coronal slice (figure 5.10 C). Again, as with DMSO alone, the 
expression pattern of pRb and PCNA was as in CD1 embryos, revealing that control 
slices obtained from a Gli3Xt/Pdn litter behaved in culture as the CD1 slices did (figure 
5.10 C’). The Gli3Xt/Pdn mutant slices retained approximately the correct shape at the 
whole telencephalon level (figure 5.10 D), however upon closer inspection there was 
disruption to the positioning of cells (figure 5.10 D’). Expression of pRb along the 
ventricular surface was reduced (figure 5.10 D’, white arrow) and the ventricular zone 
appeared to have split (figure 5.10 D’, yellow arrow). As such, it was not possible to 
accurately count the proportion of pRb+ cells, and so I was unable to determine the 








5.6 Tis21;GFP expression revealed the proportion of apical and basal 
progenitors undergoing differentiative division in the Gli3Xt/Pdn mutant  
 
As described in chapter 4, the reduction in Gli3 in the Gli3Xt/Pdn mutant resulted in a 
reduction in S-phase length at E11.5 and E12.5, in both apical and basal progenitors. 
However, unlike G1-phase length, the microarray analysis did not reveal any obvious 
candidate genes which might have resulted in Gli3’s regulation over S-phase length. 
Arai et al. (2011) revealed that in the murine neocortex, S-phase shortening occurs 
when progenitors being to undergo differentiative division. It is possible that the 
reduction in S-phase length in the Gli3Xt/Pdn mutant did not reflect a shortening of S-
phase, but a larger proportion of cells undergoing differentiative division, and thus 
going through a shorter S-phase. Overall, the reduction in S-phase length measured 
may have reflected an increased proportion of differentiative divisions in the mutant, 
indicating no regulation of S-phase length by Gli3.  
To investigate this possibly, Gli3Xt/Pdn;Tis21GFP embryos were utilised. Tis21 mRNA 
is up-regulated during G1-phase in progenitors that will undergo a differentiative 
division (Iacopetti et al., 1999). Apical progenitors will produce either basal 
progenitors or neurons, whereas basal progenitors will produce neurons. Gli3Xt/+ mice 
were crossbred with Tis21-GFP reporter mice, where GFP expression is under the 
control of the Tis21 promoter (Haubensak et al., 2004). GFP expression thus identified 
progenitors about to undergo differentiative division. As can be seen in figure 5.11 A, 
B, the morphology of the E11.5 Gli3+/+ telencephalon, used as control in preceding 
experiments, was very similar to that of the Gli3+/+;Tis21GFP, used as control in 
following experiments, respectively. The gross morphology of E11.5 Gli3Xt/Pdn 
telencephalon was slightly different from that of Gli3Xt/Pdn;Tis21GFP embryos (figure 
5.11 C, D, respectively). I therefore examined Pax6 (figure 5.12 B, D) and Tbr2 (figure 
5.13 B, D) expression in the cortex of these embryos, and both appeared to be 
unaffected. So, the proportions of proliferative and differentiative progenitors of these 









Figure 5.11: Coronal sections of E11.5 Gli3+/+, Gli3+/+;Tis21GFP, Gli3Xt/Pdn and 
Gli3Xt/Pdn;Tis21GFP telencephalons. Boxes overlaid on the lateral and medial cortex 
indicate the areas used for counting. TOPRO-3 staining was used to identify all nuclei 
to give a representation of telencephalon morphology. A, B. Comparison between 
control telencephalon (A) used in chapters 3 and 4 and sections 5.2, 5.3 and 5.5, with 
the control telencephalon of embryos crossed with the Tis21-GFP reporter line used 
in section 5.6. C, D. Comparison between Gli3Xt/Pdn telencephalon (C) used in chapters 
3 and 4 and sections 5.2, 5.3 and 5.5, with the Gli3Xt/Pdn;Tis21GFP telencephalon of 









Figure 5.12: Pax6/Tis21-GFP immunofluorescence on E11.5 coronal sections of 
control and Gli3Xt/Pdn;Tis21GFP embryos highlighting differentiative apical 
progenitors. A, B, C, D. Merged images showing the overlap between Pax6 and 
Tis21-GFP expression in control (A, B) and mutant (C, D) embryos. A’, B’, C’, D’. 
Tis21-GFP expression in control (A’, B’) and mutant (C’, D’) embryos. A”, B”, C”, D”. 
Pax6 expression in control (A”, B”) and mutant (C”, D”) embryos. Scale bars = 100m 


























Figure 5.13: Tbr2/Tis21-GFP immunofluorescence on E11.5 coronal sections of 
control and Gli3Xt/Pdn;Tis21GFP embryos highlighting differentiative basal 
progenitors. A, B, C, D. Merged images showing the overlap between Tbr2 and 
Tis21-GFP expression in control (A, B) and mutant (C, D) embryos. A’, B’, C’, D’. 
Tis21-GFP expression in control (A’, B’) and mutant (C’, D’) embryos. A”, B”, C”, D”. 
Tbr2 expression in control (A”, B”) and mutant (C”, D”) embryos. Scale bars = 100m 
(A, C), 200m (B, D).  
 
 
5.6.1 Apical progenitor differentiation was decreased in the E11.5 medial 
Gli3Xt/Pdn;Tis21GFP cortex, yet it was increased in the E12.5 lateral and medial 
mutant cortex 
To begin, the proportion of apical progenitors undergoing differentiative division was 
calculated by dividing the number of Tis21-GFP+/Pax6+ double-positive cells against 
the total number of Pax6+ cells. Conversely, the proportion of Tis21-GFP-/Pax6+ cells 
against the total Pax6+ population gave the proliferative apical progenitor proportion. 
As before, this proportion was calculated in both E11.5 and E12.5 control and mutant 
embryos, in the lateral and medial cortex separately.  
In the lateral cortex, there was no significant difference in the proportion of 
differentiative divisions in the E11.5 Gli3Xt/Pdn;Tis21GFP cortex compared to control 
(36.43±1.65% in control and 32.14±7.80% in mutant, n=4, p>0.05) (figure 5.14 A, B, 
E). Consequently, there was also no significant difference in the proportion of 
proliferative apical progenitors (63.57±1.65% in control and 67.86±7.80% in mutant, 
n=4, p>0.05) (figure 5.14 A, B, F). However, there was large variance amongst the 
mutant embryos, with one embryo potentially being anomalous. It would be 
advantageous to increase the number of embryos examined to determine if the 
tendency of the other three embryos to display decreased differentiation accurately 
represented Tis21 expression in these embryos. Furthermore, the increased 
proportion of apical progenitors and decreased basal progenitors and neurons, as 
well as increased cell cycle re-entry would indicate an increase in apical progenitor 
proliferation at the expense of differentiation. However, in the medial cortex, the 
proportion of differentiative apical progenitors was significantly decreased in the 






Figure 5.14: The proportion of differentiative apical progenitors was decreased 
in the medial E11.5 cortex. A-D. Pax6/Tis21-GFP immunofluorescence on sections 
of E11.5 cortex from control and Gli3Xt/Pdn;Tis21GFP embryos. E. The proportion of 
Pax6+/Tis21-GFP+ differentiative apical progenitors showed a tendency to be 
decreased in the mutant compared to control in the lateral cortex, note the large 
variance in mutant embryos. The proportion of Pax6+/Tis21-GFP+ differentiative apical 
progenitors was significantly decreased in the mutant compared to control in the 
medial cortex. F. The proportion of Pax6+/Tis21-GFP- proliferative apical progenitors 
showed a tendency to be increased in the mutant compared to control in the lateral 
cortex. The proportion of Pax6+/Tis21-GFP- proliferative apical progenitors was 
significantly increased in the mutant compared to control in the medial cortex. All 
statistical data represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-
Whitney U-test. Scale bars = 100m.  
 
 
p<0.05) (figure 5.14 C, D, E), whilst the proportion of proliferative apical progenitors 
was significantly increased (59.02±1.86% in control and 70.57±6.28% in mutant, n=4, 
p<0.05) (figure 5.14 C, D, F). Here, the proportions of apical and basal progenitors 
and neurons and cell cycle re-entry/exit were unaltered, but may precede changes at 
E12.5.  
At E12.5, in the lateral cortex there was a significant increase in apical progenitors 
undergoing differentiative division in the mutant (41.25±1.53% in control and 
58.54±5.27% in mutant, n=4, p<0.05) (figure 5.15 A, B, E). Simultaneously, the 
proportion of mutant apical progenitors undergoing proliferative division was 
decreased (58.75±1.53% in control and 41.46±5.27% in mutant, n=4, p<0.05) (figure 
5.15 A, B, F). Likewise, in the medial mutant cortex, the proportion of differentiative 
apical progenitors was increased (36.36±1.47% in control and 45.82±6.69% in 
mutant, n=4, p<0.05) (figure 5.15 A, B, E), whilst the proportion of proliferative apical 
progenitors was decreased (63.63±1.47% in control and 54.18±6.69% in mutant, n=4, 
p<0.05) (figure 5.15 A, B, F).  
Taken together, a change in the proportion of apical progenitors undergoing 
differentiative division would not account for the difference in S-phase length at E11.5. 






Figure 5.15: The proportion of differentiative apical progenitors was increased 
in the E12.5 cortex. A-D. Pax6/Tis21-GFP immunofluorescence on sections of E12.5 
cortex from control and Gli3Xt/Pdn;Tis21GFP embryos. E. The proportion of 
Pax6+/Tis21-GFP+ differentiative apical progenitors was significantly increased in the 
mutant compared to control in the lateral cortex. The proportion of Pax6+/Tis21-GFP+ 
differentiative apical progenitors was significantly increased in the mutant compared 
to control in the medial cortex. F. The proportion of Pax6+/Tis21-GFP- proliferative 
apical progenitors was significantly decreased in the mutant compared to control in 
the lateral cortex. The proportion of Pax6+/Tis21-GFP- proliferative apical progenitors 
was significantly decreased in the mutant compared to control in the medial cortex. 
All statistical data represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-
Whitney U-test. Scale bars = 100m.  
 
 
of differentiative divisions was unaltered, whilst in the medial cortex S-phase length 
was unaltered in the mutant, yet there was a decrease in differentiative divisions. By 
E12.5, S-phase length was reduced in the mutant both laterally and medially, and the 
proportion of apical progenitors undergoing differentiative division was increased. 
Therefore, at this age, as S-phase length gets shorter in the switch from proliferative 
to differentiative division, the larger mutant proportion of apical progenitors 
undergoing differentiative division may account for the reduction measured in S-
phase length.  
 
5.6.2 Basal progenitor differentiation was increased in the E11.5 lateral 
Gli3Xt/Pdn;Tis21GFP cortex, yet it was unchanged in the E12.5 mutant cortex   
The length of S-phase was decreased in the Gli3Xt/Pdn lateral cortex at E11.5, whilst it 
was not possible to measure S-phase length in the medial cortex. As with the apical 
progenitor population, the proportion of basal progenitors undergoing differentiative 
division was also calculated by combining Tis21-GFP expression with Tbr2 








Figure 5.16: The proportion of differentiative basal progenitors was increased 
in the lateral E11.5 cortex. A-D. Tbr2/Tis21-GFP immunofluorescence on sections 
of E11.5 cortex from control and Gli3Xt/Pdn;Tis21GFP embryos. E. The proportion of 
Tbr2+/Tis21-GFP+ differentiative basal progenitors was significantly increased in the 
mutant compared to control in the lateral cortex. The proportion of Tbr2+/Tis21-GFP+ 
differentiative basal progenitors was unaltered in the mutant compared to control in 
the medial cortex. F. The proportion of Tbr2+/Tis21-GFP- proliferative basal 
progenitors was significantly decreased in the mutant compared to control in the 
lateral cortex. The proportion of Tbr2+/Tis21-GFP- proliferative basal progenitors was 
unaltered in the mutant compared to control in the medial cortex. All statistical data 
represents mean ± 95% confidence interval; n=4; * = p<0.05; Mann-Whitney U-test. 
Scale bars = 100m.  
 
 
Unlike in the lateral apical progenitor population where there was no difference in 
differentiative division, the proportion of basal progenitors undergoing differentiative 
division was increased in the mutant at E11.5 (80.58±4.40% in control and 
87.54±1.23% in mutant, n=4, p<0.05) (figure 5.16 A, B, E). Likewise, the proportion 
of basal progenitors undergoing proliferative division was decreased (19.42±4.40% in 
control and 12.64±1.23% in mutant, n=4, p<0.05) (figure 5.16 A, B, F). In the medial 
cortex, the proportion of differentiative basal progenitors was unaltered in the mutant 
(81.18±2.74% in control and 82.96±6.29% in mutant, n=4, p>0.05) (figure 5.16 C, D, 
E), as was the proportion of proliferative basal progenitors (18.82±2.74% in control 
and 17.04±6.29% in mutant, n=4, p>0.05) (figure 5.16 C, D, F). 
By E12.5, in the lateral cortex there was no difference in basal progenitor 
differentiative division in the mutant (90.18±3.01% in control and 91.50±1.82% in 
mutant, n=4, p>0.05) (figure 5.17 A, B, E) or basal progenitor proliferative division 
(9.82±3.01% in control and 8.50±1.82% in mutant, n=4, p>0.05) (figure 5.17 A, B, F). 
Similarly, in the medial cortex, there was no change in basal progenitor differentiative 
division in the mutant compared to control (87.61±2.87% in control and 89.59±2.63% 
in mutant, n=4, p>0.05) (figure 5.17 C, D, E) or in the proportion of proliferative 
divisions (12.39±2.87% in control and 10.41±2.63% in mutant, n=4, p>0.05) (figure 






Figure 5.17: The proportion of differentiative basal progenitors was unaltered 
in the E12.5 cortex. A-D. Tbr2/Tis21-GFP immunofluorescence on sections of E12.5 
cortex from control and Gli3Xt/Pdn;Tis21GFP embryos. E. The proportion of 
Tbr2+/Tis21-GFP+ differentiative basal progenitors was unaltered in the mutant 
compared to control in the lateral and medial cortex. F. The proportion of Tbr2+/Tis21-
GFP- proliferative basal progenitors was unaltered in the mutant compared to control 
in the lateral and medial cortex. All statistical data represents mean ± 95% confidence 
interval; n=4; * = p<0.05; Mann-Whitney U-test. Scale bars = 100m.  
 
 
Although I was unable to measure S-phase length of basal progenitors in the medial 
E11.5 cortex, in the lateral E11.5 cortex S-phase length was shorter in the mutant. 
Here, there was an increase in the proportion of basal progenitors undergoing 
differentiative division, which may account for the difference in S-phase length. By 
E12.5, S-phase length was no longer altered in mutant basal progenitors compared 















5.7 Discussion  
 
In this chapter, I began to look at the mechanisms by which Gli3 may regulate the cell 
cycle, contributing to a defect in early neurogenesis. In Gli3Xt/Pdn embryos, at E11.5 
and E12.5 G1-phase length is shorter, and microarray analysis revealed that in the 
E10.5 mutant dorsal telencephalon Cdk6 was up-regulated. This coincided with an 
increase in pRb expression at E11.5 and E12.5. In CD1 mouse embryos, it was 
possible to use the Cdk4/6 specific inhibitor palbociclib in organotypic slice culture to 
decrease pRb expression. Thus, Gli3Xt/Pdn cortical slices were exposed to palbociclib 
to see if the increase in pRb expression and the delay in neurogenesis could be 
rescued. However, the mutant cortical slices failed to grow properly under these slice 
culture conditions, and so it was not possible to evaluate if palbociclib could have 
rescued the neurogenesis defect. S-phase length was also found to be shorter at 
E11.5 and E12.5 in the mutant, yet no candidate genes underlying this defect were 
identified in the microarray analysis. A possible explanation for the shortening of S-
phase was an increase in the proportion of differentiative to proliferative divisions. 
Tis21GFP expression in Gli3Xt/Pdn;Tis21GFP embryos  was used to evaluate if this 
was the case. In the apical progenitor population, a difference in the proportion of 
progenitors undergoing differentiative division did not account for the changes in S-
phase length at E11.5, but could have contributed to the reduction measured in S-
phase length at E12.5. In the basal progenitor population, the increase in Tis21GFP+ 
progenitors may have contributed to the reduction in S-phase length at E11.5, but not 
at E12.5. Taken together, Cdk6 is a viable candidate through which Gli3 may regulate 
G1-phase length, however further experimentation is required to probe this 
relationship. Based on the data presented here, the mechanism by which Gli3 
regulates S-phase length is more complicated and requires further exploration.  
 
5.7.1 Microarray analysis revealed alterations in genes regulating progenitor 
proliferation/differentiation, and Cdk6 as a possible route through which Gli3 
controls G1-phase length 
Microarray analysis was previously conducted on the E10.5 Gli3Xt/Pdn dorsal 
telencephalon to evaluate which genes were up- or down-regulated due to the 
reduction in Gli3 function. I carried out GO analysis on these data to gain an 
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understanding of the biological processes which were dysregulated in the mutant. 
Genes which were up-regulated in the mutant were associated with processes such 
as “cell proliferation”, concomitant with down-regulation in genes associated with 
processes such as “neurogenesis”. Analyses undertaken in the lateral E11.5 Gli3Xt/Pdn 
cortex exposed an increased apical progenitor proportion, alongside decreased basal 
progenitor and early-born neuron proportions. Cell cycle re-entry was also increased, 
indicating cell proliferation instead of cell differentiation. Despite the difference in time 
points between the microarray analyses and analyses of progenitor/neuron 
proportions, it would appear that at E11.5 there was also an increase in proliferative 
divisions of apical progenitors, at the expense of differentiative divisions into basal 
progenitors and neurons. Indeed, as revealed by Tis21GFP expression, there was a 
tendency towards increased apical progenitor proliferation and decreased 
differentiation. By E12.5 in the lateral and medial mutant neocortex, the apical 
progenitor proportion had decreased, whereas the basal progenitor and early-born 
neuron proportions had increased, indicative of a shift from apical progenitor 
proliferative to differentiative divisions. This was supported by Tis21GFP expression 
in the apical progenitor population.  
At both E11.5 and E12.5, G1-phase length was shorter in Gli3Xt/Pdn apical progenitors. 
Progression through the mid G1-phase restriction point is regulated by Cdk4/6 and 
their association with the D-type cyclins. Indeed, overexpression of Cyclin D1 and 
Cdk4/Cyclin D1 lead to shortening of G1-phase (Lange et al., 2009; Pilaz et al., 2009). 
Therefore, it was extremely interesting when the microarray screen revealed Cdk6 as 
up-regulated 1.59-fold in the mutant compared to control. As well as regulating 
development of the telencephalon, Gli3 also regulates the growth of the limb bud. 
Here, Vokes et al. (2008) conducted ChIP-on-ChIP analysis of Gli3 binding sites and 
found a potential binding site in the Cdk6 promoter. Based on this, Lopez-Rios et al. 
(2012) investigated the interaction of Gli3 with the Cdk6 promoter region and 
discovered that Gli3 does bind to this region. They explored Gli3;Cdk6 double mutants 
to evaluate the effect of conditionally inactivating Cdk6 on the polydactyly phenotype 
of embryos in which Gli3 had been conditionally inactivated in the limb bud. The 
conditional inactivation of Cdk6 alongside Gli3 resulted in a partial rescue of the 
polydactyly phenotype. However, as instead of reducing Cdk6 levels in the Gli3 
mutant back to control levels they inactivated Cdk6, it is difficult to draw conclusions 
about the partial rescue. It is possible, however unlikely, that the partial rescue of the 
Gli3 phenotype was not due to antagonism of Gli3’s inhibition on Cdk6 but was a by-
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product of inactivating Cdk6 and occurred through a Gli3-independent mechanism. 
Yet, electromobility shift assays and luciferase assay confirmed that Gli3 binds to the 
Cdk6 promoter region and inhibits its expression, respectively (Hasenpusch-Theil et 
al., 2018). Importantly, when the microarray analysis was conducted on Gli3X/tPdn 
dorsal telencephalon, it was also conducted on Gli3Pdn/Pdn dorsal telencephalon. The 
delay in neurogenesis observed between E11.5 and E12.5 in the Gli3Xt/Pdn cortex was 
not observed in the Gli3Pdn/Pdn mutant (Magnani et al., 2010), and in these embryos 
Cdk6 was not differentially expressed in the dorsal telencephalon. Cdk6 therefore 
represented a clear target for further investigation.  
Conversely, the microarray screen did not identify any obvious candidate genes for 
the regulation of S-phase length. The reduction in S-phase length may be accounted 
for by a shift towards differentiative divisions at the expense of proliferative divisions, 
or by regulation of genes controlling S-phase by Gli3 which were not identified in this 
screen. Indeed, when RNA sequencing (RNAseq) was conducted in the 
Emx1Cre;Gli3fl/fl conditional mutant at E11.5 Cyclin A2, which is required for 
progression through S-phase, was up-regulated, and the Cdk inhibitors p21Cip1, 
p27Kip1 and p57Kip2 were down-regulated (Hasenpusch-Theil et al., 2018). Progression 
through each phase of the cell cycle depends on a balance between Cdk/cyclin and 
Cdk inhibitor expression (Hindley & Philpott, 2012). It is therefore possible that a 
dysregulation in Gli3 expression leads to a tip towards increased Cdk expression and 
decreased Cdk inhibitor expression, leading towards faster progression through S-
phase. RNAseq proved to be a more sensitive measure of mRNA dysregulation than 
the microarray analysis, and I could not discount the possibility that genes regulating 
S-phase length were dysregulated in the Gli3Xt/Pdn dorsal telencephalon but were not 
recognised in the microarray screen.  
 
5.7.2 Up-regulation of Cdk6 led to increased pRb expression, yet it was not 
possible to determine if Cdk6 inhibition would rescue the neurogenesis defect  
As Cdk6 was up-regulated in the E10.5 Gli3Xt/Pdn dorsal telencephalon, it was 
important to determine if that up-regulation had any output in the E11.5 and E12.5 
cortex. Cdk6 hyperphosphorylates pRb on a number of different serine sites, including 
serine-780 (S780), phosphorylation of which is inhibited by palbociclib (Fry et al., 
2004). In certain cancers, Cdks are able to erroneously push cells through the cell 
cycle to divide proliferatively, and so Cdks have become a major focus in oncology. 
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In particular, Cdk4 and Cdk6 are of great interest due to their strong regulation of Rb, 
which is often identified as mutated in different cancers. Thus, great effort has been 
put into developing Cdk4/6 specific inhibitors. Palbociclib has been a successful 
discovery during this effort and is now licenced in both the United Kingdom and United 
States for the treatment of breast cancer. It is an orally active, small molecule, 
reversible Cdk4/6 inhibitor which shows no significant activity against other Cdks 
(Sherr et al., 2016; Choi & Anders, 2014). At high concentrations, it has been shown 
to block cells in G1-phase and prevent them from entering S-phase in Rb+ cancers, 
and can cause shrinkage of tumours which is reversible upon drug withdrawal 
(Toogood et al., 2005; Fry et al., 2004). 
In the E11.5 lateral Gli3Xt/Pdn cortex, the proportion of pRb S780+ apical progenitors 
was increased. In these cells G1-phase length was reduced, indicating that the 
increase in pRb hyperphosphorylation led to faster progression through that phase. 
By E12.5, the proportion of pRb+ apical progenitors was unaltered in the mutant 
compared to control, whilst G1-phase length was reduced. G1-phase length may 
therefore also be regulated by Gli3 in a non-Cdk6 dependent manner.  
In the E11.5 and E12.5 lateral basal progenitor populations, the proportions of pRb+ 
progenitors were increased, whilst G1-phase length was unaltered in these 
populations. Therefore, this may represent, in support of the E12.5 apical progenitor 
population, a regulation of G1-phase length not through Cdk6. As Gli3 is primarily 
expressed in apical progenitors and not in basal progenitors, and the regulation of 
Cdk6 was postulated to be direct due to the binding of Gli3 to the Cdk6 promoter 
region, it is possible the reduction in Gli3 indirectly influenced pRb 
hyperphosphorylation outside of its control over Cdk6. Also, it is possible there was 
signalling from apical progenitors to basal progenitors thereby altering their pRb+ 
progenitor proportions, despite their very limited expression of Gli3.  
In the E11.5 medial cortex, the proportion of pRb+ apical progenitors was unaltered, 
whilst it was not possible to accurately measure G1-phase length. Here, the 
proportions of apical and basal progenitors and early-born neurons were also 
unaffected in the mutant suggesting that the reduction in Gli3 did not influence the 
progenitor cell cycle and thereby progenitor/neuronal proportions. By E12.5, G1-
phase length was unaltered in the mutant compared to control, as was pRb 
expression. Yet here the proportion of apical progenitors had decreased in the mutant 
compared to control whilst the proportion of basal progenitors and neurons had 
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increased. This would indicate that factors outside of cell cycle regulation, such as 
alterations in signalling, influenced the decision over the mode of division undertaken 
in the E12.5 medial Gli3Xt.Pdn neocortex. As discussed in section 3.6.2, although the 
rostro-caudal level examined was chosen to minimise the impact of altered signalling 
in the Gli3Xt/Pdn medial telencephalon (Kuschel et al., 2003), it is still possible these 
alterations had an impact upon the medial apical progenitor population. Wnt signalling 
is known to promote apical progenitor proliferative division (Wrobel et al., 2007), and 
Wnt expression in the Gli3Xt/Pdn cortical hem is severely reduced. Furthermore, 
postmitotic neurons have been shown to initiate a feedback mechanism to apical 
progenitors, promoting a cell fate switch to basal progenitors (Parthasarathy et al., 
2014). Potentially, the increased neuronal proportions at E12.5 in the medial and 
lateral cortex contributed to the reduced and tendency-towards-reduced apical 
progenitor proportions, respectively.  
In the medial E11.5 basal progenitor population, the proportion of pRb+ cells was 
unaltered in the mutant, whilst it was not possible to measure G1-phase length. Here, 
as above the progenitor/neuronal proportions were unaffected, indicating the 
reduction in Gli3 function did not influence progenitor division. By E12.5, the 
proportion of pRb+ cells had increased, whilst again it was not possible to measure 
G1-phase length. As stated, there was a tip towards increased basal progenitor and 
neuronal proportions and a decreased apical progenitor proportion. Gli3 was also not 
expressed in these progenitors, so it is likely that indirect regulation over 
progenitor/neuronal proportions outside of Gli3’s direct regulation over Cdk6 is 
relevant here.  
Overall, across the two positions measured and the two ages, there were mixed 
results in terms of how pRb expression, G1-phase length, and progenitor/neuronal 
proportions related. In the E11.5 mutant lateral cortex, there was an increase in apical 
progenitor pRb expression, coinciding with G1-phase shortening and an increase in 
apical progenitor proportion. However, pRb expression was also increased in basal 
progenitors, whilst G1-phase length was unaffected, yet the proportion of basal 
progenitors was reduced alongside the proportion of neurons. By E12.5, pRb 
expression was unaltered in both apical and basal progenitors, whilst G1-phase 
length was reduced in both populations. The proportion of apical progenitors showed 
a tendency to be decreased in the mutant compared to control, whilst the basal 
progenitor and neuronal proportions were increased. In the mutant medial cortex, at 
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E11.5 pRb expression was unaltered in the apical and basal progenitor populations, 
and it was not possible to accurately measure G1-phase length. The proportion of 
apical and basal progenitors and neurons were also unaltered in the mutant. By 
E12.5, apical progenitor pRb expression was unaltered as was G1-phase length, yet 
the proportion of apical progenitors was decreased compared to control. The 
proportion of pRb+ basal progenitors was increased, but I was unable to measure G1-
phase length, and the basal progenitor and neuronal proportions were increased. 
Taken together, it appears that the reduction in Gli3 also altered G1-phase length 
outside of its regulation over Cdk6 via pRb, and altered progenitor 
proliferation/differentiation into neurons outside of its control over the cell cycle.  
To determine if Gli3’s direct regulation over Cdk6 contributed to the delay in 
neurogenesis, the effect of inhibiting Cdk6 by palbociclib was examined in vitro. Whilst 
it was possible to inhibit Cdk6 activity and cause a down-regulation in pRb expression 
in E13.5 CD1 embryos, it was not possible to conduct the same analyses in Gli3Xt/Pdn 
embryos. In E11.5 slices which were put into culture for 24 hrs, growth of Gli3Xt/Pdn 
and control slices were disrupted in the presence of DMSO alone, palbociclib 
dissolved in DMSO, and without either present. This would indicate that these 
organotypic slice culture conditions were not amenable to cortical growth of slices at 
this age. Slices taken at E12.5 and cultured for 24 hrs again showed disrupted growth 
in both the control and mutant. However, control slices of E13.5 brain appeared 
normal and showed consistent pRb/PCNA expression patterns as in CD1 cortical 
slices and embryos which had not been cultured. This would indicate that the earlier 
the age in which a slice is put into culture, not the background of the embryos, dictates 
how a slice will behave under these culture conditions. It was therefore not possible 
to examine the effect of Cdk6 inhibition in the cortex.  
In a number of the slices, rosette-like structures formed across the cortex with a ring 
of pRb+ cells surrounded by PCNA+ cells. The cortical slices were cultured with the 
agarose used for embedding still intact around the outside of the slices. It was 
postulated that in vivo, newly generated cells move radially outwards to increase the 
size of the cortex. Instead in this experimental setup, when these cells moving radially 
met the agarose barrier at the basal edge of the cortex they turned laterally or medially 
and created a rosette. With that in mind, the percentage of agarose in which the tissue 
was embedded was decreased and sections of agarose from around the cortical 
surface were removed before the slices were cultured (data not shown). This did not 
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improve the growth of the slices, and so it was concluded that these conditions do not 
represent a viable in vitro tool for measuring palbociclib activity.  
In order to test my hypothesis that the increase in Cdk6 expression contributed to the 
delayed neurogenesis phenotype in Gli3Xt/Pdn mutants, another methodology is 
required. Since completion of this work, it was shown that palbociclib administered to 
pregnant females led to effects on the embryonic cortical Tbr1+ neuronal population. 
In the Emx1Cre;Gli3fl/fl conditional embryo, the proportion of pRb+ cells was increased 
in the mutant compared to control, as was seen in the lateral Gli3Xt/Pdn cortex. In the 
conditional mutant, Cdk6 was identified as being up-regulated 1.96-fold at E11.5 by 
RNAseq and G1-phase length was also shorter, with a decrease in the proportion of 
Tbr1+ early-born neurons. In these mutants, the effect of palbociclib exposure in vivo 
was examined (Hasenpusch-Theil et al., 2018). E10.5 pregnant females were dosed 
with either sodium lactate buffer (control) or 75mg palbociclib/kg body weight, and 
embryos harvested 24 hrs later. The proportion of pRb+ cells was increased in the 
mutant compared to control after sodium lactate buffer administration, yet was 
unaltered after palbociclib exposure. Furthermore, whilst after sodium lactate buffer 
administration the proportion of Tbr1+ cells was decreased in the mutant compared to 
control, after palbociclib administration there was no difference between control and 
mutant embryos. This indicated that inhibition of Cdk6 by palbociclib rescued the 
defect in the proportion of neurons generated in the Emx1Cre;Gli3fl/fl mutant. This 
rescue of delayed neurogenesis strongly supports my hypothesis that Gli3 controls 
the onset of cortical neurogenesis by regulating Cdk6 expression levels. Therefore, it 
would be very interesting to repeat this experiment in Gli3Xt/Pdn embryos.  
Taken together, I hypothesise that Gli3 directly binds to the Cdk6 promoter and 
inhibits its expression. During normal cortical development, Gli3 reduces Cdk6 
expression, allowing a certain level of pRb hyperphosphorylation and transcription of 
G1- to S-phase progression genes by E2F transcription factors. This allows a 
progenitor to progress from G1- into S-phase at a certain rate (figure 5.18 A). When 
Gli3 expression is reduced, as in the Gli3Xt/Pdn embryo, there is less inhibition on the 
expression of Cdk6. Increased Cdk6 levels lead to increased pRb 
hyperphosphorylation, and increased transcription of G1- to S-phase progression 
genes. Cortical progenitors therefore progress through G1-phase at a faster rate 
(figure 5.18 B). However, this is influenced by the age and location under examination. 





Figure 5.18: Model summarising my hypothesis of how Gli3 may determine G1-
phase length through regulation of Cdk6. A. In control embryos, I propose Gli3 
binds to the Cdk6 promoter region, thereby inhibiting expression of Cdk6. A regulated 
amount of Cdk6 protein is therefore available for binding with cyclin D1, limiting the 
hyperphosphorylation of pRb. This prevents pRb from disassociating with E2F 
transcription factors, reducing the level of transcription of phase progression genes. 
The progenitor remains in G1-phase for longer, and differentiation is promoted. B. In 
Gli3Xt/Pdn embryos, I propose the reduced amount of Gli3 results in an increase in Cdk6 
expression, leading to increased hyperphosphorlyated pRb expression. This 
promotes disassociation of pRb from E2F transcription factors, allowing them to 
promote transcription of phase progression genes. The progenitor then proceeds 









neurons, the proportion of pRb+ cells and G1-phase length were largely unaffected 
despite a reduction in Gli3 expression. Yet by E12.5, the proportions of progenitors 
and neurons and the proportion of pRb+ basal progenitors were altered in the same 
location. Furthermore, there was a clear difference in the lateral and medial cortex, 
particularly at E11.5, which may have been related to the rostro-lateral to caudo-
medial progression of neurogenesis. These studies have been limited in their scope, 
as I have been unable to take into account fully the myriad of other factors influencing 
progenitor proliferation and differentiation in the Gli3Xt/Pdn cortex. For example, as 
discussed above, signalling plays a key role in influencing neurogenesis and is known 
to be disturbed in the Gli3Xt/Pdn cortex.  
 
 
5.7.3 Shortening of S-phase length in E12.5 Gli3Xt/Pdn embryos may be due to an 
increase in the proportion of differentiative progenitors  
The microarray screen conducted on E10.5 Gli3Xt/Pdn dorsal telencephalon did not 
provide any obvious candidate genes through which Gli3 may have regulated S-
phase length. I therefore hypothesised that perhaps the reduction observed in S-
phase length when Gli3 expression was reduced in the Gli3Xt/Pdn cortex may have 
been due to an alteration in the proportion of differentiative to proliferative progenitors.  
In the E11.5 lateral cortex, the proportion of differentiative apical progenitors was 
unaltered between the mutant and control as revealed by Tis21GFP expression, 
whilst S-phase length was shorter in the mutant. By E12.5, the proportion of 
differentiative apical progenitors was increased in the lateral cortex, whilst S-phase 
was still reduced in the mutant compared to control. This would indicate that at E11.5 
the reduction in S-phase length was not due to an increased proportion of 
differentiative apical progenitors, which was reflected in the larger proportion of apical 
progenitors and simultaneously smaller proportions of basal progenitors and neurons. 
However, at E12.5, the reduction in S-phase length may be accounted for by an 
increased proportion of differentiative apical progenitors. This would imply that the 
reduction in Gli3 had different effects on S-phase length at different time points.  
In the E11.5 lateral basal progenitor population, there was an increase in the 
proportion of differentiative basal progenitors, and a shortening of S-phase length. 
However, total cell cycle length was also reduced, indicating that an alteration in the 
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proportion of differentiative basal progenitors did not solely account for the reduction 
in S-phase length. As Gli3 was not expressed in this population, the reduction in Gli3 
must have indirectly affected the ratio of differentiative to proliferative divisions. At 
E12.5, there was no difference in the proportion of differentiative basal progenitors 
and S-phase length was unaltered, indicating that by this time Gli3 had no impact 
upon basal progenitor division in this location.  
In the E11.5 medial cortex, there was a decrease in the proportion of apical 
progenitors dividing differentiatively, whilst S-phase length was unaffected. It would 
appear then that here the alteration in the ratio of differentiative to proliferative 
divisions was not great enough to reflect as a change in S-phase length. At E12.5, 
the proportion of differentiative apical progenitors was increased in the mutant, and 
S-phase length was reduced. Here, the increase in differentiative apical progenitors 
may have contributed to the reduction in S-phase length measured. In the basal 
progenitor population, at both E11.5 and E12.5, the proportion of differentiative basal 
progenitors in the medial cortex was unaffected in the mutant compared to control, 
and it was not possible to measure S-phase length.  
Taken together, Gli3 had different spatio-temporal control over the proportions of 
differentiative versus proliferative apical and basal progenitors. At E11.5, S-phase 
length was reduced in basal progenitors in the lateral cortex, which could have been 
accounted for by an increase in differentiative basal progenitor proportion. Further, at 
E12.5, S-phase length was reduced in lateral apical progenitors and the differentiative 
proportion of these cells was increased, again possibly underlying the reduction in S-
phase length. In contrast, there was a tendency towards a decreased differentiative 
proportion of E11.5 lateral apical progenitors, whilst S-phase length was reduced, 
highlighting that the reduction in S-phase length in Gli3Xt/Pdn embryos cannot be fully 
accounted for by a change in the proportion of differentiative progenitors. Therefore, 
Gli3 must somehow affect S-phase length at least indirectly, as the proportion of 
E11.5 differentiative basal progenitors and basal progenitor S-phase length were 
altered despite the very low expression of Gli3.  
As with G1-phase length, it is possible to pharmacologically lengthen S-phase. For 
example, aphidicolin is a DNA replication inhibitor which can lengthen S-phase and 
prevent differentiation (Gonzales et al., 2015). It would be interesting to test what 
effect lengthening of S-phase had on progenitor proliferation/differentiation at E11.5 
and E12.5 laterally and medially in Gli3Xt/Pdn embryos.  
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5.8 Summary  
 
Taken together, the mechanisms by which Gli3 regulates the cell cycle are complex 
and vary based on the age and location under examination. It is likely that Gli3 directly 
regulates Cdk6, contributing to a reduction in G1-phase length. However, Cdk6 is 
likely not the only mechanism by which G1-phase length is controlled by Gli3. To 
further complicate matters, Gli3 regulates G1-phase length differently between E11.5 
and E12.5 through potentially direct and indirect mechanisms. S-phase length was 
also altered in the Gli3Xt/Pdn mutant at both E11.5 and E12.5. Whilst an alteration in 
the ratio of proliferative to differentiative divisions may have accounted for the 
reduction in S-phase length measured at E12.5, this was not the case at E11.5. 
Therefore, as with G1-phase length, S-phase length must be regulated differently by 
Gli3 at E11.5 and E12.5. Finally, in basal progenitors both S-phase length and the 
proportion of differentiative progenitors were altered, whilst Gli3 was not expressed in 
















Chapter 6: Final discussion and future work  
 
The focus of this thesis has been the role Gli3 plays in early neurogenesis. By 
examining the expression of the Gli3 protein near the onset of cortical neurogenesis, 
I revealed Gli3’s expression in apical progenitors at E11.5 and E12.5 places it in a 
critical position for influencing the development of the cortex. When Gli3 is reduced, 
as in the Gli3Xt/Pdn cortex, the proportions of apical and basal progenitors and early-
born neurons are altered at E11.5 and E12.5, indicating an early delay in 
neurogenesis. A major factor known to influence neurogenesis at this stage is this cell 
cycle, and Gli3 was previously implicated in cell cycle regulation in the limb bud 
(Lopez-Rios et al., 2012; Vokes et al., 2008). Based on this, the cell cycle was 
investigated in the Gli3Xt/Pdn embryo. Cell cycle exit was shown to be affected at E11.5 
and E12.5, and G1- and S-phase lengths were critically reduced in the apical 
progenitor population. Finally, microarray data was examined from the E10.5 Gli3Xt/Pdn 
dorsal telencephalon to search for potential mechanisms by which Gli3 may regulate 
G1- and S-phase length, and preliminary investigations into the regulation of these 
phases were undertaken. Cdk6 was revealed as a potential mechanism by which Gli3 
may regulate G1-phase, yet no candidates were identified through which Gli3 may 
regulate S-phase.  
 
6.1 Gli3 protein expression is primarily confined to apical progenitors and a 
reduction in Gli3 results in alterations to the apical and basal progenitor and 
early-born neuron populations  
 
Whilst the expression of Gli3 mRNA has been discussed in numerous studies (Pollen 
et al., 2014; Amaniti et al., 2013; Hui et al., 1994), there has been little discussion with 
regards to Gli3 protein expression. Yabut et al. (2016) described Gli3 protein to be 
expressed in the ventricular and subventricular zones (VZ and SVZ) at E16.5, in both 
the cytoplasm and nucleus of cells. However, as no cellular subtype markers were 
used it was not possible to say in which cell types Gli3 was expressed. I investigated 
this by combining Gli3 immunofluorescence with Pax6 and Tbr2 expression as 
markers of apical and basal progenitors, respectively, at E11.5 and E12.5. Gli3 protein 
expression was largely confined to the apical progenitor population with some 
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expression in a subset of basal progenitors at both ages. Although it was possible to 
identify some nuclear and cytoplasmic staining in the studies I undertook, it would be 
advantageous to combine Gli3 immunofluorescence with other cytoplasmic and 
nuclear markers and use high resolution imaging to fully investigate the subcellular 
localisation of Gli3 protein. 
Furthermore, I conducted Gli3 immunofluorescence analyses on Gli3Xt/Pdn embryos at 
E11.5 and E12.5. The Gli3 expression pattern exhibited in control embryos was 
replicated in mutant embryos, with expression chiefly in apical progenitors with some 
in basal progenitors at E12.5. The intensity of the Gli3 staining was reduced in mutant 
embryos, yet it was not possible to perform a quantitative analysis of this reduction. 
In the future, a quantification of the reduction of Gli3 protein in the Gli3Xt/Pdn cortex 
using western blotting should be undertaken.  
To determine if the reduction in Gli3 in Gli3Xt/Pdn embryos had any effect on the apical 
and basal progenitor populations I combined Pax6 and Tbr2 immunofluorescence 
with PCNA, a pan progenitor marker, and quantified the proportion of progenitors 
which were either apical or basal progenitors compared to the total progenitor 
population. I then calculated the proportion of early-born neurons using Tbr1, a marker 
of early-born cortical neurons, and TOPRO-3, as a nuclear marker. At E11.5, in the 
lateral cortex there was an increase in the proportion of apical progenitors and 
decreases in the proportion of basal progenitors and neurons in the Gli3Xt/Pdn cortex. 
However, these proportions were unaffected in the medial cortex. By E12.5, there was 
no difference between the control and mutant apical progenitor proportions laterally 
whilst the basal and neuronal proportions were increased in the mutant. In the medial 
mutant cortex, the apical progenitor proportion was decreased and the basal 
progenitor and neuronal proportions were increased. Taken together, it appeared the 
reduction in Gli3 altered the progenitor and neuronal proportions at both ages.  
Generally, progenitors are able to undergo two modes of division; proliferative division 
to form two new progenitors or differentiative division to form one new progenitor of 
the same subtype and either a basal progenitor (in the case of an apical progenitor 
division) or neuron (produced from either an apical or basal progenitor). Therefore, 
the differences in apical and basal progenitor and early-born neuron proportions may 




At E11.5 laterally, an increase in apical progenitor proliferation could justify the 
increased proportion of apical progenitors and decreased proportions of basal 
progenitors and neurons in the Gli3Xt/Pdn cortex. When Tis21, a marker of 
differentiative division, was investigated there was a tendency in the mutant towards 
increased apical progenitor proliferative divisions at the expense of differentiative 
divisions. There was also an increase in basal progenitor differentiative divisions, 
possibly reflecting the reduced basal progenitor proportion. As apical progenitors 
constitute the largest progenitor population and give rise to the majority of early-born 
neurons formed at this age, the reduced early-born neuronal proportion probably 
reflects the decrease in apical progenitor differentiation. By E12.5, there was no 
difference between mutant and control in the proportion of apical progenitors, yet the 
proportions of basal progenitors and early-born neurons were increased in the mutant. 
Here, both apical and basal mutant progenitors exhibited an increase in differentiative 
divisions. An interesting future experiment could examine these three cell populations 
at E13.5 to see if both progenitor populations are decreased due to the increased 
differentiative divisions and the impact upon the neuronal population. Further, 
neuronal composition of the E18.5 cortex could be examined, identifying the relative 
numbers and position of cortical neurons from distinct layers. However, this may be 
hampered as lamination is disturbed in the mutant. Kuschel et al. (2003) reported that 
at E14.5 there was a dramatic reduction in Pax6 expression, yet this was not 
quantified, and neither Tbr2 nor Tbr1 were examined. Magnani et al. (2013) also 
reported a near complete loss of subplate neurons in the Gli3Xt/Pdn embryo, which may 
reflect a delay in neurogenesis, and when it finally begins layer VI neurons are formed 
instead of subplate neurons.  
Medially at E11.5 in the Gli3Xt/Pdn embryo, there were no differences in the proportions 
of apical and basal progenitors and early-born neurons or basal progenitor 
proliferative/differentiative divisions, yet there was an increase in apical progenitor 
proliferative divisions. One would expect an increase in apical progenitor proliferative 
division to lead to an increase in the proportion of apical progenitors at E12.5, yet this 
was not the case. By E12.5, the proportion of apical progenitors in the mutant was 
decreased compared to control, whilst the proportions of basal progenitors and 
neurons were increased. In the 24 hrs between analyses apical progenitors could 
undergo 2-3 full cell cycles (based on total cell cycle length calculated in section 4.4). 
Potentially medial apical progenitors have begun to divide proliferatively as in the 
lateral cortex at E11.5 at the time of analysis, but by E12.5 they had begun to divide 
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differentiatively, as reflected by the increase in differentiative divisions to produce the 
smaller apical progenitor and larger basal progenitor and neuronal proportions 
measured. As neurogenesis proceeds laterally to medially, the increase in 
proliferative apical divisions may have begun first in the lateral hemisphere and 
resulted in quantifiable changes in progenitor and neuronal proportions by the time of 
analysis. An increase in proliferative apical divisions may then have begun medially 
and was measured here but may not have yet produced a perceptible effect on 
progenitor and neuronal proportions. By E12.5, increased apical progenitor 
differentiative divisions both medially and laterally reflected the medially decreased 
apical progenitor proportion and, relative to E11.5, decrease in lateral apical 
progenitor proportion. Again, an analysis of the proportions of these cells at E13.5 
would be of interest.  
Due to Gli3 protein being primarily expressed in apical progenitors, and both basal 
progenitors and early-born neurons arising from apical progenitors, I suggest the 
alterations in basal progenitor and neuronal proportions were likely in part due to cell 
autonomous effects in apical progenitors. However, as described, there are also 
alterations to the signalling centres in Gli3Xt/Pdn embryos and so alterations in 
signalling may have influenced the changes observed in apical and basal progenitor 
and early-born neuronal proportions. As in the rostral telencephalon there is ectopic 
Fgf8 expression and Wnt2b, Wnt3a and Bmp4 expression are abolished, I conducted 
my analyses further caudally in order to circumvent the largest alterations in signalling. 
Nevertheless, it is likely that signalling changes impacted upon the proportions 
measured. It would be interesting to repeat the analyses performed here at other 
rostrocaudal levels in Gli3Xt/Pdn embryos to assess the impact of altered signalling.  
On the other hand, repeating these analyses in a conditional mutant such as the 
Emx1Cre;Gli3fl/fl mutant, where there is little alteration in signalling, would also be 
interesting. This has in fact been undertaken (Hasenpusch-Theil et al., 2018); at 
E11.5, the proportion of basal progenitors and early-born neurons were decreased in 
the mutant compared to control, whilst at E12.5 there was an increase in the 
proportion of basal progenitors yet a decrease in the proportion of neurons. The 
proportion of apical progenitors is increased at both ages. Furthermore, there was no 
change in apical progenitor proliferative/differentiative divisions at E11.5, yet there 
was a decrease in apical progenitor proliferative divisions at E12.5. In the basal 
progenitor population, there was an increase in differentiative divisions at E11.5 but 
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no change at E12.5. These analyses provide evidence that a mutation in Gli3 is able 
to influence progenitor and early-neuronal proportions and differentiative/proliferative 
division even in the absence of changes to signalling, and so provides further 
indication that Gli3 acts cell autonomously on these processes. It is important to note 
however that these analyses in the conditional mutant were conducted in the 
rostromedial telencephalon, whereas my analyses were conducted further caudally 
and further laterally. They were performed there as Wnt signalling is altered in the 
caudal telencephalon of these embryos and as Gli3 protein is not lost from the lateral 
telencephalon until E12.5.  
 
 
6.2 Cell cycle kinetics are disturbed in the Gli3Xt/Pdn cortex  
 
Cell cycle has long been implicated in determining if a progenitor will undergo a 
proliferative or differentiative division (Pilaz et al., 2016; Gonzales et al., 2015; Arai et 
al., 2011; Lange et al., 2009; Pilaz et al., 2009; Calegari & Huttner, 2003). Gli3 has 
also been reported to regulate the cell cycle in the limb bud (Lopez-Rios et al., 2012; 
Vokes et al., 2008), and so I focussed on the cell cycle of cortical progenitors.  
In the lateral apical progenitor population, there was an increase in cell cycle re-entry 
at E11.5 and G1- and S-phase and total cell cycle length were decreased in the 
mutant compared to control. By E12.5 there was an increase in cell cycle exit, yet G1-
, S- and M-phase and total cell cycle length remained shorter in the mutant compared 
to control. G1- and M-phase and total cell cycle length get longer as progenitors 
undertake differentiative division as opposed to proliferative division, whilst S-phase 
gets shorter. Therefore, the cell cycle phase lengths measured at both ages appear 
to be at odds. At E11.5, when cell cycle re-entry is increased one would expect G1-
phase and total cell cycle length to be shorter in the mutant, as was recorded. 
However, S-phase length would be expected to be longer. Conversely, at E12.5 cell 
cycle exit was increased in the mutant and so S-phase would be expected to be 
shorter, as was seen, yet G1- and M-phase and total cell cycle length should have 
been longer in the mutant. Together, I would suggest that perhaps when Gli3 levels 
are reduced, G1-phase length is more critical to determining if an apical progenitor 
will undergo proliferative/differentiative division at E11.5, whilst S-phase length may 
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be more important at E12.5, as has been reported to be the case in ESCs (Gonzales 
et al., 2015). However, these results should not be considered in isolation, and again 
factors other than cell cycle phase length will have contributed to the defects 
measured in Gli3Xt/Pdn apical progenitors.  
In the medial apical progenitor population, at E11.5 cell cycle exit was unaltered in 
the mutant compared to control and S-, G2- and M-phase and total cell cycle length 
were also unaltered. I was unable to make a measurement for G1-phase, probably 
due to inaccuracies in measuring other phase lengths. In the future it would be 
possible to measure the cell cycle phases by other methodologies, such as crossing 
Gli3Xt/Pdn embryos with a FUCCI reporter line to give a direst measurement of G1-
phase length in individual cells when using live imagining or time lapse microscopy 
(Roccio et al., 2013). Alternatively, flow cytometry can be used to measure different 
cell cycle phases at a single time-point, giving an estimate of G1-, S- and G2/M-phase 
lengths (Pozarowski & Darzynkiewicz, 2004). It would be interesting to compare the 
differences in cell cycle phase lengths between the different methodologies. In the 
E11.5 medial apical progenitors, there was little difference between the Gli3Xt/Pdn 
mutant and control in the measurements conducted. In contrast, in the lateral apical 
progenitor population there were many differences recorded between Gli3Xt/Pdn 
embryos and control. As neurogenesis proceeds laterally to medially, I would propose 
the effects on progenitor and neuronal populations resulting from the reduction in Gli3 
increase over time and as neurogenesis proceeds. Perhaps in the E11.5 medial 
cortex neurogenesis is not advanced enough yet in the mutant for recognisable 
changes to be measured.  
In the E12.5 medial apical progenitor population, there was an increase in cell cycle 
exit in the mutant compared to control, and S- and M-phase and total cell cycle length 
were decreased in the mutant. According to Gonzales et al. (2015) and Arai et al. 
(2011), S-phase shortens as progenitors transition from proliferative to differentiative 
divisions as the need for checking DNA fidelity is reduced when progenitors lose their 
stemness. Here, the proportion of apical progenitors was decreased whilst the 
proportions of basal progenitors and neurons were increased, again fitting with the 
notion of apical progenitors dividing differentiatively and/or exiting the cell cycle to 
form basal progenitors or neurons. Therefore, Gli3 likely plays a role in maintaining 
progenitors in active cell cycle in the medial cortex at E12.5.  
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In E11.5 lateral basal progenitors, S-phase and total cell cycle length were decreased 
in the Gli3Xt/Pdn mutant compared to control. Cell cycle re-entry was also increased 
here, although I measured cell cycle re-entry/exit in the total progenitor population. In 
the future this measurement should be repeated using BrdU and Pax6/Tbr2 instead 
of BrdU and PCNA to differentiate between the two progenitor populations. The 
proportion of lateral basal progenitors at E11.5 was decreased in the mutant 
compared to control, and the reduction in S-phase length would indicate basal 
progenitor differentiative divisions as opposed to proliferative divisions. However, at 
E12.5 the basal progenitor proportion was increased in the mutant compared to 
control, so I would suggest the increase in cell cycle re-entry primarily reflected an 
increase in apical progenitor cell cycle re-entry at the expense of differentiation into 
basal progenitors. Therefore, the decrease in basal progenitor proportion may reflect 
(1) an increase in basal progenitor differentiation as suggested by the decrease in S-
phase length, (2) a decrease in basal progenitor production due to a decrease in 
apical progenitor differentiation, or (3) an increase in basal progenitor apoptosis. It is 
likely the decrease in basal progenitor proportion here was due to decreased basal 
progenitor production, however an analysis of apoptosis could be conducted to rule 
out that possibility.  
In the lateral E12.5 basal progenitor population, the only cell cycle phase altered in 
the mutant compared to control was M-phase, which was significantly longer in the 
mutant. As there was no change in total cell cycle length I would suggest the increase 
in M-phase instead represented a larger proportion of basal progenitors undergoing 
mitosis, which could be tested by examining pHH3/PCNA double-expression. The 
increased proportion of basal progenitors measured at E12.5 could therefore be due 
to an increase in apical progenitor differentiation into basal progenitors and an 
increase in basal progenitor proliferative division, triggered by a mechanism other 
than the cell cycle.  
Overall, Gli3 reduction in the Gli3Xt/Pdn embryo had little impact upon the cell cycle in 
basal progenitors compared to apical progenitors, particularly in the length of G1-
phase which was only reduced in the apical progenitor population. Hence, as Gli3 is 






6.3 Cellular mechanisms by which Gli3 may regulate cell cycle length  
 
To begin to understand the mechanisms behind which Gli3 regulates cell cycle length, 
I examined microarray gene expression data from E10.5 Gli3Xt/Pdn dorsal 
telencephalon and littermate controls. From this, I identified Cdk6 as a potential 
candidate gene which may regulate the length of G1-phase, yet I did not identify any 
specific genes which may regulate S-phase. To test if G1-phase length was altered 
by the increase in Cdk6 levels, I performed organotypic slice cultures in the presence 
of a Cdk6 inhibitor, palbociclib, to ameliorate the influence of increased Cdk6 activity. 
As no candidate genes were identified to regulate the length of S-phase, I tested the 
hypothesis that the reduction in S-phase was due to an increase in the proportion of 
differentiative to proliferative divisions.  
As a key regulator of G1-phase length, the increase in Cdk6 microarray expression 
provided a viable candidate for Gli3’s regulation of G1-phase, complimenting other 
studies providing evidence that Gli3 regulates Cdk6 in the limb bud (Lopez-Rios et 
al., 2012; Vokes et al., 2008). To determine if the up-regulation of Cdk6 at E10.5 in 
the Gli3Xt/Pdn embryo had any measurable output, I examined the level of pRb 
hyperphosphorylation. In concert with the D-type cyclins, Cdk6 hyperphosphorylates 
Rb thereby inhibiting its repression of E2F transcription factors, allowing for 
expression of G1- to S-phase progression genes. If the increase in Cdk6 expression 
had any effect on the cell, I would have expected hyperphosphorylated Rb (pRb) to 
be increased.  
Indeed, in the E11.5 lateral cortex, where I measured a reduction in G1-phase length 
in apical progenitors, I saw an increase in apical progenitor pRb expression. In the 
medial cortex, I was unable to accurately measure G1-phase length in the apical 
progenitor population and unable to measure G1-phase in the basal progenitor 
population, but there were no differences in the proportions of apical and basal 
progenitors or early-born neurons, and no change in cell cycle exit, reflecting no 
difference in pRb expression. At E12.5, the proportion of pRb+ cells was unaltered in 
the mutant lateral apical progenitor population compared to control, whilst G1-phase 
length was reduced. This suggested that G1-phase length may be regulated in a non 
Cdk6-dependent manner also. Conversely, the proportions of pRb+ basal progenitors 
in the lateral and medial cortex were increased in the mutant compared to control, 
whilst G1-phase length was unaltered. As Gli3 shows reduced expression in basal 
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progenitors, it is likely that Gli3 also indirectly regulates pRb hyperphosphorylation via 
a Cdk6-independent mechanism.  
Besides my finding of an increase in Cdk6 expression at E10.5 and an increase in 
pRb expression in the E11.5 mutant lateral cortex coinciding with a reduction in G1-
phase length, a Gli3 binding site has been identified in the Cdk6 promoter (Lopez-
Rios et al., 2012; Vokes et al., 2008). Hasenpusch-Theil et al. (2018) confirmed that 
binding of Gli3 to this site results in a decrease in Cdk6 expression in vitro. To test if 
Gli3 was able to regulate G1-phase length through Cdk6 regulation, I attempted to 
inhibit Cdk6 in vitro in organotypic slices cultures using palbociclib, a Cdk4/6-specific 
inhibitor. As a measure of Cdk6 inhibition, I assessed the proportion of pRb+ cells in 
the presence of palbociclib compared to in the presence of DMSO, as control. To 
evaluate the concentration of palbociclib required to alter pRb expression, I used CD1 
embryos. In these embryos, a concentration of 0.38g/ml palbociclib was enough to 
reduce the proportion of pRb+ cells in slice cultures after 24 hrs. I wanted to use a low 
concentration of palbociclib to reduce the chance of blocking progenitors in G1-phase 
and only prolonging the phase length. I subsequently repeated the experiment with 
palbociclib in Gli3Xt/Pdn mutant slices alongside their littermate controls.  
In the E11.5 lateral mutant cortex, I recorded an increase in the proportion of apical 
progenitors and decreased basal progenitor and neuronal proportions, with a 
decrease in apical progenitor G1-phase length and increase in pRb+ apical progenitor 
proportion. Therefore, I first evaluated the effect of palbociclib on slices harvested 
from E11.5 embryos. When cultured for 24 hrs, both control and mutant slices failed 
to grow correctly in the presence of either palbociclib or DMSO. Slices from both lost 
the characteristic shape of coronal brain slices, making it difficult to accurately identify 
lateral and medial cortex. Furthermore, pRb+ cells began to form rosette-like 
structures, also making it difficult to stipulate if they represented apical or basal 
progenitors. To assess if the presence of palbociclib or DMSO or if the slice culture 
conditions were responsible for the abnormal growth of the slices, I cultured control 
slices in the absence of palbociclib and DMSO. These slices also showed abnormal 
growth, indicating that these experimental conditions were not conducive to growth of 
slices at this age.  
 Following this, I repeated the slice cultures with slices from embryos harvested at 
E12.5. As at E11.5, both control and mutant slices failed to grow correctly in the 
presence of either palbociclib or DMSO, yet growth of control slices was not as 
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abnormal as at E11.5. Rosette-like formations of pRb+ cells were still present in 
control and mutant, making quantification of apical and basal pRb+ progenitors not 
possible.  
Finally, I harvested brains from E13.5 control and Gli3Xt/Pdn embryos and cultured 
slices for 24 hrs. Here, slices from control embryos showed normal growth in culture 
and resembled slices from E13.5 CD1 embryos after 24 hrs in culture. They retained 
the characteristic shape of a coronal brain slice of this age, and pRb expression 
retained its in vivo pattern, in the presence of DMSO and palbociclib. This showed 
that the younger a slice was put into culture, the more atypical its growth was, 
although I cannot rule out that younger CD1 slices would have not grown normally in 
culture. Therefore, in terms of this technique, it would be noteworthy to repeat the 
slice cultures at earlier ages to further examine if the background of the embryos or 
the age of the slices influenced their behaviour in vitro. In contrast to control embryos 
at E13.5, slices from mutant brains exhibited abnormal growth in culture. Additional 
tissue was present inside the ventricles and the pRb expression pattern was 
disrupted, with pRb+ cells forming rosette-like rings of cells. Fotaki et al. (2006) 
described neural progenitors forming rosettes in the cortex of Gli3Xt/Xt embryos, and 
so perhaps the slice culture conditions here attenuated that behaviour of Gli3 deficient 
progenitors.  
Altogether, I am unable to say if the up-regulation of Cdk6 in the Gli3Xt/Pdn cortex 
contributed to the reduction in G1-phase length. Therefore, additional experiments 
are required to further investigate this link. G1-phase lengthening has subsequently 
been shown to rescue delayed neurogenesis in Emx1Cre;Gli3fl/fl embryos after 
administration of palbociclib to pregnant dams 24 hrs before embryo harvesting 
(Hasenpusch-Theil et al., 2018). In these mutants, Cdk6 was also up-regulated and 
there was a reduction in G1-phase length. Additionally, inhibition of Cdk6 could be 
achieved by electroporation of RNAi or a dominant-negative construct against Cdk6 
(Mi et al., 2013). Overexpression of Cdk6/cyclin D1 via electroporation of expression 
plasmids into control embryos to recapitulate the mutant phenotype may also prove 
attractive (Lange et al., 2009; Pilaz et al., 2009), although as this would not be due to 
alterations in Gli3 expression it may not provide insight into the role of Gli3.  
As well as a reduction in G1-phase length, which many have linked to an increased 
capacity for proliferative division, I recorded a reduction in S-phase length, which has 
been linked to an increased capacity for differentiative division. The microarray 
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analyses did not identify any obvious candidate genes dysregulated in the Gli3Xt/Pdn 
dorsal telencephalon which may have accounted for the alteration in S-phase length 
and which could be further examined. Instead, I hypothesised that the reduction in S-
phase length which I measured at E11.5 and E12.5 in the mutant cortex, particularly 
in apical progenitors, may have been due to an increase in differentiative divisions. At 
the population level, a larger proportion of progenitors undergoing differentiative 
division and exhibiting a shorter S-phase would be measured as a reduction in S-
phase length using the BrdU/IdU double labelling method. Therefore, I examined 
Tis21 expression as a measure of the proportion of progenitors undergoing 
differentiative division.  
In the apical progenitor population, at E11.5 there was a decrease in the proportion 
of differentiative divisions in the mutant compared to control in the medial cortex, with 
a tendency towards a decrease in the lateral cortex. There was a potential outlier in 
the lateral mutant data here, and additional embryos should be examined to determine 
if this was an outlier or if it reflected the mutant population. Here, S-phase length was 
decreased in the lateral cortex but unchanged in the medial. The reduction in S-phase 
length in the lateral cortex could not be accounted for by an alteration in the proportion 
of proliferative to differentiative divisions, whilst the decrease in differentiative 
divisions medially did not lead to an alteration in S-phase length. Conversely, in the 
E12.5 apical progenitor population both laterally and medially there was an increase 
in the proportion of differentiative divisions, whilst S-phase length was decreased in 
both locations. Consequently, the imbalance in differentiative to proliferative divisions 
here may account for the decreases recorded in S-phase length at E12.5 but not 
E11.5.  
In basal progenitors, there was an increase in the proportion of differentiative divisions 
in the mutant lateral E11.5 population, whilst the medial population was unchanged. 
As in the apical progenitor population, S-phase length was decreased in the mutant 
laterally, whilst I was unable to measure it medially. Again, the alteration in 
differentiative divisions could not account for the reduction in S-phase length laterally. 
At E12.5, there was no change in the proportion of differentiative to proliferative 
divisions in the mutant laterally or medially, and S-phase length was unaltered in the 
lateral cortex.  
Overall, a disruption in differentiative to proliferative divisions in the mutant could not 
fully account for the reductions measured in S-phase length. I therefore propose that 
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Gli3 could regulate S-phase length. The microarray was performed on E10.5 dorsal 
telencephalic tissue, and so it is possible that genes regulating S-phase length only 
became dysregulated at E11.5 or E12.5. Further, the microarray may not have been 
sensitive enough to identify genes which were not dysregulated at a high level. The 
analysis was also performed on whole dorsal telencephalons pooled together, and so 
examination of the cortex alone would be interesting. Other techniques, such as 
RNAseq, could be performed on the Gli3Xt/Pdn cortex at E11.5 and E12.5 to identify 
other potential gene candidates regulating the cell cycle. Indeed, RNAseq was 
performed on the Emx1Cre;Gli3fl/fl dorsal telencephalic midline specifically 
(Hasenpusch-Theil et al., 2018). At E11.5, when S-phase length was also reduced in 
this mutant in the midline, Cyclin A2 was up-regulated and p21Cip1, p27Kip1 and p57Kip2 
were down-regulated. Cyclin A2 is responsible for progressing a cell through S-phase, 
whilst p21Cip1, p27Kip1 and p57Kip2 are cyclin inhibitors which seek to stall progression 
through the cell cycle. Therefore, an imbalance in the ratio of cyclins to cyclin inhibitors 
may have tipped towards increased progression through S-phase in this mutant. 
Possibly, the same situation arises in the Gli3Xt/Pdn mutant, yet the microarray was not 
sensitive enough or performed at too early an age to identify these changes.  
 
 
6.4 Synopsis and concluding remarks  
 
The aim of this thesis was to further understand the role of Gli3 in early dorsal 
telencephalon development. Through immunofluorescent analyses, I revealed that in 
the cortex Gli3 protein was expressed primarily in apical progenitors between E11.5 
and E12.5, and the intensity of that staining was reduced in the Gli3Xt/Pdn mutant. In 
this mutant the proportions of apical and basal progenitors and early-born neurons 
were altered at E11.5 and E12.5, indicating a delay in neurogenesis. As in the limb 
bud Gli3 had previously been linked to cell cycle regulation, a factor which can also 
alter the production of progenitors and neurons, I examined the cell cycle in the 
Gli3Xt/Pdn cortex. In general, the total cell cycle and particularly G1- and S-phase length 
were reduced in the mutant at both E11.5 and E12.5, indicating Gli3 also regulates 
the cell cycle of cortical progenitors. Through examination of Gli3Xt/Pdn microarray 
expression data, I identified Cdk6 as a potential target of Gli3 for the regulation of G1-
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phase in the cortex. However, I was unable to test if reducing Cdk6 levels in the 
Gli3Xt/Pdn cortex would ameliorate the delay in neurogenesis. Finally, I was also unable 
to identify any candidate genes which may have mediated the reduction in S-phase 
length. Instead, I examined the ratio of differentiative to proliferative divisions in the 
mutant to test whether the reduction in S-phase was due to an alteration in this ratio. 
Potentially, this could have explained the reduction recorded at E12.5.  
Whilst there was little Gli3 protein expression in basal progenitors, I recorded 
alterations in the proportion of basal progenitors in the mutant at E11.5 and E12.5, 
alongside a reduction in S-phase and total cell length at E11.5 and alterations in 
hyperphosphorylated pRb expression at E11.5 and E12.5. Finally, the proportion of 
basal progenitors undergoing differentiative division was increased in the mutant 
compared to control at E11.5. Taken together, these results suggest Gli3 likely 
regulates basal progenitor dynamics non-cell autonomously. A likely candidate 
through which these features became dysregulated in the Gli3Xt/Pdn mutant was 
alterations in signalling, which requires much further exploration in the context of basal 
progenitors in this mutant.  
On the other hand, as Gli3 was primarily expressed in apical progenitors and the 
biggest changes in the features examined occurred within this population, it was 
easier to hypothesise about these cells. G1-phase length was decreased in these 
cells at E11.5 and Cdk6, described previously as a direct Gli3 target gene (Lopez-
Rios et al., 2012; Vokes et al., 2008), was identified as up-regulated 1.59-fold in the 
E10.5 Gli3Xt/Pdn mutant dorsal telencephalon compared to control, alongside an 
increase in pRb hyperphosphorylation in the E11.5 mutant cortex. This therefore 
became a good starting point for examining cell cycle regulation by Gli3 in the cortex. 
I formulated the hypothesis that a decrease in Gli3 expression would lead to an 
increase in Cdk6 expression, resulting in increased pRb hyperphosphorylation. This 
would lead to a de-repression of the E2F family of transcription factors, allowing for 
transcription of G1- to S-phase progressing genes. Whilst this hypothesis may well 
reflect the situation in the lateral E11.5 cortex, it did not fit the medial E11.5 cortex, 
where pRb expression was not significantly increased in the mutant, or for the lateral 
and medial E12.5 cortex, where again pRb expression was not significantly increased 
and G1-phase length was not significantly reduced in the medial cortex. Therefore, 
considering together all of the analyses performed in this study, I would now suggest 
that Gli3 exhibits dynamic temporal and spatial regulation over cortical development. 
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One reason behind this may be due to the uneven progression of neurogenesis 
across the cortex, progressing rostro-laterally to caudo-medially, but again differences 
in signalling across the cortex also likely play a major role.  
Overall, this thesis has confirmed the existence of a delay in neurogenesis in the 
Gli3Xt/Pdn cortex between E11.5 and E12.5. It is plausible that alterations in the cell 
cycle due to the reduction in Gli3 partially underlie this defect. However, this thesis 
has also highlighted the complexity of the situation in such a mutant, where many 
factors are altered by the constitutive reduction of a transcription factor known to play 
key roles in dorsal telencephalon development. In the future, identification of other 
Gli3 gene targets will help in understanding the roles played by Gli3 in cell cycle 
regulation, as well as in early cortical neurogenesis.   
 
 
6.5 Overall model  
 
In the E11.5 lateral cortex, the proportion of Gli3Xt/Pdn apical progenitors was increased 
compared to control, alongside reduced proportions of basal progenitors and neurons. 
G1- and S-phase of the cell cycle were also reduced in Gli3Xt/Pdn apical progenitors, 
and so the increased proportion of apical progenitors combined with the obvious 
expression of Gli3 protein in those cells (figure 6.1 A, B), may signify Gli3 acting 
directly upon apical progenitors at E11.5 to cause them to differentiate and exit the 
cell cycle. However, there was very little Gli3 protein expressed in basal progenitors 
at this time yet S-phase length was reduced in the mutant compared to control (figure 
6.1 A, B). In these cells, it was likely that Gli3 was acting indirectly to influence S-
phase length, and whilst a reduction in S-phase length corresponds with cell cycle 
exit, I would propose that the reduced basal progenitor proportion likely reflected a 
reduced production of basal progenitors from apical progenitors.  
In the E11.5 medial cortex, Gli3 was expressed at a lower level compared to laterally 
in both control and Gli3Xt/Pdn embryos (figure 6.1 C, D). In the mutant, I did not measure 
any difference in apical and basal progenitor and neuronal proportions, or cell cycle 
measurements, compared to control. It is therefore likely that progenitor cell cycle and 
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proliferation/differentiation were regulated by factors other than Gli3, which is why the 
reduction in Gli3 protein in Gli3Xt/Pdn embryos had little effect.  
Taken together, the E11.5 high-lateral to low-medial gradient in Gli3 expression may 
explain why I measured changes in the progenitor and neuronal proportions and the 
cell cycle in the lateral Gli3Xt/Pdn cortex compared to control, but did not measure any 
changes medially, where Gli3 would normally be expressed at a low level (figure 6.1 
A-D). Gli3 expression was largely confined to the apical progenitor population at this 
age, and so I propose any changes measured in the basal progenitor and neuronal 
populations were due to indirect effects upon the apical progenitor population.  
By E12.5, there appeared to be more Gli3 expression in basal progenitors in control 
and mutant embryos than at E11.5, and the high-lateral to low-medial gradient was 
less apparent (figure 6.1 E-H). In the lateral cortex, the proportion of apical progenitors 
was unaltered in mutant compared to control, whilst there were larger proportions of 
both basal progenitors and neurons in the mutant. Further, G1-, S-, and M-phase were 
shorter in mutant apical progenitors, whilst M-phase was longer in mutant basal 
progenitors (figure 6.1 E, F). As there was a larger proportion of apical progenitors in 
the mutant at E11.5, and no difference between control and mutant at E12.5, the 
apical progenitor population effectively decreased in the mutant between the two time 
points and there was an increase in cell cycle exit and progenitor differentiation. This 
links to the increased basal progenitor and neuronal proportions. The reduction in S-
phase length would correspond with an increase in apical progenitor differentiation, 
yet the reduction in G1-phase does not, so in lateral apical progenitors perhaps S-
phase length is more important than G1-phase length at E12.5, in contrast to E11.5.  
The reduced gradient of Gli3 from lateral to medial cortex at E12.5 could explain why 
I measured differences between the progenitor and neuronal proportions in control 
and mutant at E12.5 but not E11.5. In the E12.5 medial cortex, the proportion of apical 
progenitors was reduced in Gli3Xt/Pdn embryos compared to control, whilst the 
proportions of basal progenitors and neurons were increased. Again, S- and M-phase 
were shorter in the mutant compared to control in apical progenitors (figure 6.1 G, H). 
As neurogenesis progresses laterally to medially, the decrease in Gli3 gradient may 
act as a mechanism to allow the medial cortex to catch up with the lateral cortex in 
neurogenesis. Gli3 expression may be switched on in basal progenitors at E12.5 to 
allow them to exit the cell cycle and differentiate into neurons.  
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Altogether, I propose that under wild type conditions in the E11.5 lateral cortex Gli3 is 
highly expressed in apical progenitors. Here, it acts to prolong G1-phase of the cell 
cycle, inducing apical progenitor differentiation into basal progenitors and neurons. 
This prevents the apical progenitor population from over proliferating and resulting in 
an increased progenitor population, which would favour an increased production of 
lower layer neurons, as is seen in the Gli3Xt/Pdn embryo (Friedrichs et al., 2008). In the 
medial cortex, Gli3 is lowly expressed in comparison with the lateral cortex, and does 
not appear to impact as greatly upon the cell cycle and so progenitor proliferation and 
differentiation. By E12.5, the gradient in Gli3 expression between lateral and medial 
cortex is reduced, and basal progenitors as well as apical progenitors now express 
Gli3. The role of Gli3 in the lateral and medial cortex is now similar, acting to lengthen 
the cell cycle in apical progenitors. The switching on of Gli3 expression in basal 
progenitors at this time point might act as a mechanism to induce basal progenitors 
to undergo differentiation into neurons. In summary, the alterations in progenitor and 
neuronal proportions combined with the alterations in cell cycle highlight the 
pleiotropic role of Gli3 in cortical development, allowing different regions of the cortex 




Figure 6.1: Schematic summarising how differing Gli3 levels across control and 
Gli3Xt/Pdn neocortex impact upon cortical layer proportions and cell cycle phase 
lengths. A-D. Representations of E11.5 control (A, C) and Gli3Xt/Pdn (B, D) lateral 
boxes (A, B) and medial boxes (C, D) in which cell counts were performed. The red 
gradient across boxes shows how the relative level of Gli3 expression differed, 
although it is important to note that the colour intensity does not represent a 
quantitative measurement of Gli3 expression. In the control cortex, Gli3 expression 
was highest laterally in the ventricular zone with little expression in the subventricular 
zone, and reduced expression in the medial cortex. In the Gli3Xt/Pdn cortex, Gli3 
expression was reduced compared to control. In the lateral cortex, there was a 1.16-
fold increase in the proportion of apical progenitors in the ventricular zone of the 
mutant, concomitant with 1.36- and 1.98-fold decreases in the proportion of basal 
progenitors (subventricular zone) and early-born neurons (cortical plate). This was in 
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alignment with decreases in the cell cycle in both apical and basal progenitors. In the 
medial cortex, the proportions of apical and basal progenitors and early-born neurons 
were unaltered in the mutant compared to control, as was the apical cell cycle. E-H. 
Representations of E12.5 control (E, G) and Gli3Xt/Pdn (F, H) lateral boxes (E, F) and 
medial boxes (G, H) in which cell counts were performed. Gli3 expression was highest 
in the lateral control cortex in the ventricular zone with some expression in the 
subventricular zone. However, the Gli3 gradient was not as profound between lateral 
and medial at E12.5 as at E11.5. Gli3 expression was also reduced in the Gli3Xt/Pdn 
cortex compared to control, and although the high-lateral to low-medial gradient was 
maintained, is was not as apparent as at E11.5. Laterally, the proportion of apical 
progenitors was unaltered between control and mutant whilst there were 1.47- and 
1.16-fold increases in the proportions of basal progenitors and early-born neurons. 
Here, there was a shortening of the apical progenitor cell cycle. Medially the 
proportion of apical progenitors was reduced 1.23-fold in the mutant, whilst the 
proportions of basal progenitors and early-born neurons were increased 2.08- and 
1.52-fold, respectively. The apical progenitor cell cycle was reduced in the mutant. 
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